Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.

Drug Formulary

The drug library provides access to information on over 100 cancer drugs available for use in Canada.

 Find more safety information in the supplementary patient handouts:

Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.

Suggested Pages
    Suggested Searches

      Filters

      Filters

      Cancer Type

      Breast
      Genitourinary
      Prostate
      Bladder Urothelial
      Renal cell Kidney
      Testis
      Penile
      Endocrine
      Adrenal
      Pancreatic Neuroendocrine
      Thyroid
      Thymoma
      Neuroendocrine
      Parathyroid
      Hematologic
      Lymphoma - Non-Hodgkin's Low Grade
      Leukemia - Chronic Lymphocytic (CLL)
      Lymphoma - T-cell
      Rare Diseases
      Myeloproliferative Neoplasms (MPNs)
      Leukemia - Acute Promyelocytic (APL)
      Leukemia - Chronic Myeloid (CML)
      Myelodysplastic Syndrome (MDS)
      Leukemia - Acute Myeloid (AML)
      Lymphoma - Non-Hodgkin's High Grade
      Lymphoma - Non-Hodgkin's Intermediate Grade
      Lymphoma - Hodgkin
      Leukemia - Acute Lymphoblastic (ALL)
      Multiple Myeloma
      Amyloidosis
      Leukemia - Hairy Cell
      Lung
      Non-Small Cell
      Small Cell
      Mesothelioma (Pleural)
      Neuroendocrine (Lung)
      Skin
      Melanoma
      Merkel Cell
      Squamous Cell
      Basal Cell
      Gynecologic
      Endometrial
      Ovary
      Cervix
      Germ Cell
      Vulva
      Uterine Sarcoma
      Gestational Trophoblastic Disease
      Vagina
      Gastrointestinal
      Hepatobiliary Liver Bile Duct
      Colorectal
      Small bowel and appendix
      Esophagus
      Gastric Stomach
      Rectal
      Pancreas
      Neuroendocrine (GI)
      Anus
      Mesothelioma (Peritoneal)
      Gastrointestinal Stromal Tumours
      Central Nervous System
      Unknown Primary
      Head and Neck
      Squamous Cell
      Nasopharynx
      Salivary Gland
      Larynx
      Pharynx
      Paranasal Sinus
      Oral
      Sarcoma
      Uterine
      Osteogenic Bone
      Soft Tissue
      Ewing's
      Wilm's Tumour
      Giant Cell Tumour
      GIST
      Ewing's and Soft Tissue
      Desmoid Tumour
      Kaposi's Sarcoma
      Kaposi's Sarcoma
      Mesothelioma
      Ocular Eye

      nid

      Suggested Pages
        Suggested Searches
          231
          110
          232
          111
          233
          112
          234
          114
          236
          115
          237
          116
          117
          118
          239
          119
          10
          11
          12
          13
          14
          15
          16
          17
          18
          19
          241
          120
          242
          121
          1
          243
          122
          123
          3
          245
          124
          4
          246
          125
          5
          126
          6
          127
          248
          7
          249
          129
          9
          20
          21
          22
          23
          24
          25
          26
          27
          28
          29
          250
          130
          131
          253
          132
          133
          134
          256
          135
          136
          258
          137
          138
          139
          30
          31
          32
          33
          34
          35
          36
          37
          38
          39
          260
          140
          141
          263
          142
          143
          265
          144
          145
          146
          147
          269
          148
          149
          40
          41
          42
          43
          44
          45
          46
          48
          49
          270
          271
          150
          151
          152
          274
          153
          275
          154
          276
          155
          156
          278
          157
          279
          158
          50
          51
          55
          56
          57
          58
          59
          280
          281
          160
          282
          161
          284
          285
          164
          165
          166
          167
          289
          169
          60
          61
          62
          63
          64
          65
          66
          67
          68
          69
          290
          170
          171
          172
          293
          173
          294
          295
          174
          175
          296
          176
          177
          299
          178
          179
          70
          71
          74
          75
          76
          77
          78
          79
          180
          183
          184
          187
          188
          80
          81
          82
          83
          84
          85
          86
          87
          88
          191
          193
          194
          195
          196
          198
          199
          90
          91
          93
          94
          95
          96
          97
          98
          99
          201
          202
          203
          204
          205
          206
          208
          209
          210
          211
          212
          215
          216
          217
          218
          220
          101
          223
          102
          103
          224
          225
          104
          226
          227
          106
          228
          107
          108
          Showing 10 of 235 results

          bendamustine
          Jul 2026
          Trade Name:
          Treanda®
          Cancer Type:
          Hematologic, Leukemia - Chronic Lymphocytic (CLL), Lymphoma - Non-Hodgkin's Low Grade, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Hodgkin
          nid:
          16
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          bevacizumab
          Jul 2026
          Cancer Type:
          Central Nervous System, Lung, Non-Small Cell, Gastrointestinal, Colorectal, Small bowel and appendix, Gynecologic, Ovary, Cervix, Mesothelioma (Pleural), Hepatobiliary Liver Bile Duct
          nid:
          17
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          bleomycin
          Jul 2026
          Cancer Type:
          Genitourinary, Testis, Hematologic, Lymphoma - Hodgkin, Gynecologic, Germ Cell, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade
          nid:
          19
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          capecitabine
          Jul 2026
          Trade Name:
          Xeloda®
          Cancer Type:
          Gastrointestinal, Esophagus, Gastric Stomach, Colorectal, Small bowel and appendix, Hepatobiliary Liver Bile Duct, Breast, Rectal, Pancreas, Neuroendocrine (GI), Genitourinary, Renal cell Kidney, Unknown Primary, Anus, Endocrine, Adrenal, Head and Neck, Penile
          nid:
          28
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          CARBOplatin
          Jul 2026
          Cancer Type:
          Gastrointestinal, Gastric Stomach, Esophagus, Lung, Small Cell, Head and Neck, Central Nervous System, Colorectal, Hepatobiliary Liver Bile Duct, Pancreas, Genitourinary, Prostate, Bladder Urothelial, Unknown Primary, Neuroendocrine (GI), Gynecologic, Ovary, Breast, Testis, Vulva, Uterine Sarcoma, Sarcoma, Uterine, Endometrial, Non-Small Cell, Skin, Melanoma, Mesothelioma (Pleural), Thymoma, Merkel Cell, Squamous Cell, Hematologic, Lymphoma - Hodgkin, Cervix, Anus, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade, Endocrine, Thyroid, Osteogenic Bone, Squamous Cell, Mesothelioma (Peritoneal), Nasopharynx
          nid:
          25
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          chlorambucil
          Jul 2026
          Trade Name:
          Leukeran®
          Cancer Type:
          Hematologic, Lymphoma - Non-Hodgkin's Low Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Leukemia - Chronic Lymphocytic (CLL), Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Hodgkin
          nid:
          32
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          CISplatin
          Jul 2026
          Cancer Type:
          Gynecologic, Germ Cell, Gastrointestinal, Gastric Stomach, Esophagus, Head and Neck, Hepatobiliary Liver Bile Duct, Ovary, Gestational Trophoblastic Disease, Genitourinary, Bladder Urothelial, Testis, Lung, Thymoma, Cervix, Uterine Sarcoma, Sarcoma, Uterine, Endocrine, Adrenal, Neuroendocrine (GI), Small Cell, Central Nervous System, Endometrial, Colorectal, Pancreas, Prostate, Breast, Unknown Primary, Non-Small Cell, Mesothelioma (Pleural), Hematologic, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Hodgkin, Osteogenic Bone, Vulva, Penile, Skin, Squamous Cell, Soft Tissue, Anus, Lymphoma - T-cell, Lymphoma - Non-Hodgkin's Low Grade, Merkel Cell, Nasopharynx, Squamous Cell, Mesothelioma (Peritoneal)
          nid:
          26
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          cyclophosphamide
          NEW Jul 2026
          Trade Name:
          Procytox®
          Cancer Type:
          Breast, Sarcoma, Ewing's, Soft Tissue, Gynecologic, Gestational Trophoblastic Disease, Hematologic, Leukemia - Chronic Lymphocytic (CLL), Lung, Thymoma, Lymphoma - Non-Hodgkin's Low Grade, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Multiple Myeloma, Lymphoma - Hodgkin, Small Cell, Gastrointestinal, Colorectal, Cervix, Endometrial, Ovary, Gastric Stomach, Esophagus, Hepatobiliary Liver Bile Duct, Pancreas, Genitourinary, Prostate, Bladder Urothelial, Endocrine, Adrenal, Lymphoma - T-cell, Head and Neck, Leukemia - Acute Lymphoblastic (ALL), Wilm's Tumour, Neuroendocrine (GI), Rare Diseases, Amyloidosis
          nid:
          36
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          cytarabine
          Jul 2026
          Trade Name:
          Cytosar®
          Cancer Type:
          Hematologic, Lymphoma - Hodgkin, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade, Leukemia - Acute Lymphoblastic (ALL), Leukemia - Acute Myeloid (AML), Lymphoma - Non-Hodgkin's Low Grade, Rare Diseases, Multiple Myeloma
          nid:
          38
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          dacarbazine
          Jul 2026
          Cancer Type:
          Skin, Melanoma, Sarcoma, Soft Tissue, Hematologic, Lymphoma - Hodgkin, Endocrine, Adrenal, Gastrointestinal, Neuroendocrine (GI), Lung, Neuroendocrine (Lung)
          nid:
          43
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          denosumab
          Jul 2026
          Trade Name:
          Xgeva®; Wyost™; Osenvelt™
          Cancer Type:
          Genitourinary, Prostate, Sarcoma, Giant Cell Tumour, Breast, Lung, Non-Small Cell, Unknown Primary, Mesothelioma (Pleural), Thymoma, Renal cell Kidney, Small Cell, Hematologic, Multiple Myeloma
          nid:
          49
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          DOCEtaxel
          Jul 2026
          Trade Name:
          Taxotere®
          Cancer Type:
          Breast, Genitourinary, Prostate, Head and Neck, Sarcoma, Soft Tissue, Uterine, Gynecologic, Uterine Sarcoma, Lung, Non-Small Cell, Gastrointestinal, Gastric Stomach, Esophagus, Bladder Urothelial, Ovary, Anus, Salivary Gland, Squamous Cell
          nid:
          40
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          DOXOrubicin
          Jul 2026
          Trade Name:
          Adriamycin®
          Cancer Type:
          Genitourinary, Bladder Urothelial, Breast, Lung, Thymoma, Gynecologic, Uterine Sarcoma, Sarcoma, Uterine, Endocrine, Adrenal, Endometrial, Soft Tissue, Ewing's, Hematologic, Multiple Myeloma, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Hodgkin, Lymphoma - Non-Hodgkin's Low Grade, Osteogenic Bone, Small Cell, Gastrointestinal, Colorectal, Cervix, Ovary, Gastric Stomach, Esophagus, Hepatobiliary Liver Bile Duct, Pancreas, Prostate, Renal cell Kidney, Lymphoma - T-cell, Head and Neck, Leukemia - Acute Lymphoblastic (ALL), Wilm's Tumour, Unknown Primary, Thyroid, Neuroendocrine (GI), Rare Diseases
          nid:
          41
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          durvalumab
          Jul 2026
          Trade Name:
          Imfinzi®
          Cancer Type:
          Genitourinary, Bladder Urothelial, Lung, Non-Small Cell, Small Cell, Gastrointestinal, Hepatobiliary Liver Bile Duct, Gynecologic, Endometrial, Gastric Stomach, Esophagus
          nid:
          196
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          entrectinib
          Jul 2026
          Trade Name:
          Rozlytrek®
          Cancer Type:
          Lung, Non-Small Cell, Breast, Endocrine, Adrenal, Neuroendocrine, Thymoma, Thyroid, Pancreatic Neuroendocrine, Parathyroid, Gastrointestinal, Anus, Colorectal, Esophagus, Gastric Stomach, Hepatobiliary Liver Bile Duct, Pancreas, Rectal, Small bowel and appendix, Neuroendocrine (GI), Gastrointestinal Stromal Tumours, Mesothelioma (Peritoneal), Genitourinary, Bladder Urothelial, Penile, Prostate, Renal cell Kidney, Testis, Gynecologic, Cervix, Endometrial, Gestational Trophoblastic Disease, Ovary, Uterine Sarcoma, Vulva, Germ Cell, Vagina, Head and Neck, Larynx, Pharynx, Nasopharynx, Paranasal Sinus, Oral, Salivary Gland, Squamous Cell, Mesothelioma (Pleural), Small Cell, Neuroendocrine (Lung), Skin, Basal Cell, Merkel Cell, Squamous Cell, Melanoma, Sarcoma, Ewing's, GIST, Osteogenic Bone, Soft Tissue, Ewing's and Soft Tissue, Uterine, Desmoid Tumour, Wilm's Tumour, Giant Cell Tumour, Kaposi's Sarcoma, Unknown Primary
          nid:
          260
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          EPIrubicin
          Jul 2026
          Cancer Type:
          Gastrointestinal, Gastric Stomach, Esophagus, Breast, Sarcoma, Soft Tissue, Hematologic, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade, Unknown Primary, Genitourinary, Prostate, Neuroendocrine (GI), Lung, Neuroendocrine (Lung)
          nid:
          55
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          etoposide
          Jul 2026
          Trade Name:
          Vepesid®
          Cancer Type:
          Gynecologic, Germ Cell, Gastrointestinal, Gastric Stomach, Esophagus, Gestational Trophoblastic Disease, Central Nervous System, Ovary, Genitourinary, Testis, Endocrine, Adrenal, Neuroendocrine (GI), Lung, Thymoma, Small Cell, Head and Neck, Cervix, Endometrial, Colorectal, Hepatobiliary Liver Bile Duct, Pancreas, Prostate, Bladder Urothelial, Breast, Unknown Primary, Non-Small Cell, Sarcoma, Ewing's, Soft Tissue, Hematologic, Lymphoma - Hodgkin, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade, Skin, Merkel Cell, Lymphoma - T-cell, Leukemia - Acute Myeloid (AML), Wilm's Tumour, Leukemia - Acute Lymphoblastic (ALL), Lymphoma - Non-Hodgkin's Low Grade
          nid:
          61
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          filgrastim
          Jul 2026
          Trade Name:
          Neupogen®, Grastofil®, Nivestym®, Nypozi®, Filra™
          Cancer Type:
          Sarcoma, Soft Tissue, Genitourinary, Bladder Urothelial, Breast, Hematologic, Lymphoma - Hodgkin, Testis, Renal cell Kidney, Leukemia - Acute Myeloid (AML), Leukemia - Acute Lymphoblastic (ALL)
          nid:
          64
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          fludarabine
          Jul 2026
          Trade Name:
          Fludara®
          Cancer Type:
          Hematologic, Leukemia - Chronic Lymphocytic (CLL), Lymphoma - Non-Hodgkin's Low Grade, Leukemia - Acute Myeloid (AML), Leukemia - Acute Lymphoblastic (ALL)
          nid:
          65
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          fluorouracil
          Jul 2026
          Cancer Type:
          Gastrointestinal, Gastric Stomach, Esophagus, Head and Neck, Colorectal, Small bowel and appendix, Pancreas, Anus, Breast, Gynecologic, Vulva, Genitourinary, Penile, Bladder Urothelial, Skin, Squamous Cell, Hepatobiliary Liver Bile Duct, Renal cell Kidney, Unknown Primary, Prostate, Neuroendocrine (GI), Lung, Neuroendocrine (Lung), Ovary, Rectal, Squamous Cell
          nid:
          66
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          gemcitabine
          Jul 2026
          Trade Name:
          Gemzar®
          Cancer Type:
          Gastrointestinal, Hepatobiliary Liver Bile Duct, Gynecologic, Ovary, Lung, Non-Small Cell, Head and Neck, Pancreas, Genitourinary, Bladder Urothelial, Sarcoma, Soft Tissue, Uterine, Uterine Sarcoma, Breast, Hematologic, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Hodgkin, Testis, Renal cell Kidney, Unknown Primary, Cervix, Endocrine, Adrenal, Lymphoma - Non-Hodgkin's Low Grade, Mesothelioma (Pleural), Germ Cell, Lymphoma - T-cell, Nasopharynx, Rare Diseases, Thyroid
          nid:
          70
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          hydroxyurea
          Jul 2026
          Trade Name:
          Hydrea®
          Cancer Type:
          Hematologic, Leukemia - Chronic Myeloid (CML), Leukemia - Acute Lymphoblastic (ALL), Leukemia - Acute Myeloid (AML), Myeloproliferative Neoplasms (MPNs)
          nid:
          74
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          iBRUtinib
          Jul 2026
          Trade Name:
          Imbruvica®
          Cancer Type:
          Hematologic, Lymphoma - Non-Hodgkin's Low Grade, Leukemia - Chronic Lymphocytic (CLL), Lymphoma - Non-Hodgkin's High Grade
          nid:
          77
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          ifosfamide
          Jul 2026
          Trade Name:
          Ifex®
          Cancer Type:
          Gynecologic, Germ Cell, Sarcoma, Soft Tissue, Ewing's, Uterine Sarcoma, Uterine, Osteogenic Bone, Genitourinary, Testis, Hematologic, Lymphoma - Hodgkin, Lymphoma - T-cell, Penile, Endometrial, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade
          nid:
          78
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          iMAtinib
          Jul 2026
          Trade Name:
          Gleevec®
          Cancer Type:
          Sarcoma, GIST, Gastrointestinal, Gastrointestinal Stromal Tumours, Hematologic, Leukemia - Chronic Myeloid (CML), Soft Tissue, Leukemia - Acute Lymphoblastic (ALL)
          nid:
          79
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          ipilimumab
          Jul 2026
          Trade Name:
          Yervoy®
          Cancer Type:
          Skin, Melanoma, Genitourinary, Renal cell Kidney, Gastrointestinal, Colorectal, Lung, Non-Small Cell, Mesothelioma (Pleural), Hepatobiliary Liver Bile Duct
          nid:
          81
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          irinotecan
          Jul 2026
          Trade Name:
          Camptosar®
          Cancer Type:
          Gastrointestinal, Colorectal, Small bowel and appendix, Pancreas, Gastric Stomach, Esophagus, Sarcoma, Ewing's, Hepatobiliary Liver Bile Duct, Lung, Small Cell, Breast, Genitourinary, Bladder Urothelial, Prostate, Gynecologic, Cervix, Endometrial, Ovary, Head and Neck, Central Nervous System, Neuroendocrine (GI), Rectal
          nid:
          82
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          larotrectinib
          Jul 2026
          Trade Name:
          Vitrakvi®
          Cancer Type:
          Breast, Central Nervous System, Endocrine, Adrenal, Neuroendocrine, Thymoma, Thyroid, Pancreatic Neuroendocrine, Parathyroid, Gastrointestinal, Anus, Colorectal, Esophagus, Gastric Stomach, Hepatobiliary Liver Bile Duct, Pancreas, Rectal, Small bowel and appendix, Neuroendocrine (GI), Gastrointestinal Stromal Tumours, Mesothelioma (Peritoneal), Genitourinary, Bladder Urothelial, Penile, Prostate, Renal cell Kidney, Testis, Gynecologic, Cervix, Endometrial, Gestational Trophoblastic Disease, Ovary, Uterine Sarcoma, Vulva, Germ Cell, Vagina, Head and Neck, Larynx, Pharynx, Nasopharynx, Paranasal Sinus, Oral, Salivary Gland, Squamous Cell, Kaposi's Sarcoma, Lung, Mesothelioma (Pleural), Non-Small Cell, Small Cell, Neuroendocrine (Lung), Skin, Basal Cell, Merkel Cell, Squamous Cell, Melanoma, Sarcoma, Ewing's, GIST, Osteogenic Bone, Soft Tissue, Ewing's and Soft Tissue, Uterine, Desmoid Tumour, Wilm's Tumour, Giant Cell Tumour, Kaposi's Sarcoma, Unknown Primary
          nid:
          249
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          lenalidomide
          Jul 2026
          Trade Name:
          Revlimid®
          Cancer Type:
          Hematologic, Myelodysplastic Syndrome (MDS), Multiple Myeloma, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's Low Grade
          nid:
          85
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          lenvatinib
          Jul 2026
          Trade Name:
          Lenvima®
          Cancer Type:
          Endocrine, Thyroid, Genitourinary, Renal cell Kidney, Gastrointestinal, Hepatobiliary Liver Bile Duct, Gynecologic, Endometrial
          nid:
          175
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          leucovorin
          Jul 2026
          Trade Name:
          Lederle Leucovorin®
          Cancer Type:
          Gastrointestinal, Gastric Stomach, Esophagus, Gynecologic, Gestational Trophoblastic Disease, Colorectal, Small bowel and appendix, Pancreas, Hepatobiliary Liver Bile Duct, Hematologic, Leukemia - Acute Lymphoblastic (ALL), Lymphoma - Non-Hodgkin's High Grade, Genitourinary, Bladder Urothelial, Ovary, Rectal, Neuroendocrine (GI), Lymphoma - T-cell
          nid:
          87
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          melphalan
          Jul 2026
          Trade Name:
          Alkeran®
          Cancer Type:
          Hematologic, Multiple Myeloma, Lymphoma - Hodgkin, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade
          nid:
          96
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          mesna
          Jul 2026
          Trade Name:
          Uromitexan®
          Cancer Type:
          Gynecologic, Germ Cell, Sarcoma, Soft Tissue, Ewing's, Uterine Sarcoma, Uterine, Osteogenic Bone, Genitourinary, Testis, Hematologic, Lymphoma - Hodgkin, Lymphoma - T-cell, Penile, Endometrial, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade, Leukemia - Acute Lymphoblastic (ALL)
          nid:
          98
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          methotrexate
          Jul 2026
          Cancer Type:
          Gynecologic, Gestational Trophoblastic Disease, Genitourinary, Bladder Urothelial, Head and Neck, Sarcoma, Desmoid Tumour, Breast, Hematologic, Lymphoma - Non-Hodgkin's Low Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade, Leukemia - Acute Lymphoblastic (ALL), Leukemia - Acute Myeloid (AML), Leukemia - Acute Promyelocytic (APL), Multiple Myeloma, Lymphoma - T-cell
          nid:
          99
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          mitoXANTRONE
          Jul 2026
          Trade Name:
          Novantrone®
          Cancer Type:
          Genitourinary, Prostate, Hematologic, Leukemia - Chronic Lymphocytic (CLL), Lymphoma - Non-Hodgkin's Low Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade, Leukemia - Acute Myeloid (AML), Leukemia - Acute Lymphoblastic (ALL)
          nid:
          101
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          nab-PACLitaxel
          Jul 2026
          Trade Name:
          Abraxane®
          Cancer Type:
          Breast, Skin, Melanoma, Genitourinary, Bladder Urothelial, Gastrointestinal, Pancreas, Gynecologic, Cervix, Endometrial, Ovary, Lung, Non-Small Cell, Gastric Stomach, Esophagus
          nid:
          104
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          nivolumab
          Jul 2026
          Trade Name:
          Opdivo®
          Cancer Type:
          Skin, Melanoma, Lung, Non-Small Cell, Hematologic, Lymphoma - Hodgkin, Genitourinary, Renal cell Kidney, Head and Neck, Gastrointestinal, Gastric Stomach, Esophagus, Colorectal, Mesothelioma (Pleural), Bladder Urothelial, Hepatobiliary Liver Bile Duct
          nid:
          167
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          oBINutuzumab
          Jul 2026
          Trade Name:
          Gazyva®
          Cancer Type:
          Hematologic, Leukemia - Chronic Lymphocytic (CLL), Lymphoma - Non-Hodgkin's Low Grade, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade
          nid:
          110
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          oxaliplatin
          Jul 2026
          Cancer Type:
          Gastrointestinal, Colorectal, Small bowel and appendix, Pancreas, Gastric Stomach, Esophagus, Unknown Primary, Genitourinary, Testis, Bladder Urothelial, Gynecologic, Ovary, Rectal, Hepatobiliary Liver Bile Duct, Neuroendocrine (GI), Hematologic, Lymphoma - T-cell, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade, Endocrine, Thyroid
          nid:
          114
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          PACLitaxel
          Jul 2026
          Trade Name:
          Taxol®
          Cancer Type:
          Gynecologic, Ovary, Gestational Trophoblastic Disease, Unknown Primary, Sarcoma, Kaposi's Sarcoma, Soft Tissue, Breast, Endometrial, Lung, Non-Small Cell, Cervix, Skin, Melanoma, Genitourinary, Bladder Urothelial, Testis, Gastrointestinal, Gastric Stomach, Esophagus, Thymoma, Merkel Cell, Prostate, Head and Neck, Endocrine, Thyroid, Germ Cell, Anus, Vulva, Penile, Squamous Cell
          nid:
          115
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          pamidronate
          Jul 2026
          Cancer Type:
          Breast, Hematologic, Multiple Myeloma, Genitourinary, Gynecologic, Head and Neck, Lung, Skin, Sarcoma, Unknown Primary, Central Nervous System, Endocrine, Gastrointestinal
          nid:
          116
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          pembrolizumab
          Jul 2026
          Trade Name:
          Keytruda®
          Cancer Type:
          Skin, Melanoma, Lung, Non-Small Cell, Genitourinary, Bladder Urothelial, Renal cell Kidney, Hematologic, Lymphoma - Hodgkin, Head and Neck, Squamous Cell, Gastrointestinal, Colorectal, Small bowel and appendix, Breast, Gynecologic, Cervix, Endometrial, Gastric Stomach, Hepatobiliary Liver Bile Duct, Esophagus, Mesothelioma (Pleural), Mesothelioma (Peritoneal), Central Nervous System, Endocrine, Adrenal, Neuroendocrine, Thymoma, Thyroid, Pancreatic Neuroendocrine, Parathyroid, Anus, Pancreas, Rectal, Neuroendocrine (GI), Gastrointestinal Stromal Tumours, Penile, Prostate, Testis, Gestational Trophoblastic Disease, Ovary, Uterine Sarcoma, Vulva, Germ Cell, Vagina, Larynx, Pharynx, Nasopharynx, Paranasal Sinus, Oral, Salivary Gland, Kaposi's Sarcoma, Small Cell, Neuroendocrine (Lung), Basal Cell, Merkel Cell, Squamous Cell, Sarcoma, Ewing's, GIST, Osteogenic Bone, Soft Tissue, Ewing's and Soft Tissue, Uterine, Desmoid Tumour, Wilm's Tumour, Giant Cell Tumour, Kaposi's Sarcoma, Mesothelioma, Unknown Primary, Ocular Eye
          nid:
          166
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          procarbazine
          Jul 2026
          Trade Name:
          Matulane®
          Cancer Type:
          Central Nervous System, Hematologic, Lymphoma - Hodgkin, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade
          nid:
          127
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          regorafenib
          Jul 2026
          Trade Name:
          Stivarga®
          Cancer Type:
          Gastrointestinal, Colorectal, Sarcoma, GIST, Gastrointestinal Stromal Tumours, Hepatobiliary Liver Bile Duct, Osteogenic Bone
          nid:
          131
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          riTUXimab
          Jul 2026
          Cancer Type:
          Hematologic, Lymphoma - Non-Hodgkin's Low Grade, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Leukemia - Chronic Lymphocytic (CLL), Leukemia - Hairy Cell, Leukemia - Acute Lymphoblastic (ALL), Lymphoma - Hodgkin
          nid:
          132
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          riTUXimab (subcut)
          Jul 2026
          Trade Name:
          Rituxan® SC
          Cancer Type:
          Hematologic, Lymphoma - Non-Hodgkin's Low Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade, Leukemia - Chronic Lymphocytic (CLL), Lymphoma - Hodgkin
          nid:
          201
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          SORAfenib
          Jul 2026
          Trade Name:
          Nexavar®
          Cancer Type:
          Gastrointestinal, Hepatobiliary Liver Bile Duct, Genitourinary, Renal cell Kidney, Endocrine, Thyroid, Hematologic, Leukemia - Acute Myeloid (AML)
          nid:
          135
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          SUNItinib
          Jul 2026
          Trade Name:
          Sutent®
          Cancer Type:
          Sarcoma, GIST, Gastrointestinal, Gastrointestinal Stromal Tumours, Genitourinary, Renal cell Kidney, Neuroendocrine (GI)
          nid:
          136
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          temozolomide
          Jul 2026
          Trade Name:
          Temodal®
          Cancer Type:
          Skin, Melanoma, Central Nervous System, Gastrointestinal, Neuroendocrine (GI), Lung, Neuroendocrine (Lung), Sarcoma, Ewing's, Soft Tissue
          nid:
          140
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          topotecan
          Jul 2026
          Trade Name:
          Hycamtin®
          Cancer Type:
          Sarcoma, Ewing's, Soft Tissue, Gynecologic, Cervix, Ovary, Lung, Small Cell, Breast, Central Nervous System, Gastrointestinal, Colorectal, Esophagus, Gastric Stomach, Hepatobiliary Liver Bile Duct, Pancreas, Neuroendocrine (GI), Endometrial, Unknown Primary, Head and Neck, Genitourinary, Bladder Urothelial, Prostate
          nid:
          145
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          trastuzumab
          Jul 2026
          Cancer Type:
          Gastrointestinal, Gastric Stomach, Esophagus, Breast, Gynecologic, Endometrial, Head and Neck, Salivary Gland, Hematologic, Leukemia - Chronic Lymphocytic (CLL), Leukemia - Hairy Cell, Lymphoma - Hodgkin, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's Low Grade, Leukemia - Acute Lymphoblastic (ALL)
          nid:
          149
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          vinBLAStine
          Jul 2026
          Cancer Type:
          Genitourinary, Bladder Urothelial, Sarcoma, Kaposi's Sarcoma, Desmoid Tumour, Testis, Hematologic, Lymphoma - Hodgkin, Central Nervous System, Lung, Non-Small Cell, Rare Diseases
          nid:
          154
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          vinCRIStine
          Jul 2026
          Trade Name:
          Oncovin®
          Cancer Type:
          Gynecologic, Gestational Trophoblastic Disease, Central Nervous System, Lung, Thymoma, Sarcoma, Ewing's, Soft Tissue, Hematologic, Leukemia - Chronic Lymphocytic (CLL), Lymphoma - Non-Hodgkin's Low Grade, Multiple Myeloma, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Hodgkin, Small Cell, Breast, Gastrointestinal, Colorectal, Cervix, Endometrial, Ovary, Gastric Stomach, Esophagus, Hepatobiliary Liver Bile Duct, Pancreas, Genitourinary, Prostate, Bladder Urothelial, Endocrine, Adrenal, Lymphoma - T-cell, Leukemia - Acute Lymphoblastic (ALL), Wilm's Tumour, Neuroendocrine (GI), Rare Diseases
          nid:
          155
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          vinorelbine
          Jul 2026
          Trade Name:
          Navelbine®
          Cancer Type:
          Lung, Non-Small Cell, Breast, Gynecologic, Ovary, Sarcoma, Desmoid Tumour, Hematologic, Lymphoma - Hodgkin, Soft Tissue, Mesothelioma (Pleural), Head and Neck, Vulva
          nid:
          156
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          zoledronic acid
          Jul 2026
          Trade Name:
          Zometa®
          Cancer Type:
          Genitourinary, Prostate, Renal cell Kidney, Hematologic, Multiple Myeloma, Breast, Lung, Small Cell, Non-Small Cell, Central Nervous System, Endocrine, Gastrointestinal, Gynecologic, Head and Neck, Skin, Sarcoma, Unknown Primary, Anus, Colorectal, Esophagus, Hepatobiliary Liver Bile Duct, Pancreas, Small bowel and appendix, Gastric Stomach, Neuroendocrine (GI), Gastrointestinal Stromal Tumours, GIST
          nid:
          160
          Quick Link(s):
          Drug Monograph ,  Patient Info Sheet

          No results found

          We were unable to find a match. Please reset the filters or search again.
          / 24

          Funded Evidence-informed Regimens

          Drug and regimen monographs and information sheets for patients provide information on dosing and administering cancer treatment protocols. They are for general reference and are not meant to replace prescribing information or physician recommendations.


          For patient information about regimens that include both chemotherapy and immunotherapy, download Treating cancer with chemotherapy and immunotherapy: What you need to know.


          If you have questions about ST-QBP funding on our website, please visit our Frequently Asked Questions page.

          Find enhanced Regimen Patient Information Sheets, created in collaboration with patient and family advisors.

          Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.

          Suggested Pages
            Suggested Searches

              Filters

              Filters

              Sort By

              Cancer Type

              Hematologic
              Lymphoma - Non-Hodgkin's High Grade
              Lymphoma - Non-Hodgkin's Intermediate Grade
              Lymphoma - Non-Hodgkin's Low Grade
              Leukemia - Chronic Myeloid (CML)
              Multiple Myeloma
              Leukemia - Acute Lymphoblastic (ALL)
              Lymphoma - Hodgkin
              Lymphoma - T-cell
              Myelodysplastic Syndrome (MDS)
              Leukemia - Chronic Lymphocytic (CLL)
              Leukemia - Acute Promyelocytic (APL)
              Leukemia - Acute Myeloid (AML)
              Myeloproliferative Neoplasms (MPNs)
              Rare Diseases
              Leukemia - Hairy Cell
              Amyloidosis
              Myelofibrosis
              Breast
              Gynecologic
              Ovary
              Germ Cell
              Endometrial
              Cervix
              Uterine Sarcoma
              Vulva
              Gestational Trophoblastic Disease
              Vagina
              Gastrointestinal
              Pancreas
              Rectal
              Hepatobiliary Liver Bile Duct
              Gastric Stomach
              Esophagus
              Neuroendocrine (GI)
              Colorectal
              Mesothelioma (Peritoneal)
              Anus
              Small bowel and appendix
              Gastrointestinal Stromal Tumours
              Genitourinary
              Renal cell Kidney
              Testis
              Prostate
              Bladder Urothelial
              Penile
              Lung
              Non-Small Cell
              Mesothelioma (Pleural)
              Small Cell
              Neuroendocrine (Lung)
              Sarcoma
              Soft Tissue
              Uterine
              Osteogenic Bone
              Ewing's
              GIST
              Ewing's and Soft Tissue
              Desmoid Tumour
              Wilm's Tumour
              Giant Cell Tumour
              Kaposi's Sarcoma
              Skin
              Squamous Cell
              Merkel Cell
              Basal Cell
              Melanoma
              Head and Neck
              Nasopharynx
              Squamous Cell
              Larynx
              Pharynx
              Paranasal Sinus
              Oral
              Salivary Gland
              Central Nervous System
              Unknown Primary
              Endocrine
              Thymoma
              Adrenal
              Pancreatic Neuroendocrine
              Thyroid
              Neuroendocrine
              Parathyroid
              Kaposi's Sarcoma
              Mesothelioma
              Ocular Eye

              nid

              Suggested Pages
                Suggested Searches
                  326190
                  326192
                  326191
                  326194
                  326193
                  326196
                  326195
                  326198
                  326197
                  307437
                  328119
                  326181
                  306351
                  307440
                  326180
                  326183
                  326182
                  328121
                  326185
                  328120
                  326184
                  326187
                  307205
                  326186
                  328122
                  307446
                  326189
                  326188
                  328366
                  307442
                  307444
                  94703
                  306559
                  306317
                  307407
                  94701
                  328590
                  326172
                  326174
                  326173
                  328597
                  253936
                  328598
                  326178
                  328114
                  306326
                  328596
                  328358
                  328116
                  328115
                  326179
                  306321
                  328599
                  328118
                  328117
                  307418
                  326161
                  326160
                  327491
                  326163
                  328586
                  326167
                  326166
                  328102
                  326168
                  307420
                  281150
                  94721
                  94725
                  306538
                  94723
                  326392
                  326150
                  326391
                  326394
                  328330
                  326152
                  326393
                  328332
                  328575
                  326395
                  94717
                  328331
                  328576
                  306303
                  328334
                  101224
                  326156
                  94715
                  328333
                  327486
                  326397
                  306540
                  328335
                  306542
                  156110
                  94719
                  328559
                  306306
                  94713
                  100394
                  306308
                  94711
                  326381
                  327470
                  328560
                  326383
                  326382
                  327471
                  94707
                  326385
                  327474
                  326384
                  327473
                  94705
                  307405
                  306315
                  326147
                  306552
                  306310
                  101238
                  94709
                  326149
                  307401
                  306312
                  94501
                  94743
                  328548
                  328309
                  94741
                  328549
                  328308
                  94505
                  94747
                  94503
                  94745
                  306518
                  328550
                  327460
                  328553
                  328310
                  327463
                  94739
                  328554
                  328551
                  327465
                  328312
                  328552
                  328794
                  94737
                  328311
                  327464
                  327467
                  328557
                  328314
                  328313
                  328558
                  327466
                  328555
                  327469
                  284472
                  327468
                  328556
                  326359
                  326117
                  94731
                  328537
                  306526
                  94735
                  155269
                  306528
                  94733
                  327692
                  327450
                  327691
                  94729
                  327452
                  327694
                  326363
                  327693
                  328543
                  155271
                  327696
                  94727
                  327454
                  327695
                  326364
                  328788
                  327456
                  306530
                  328547
                  328789
                  306532
                  327457
                  328545
                  327438
                  328528
                  326349
                  328529
                  326348
                  327437
                  328768
                  327439
                  328527
                  328769
                  305888
                  306978
                  94085
                  94083
                  94087
                  328770
                  94081
                  326350
                  326352
                  327441
                  328773
                  328531
                  327683
                  326351
                  327440
                  328774
                  328771
                  327685
                  326112
                  328530
                  328772
                  306987
                  326111
                  327684
                  326353
                  326114
                  326356
                  328777
                  306980
                  327686
                  328533
                  326116
                  328775
                  327446
                  328776
                  326115
                  328534
                  327669
                  328517
                  327668
                  327426
                  328515
                  94075
                  94073
                  94079
                  94077
                  94071
                  327672
                  326341
                  327671
                  327674
                  328760
                  326342
                  326100
                  327673
                  326103
                  327434
                  303247
                  327676
                  326345
                  327675
                  326344
                  328767
                  326105
                  327435
                  326346
                  327416
                  328748
                  327657
                  327415
                  328749
                  328746
                  327418
                  327417
                  328505
                  328747
                  305866
                  327419
                  306958
                  305869
                  326330
                  328751
                  328510
                  305874
                  327421
                  306964
                  327420
                  328750
                  327423
                  328513
                  328514
                  327425
                  327667
                  305872
                  327424
                  327889
                  327888
                  327649
                  327648
                  305878
                  306967
                  306969
                  94097
                  94099
                  94093
                  94091
                  327890
                  327650
                  327894
                  305886
                  326321
                  326320
                  327893
                  327651
                  328744
                  326323
                  327654
                  328502
                  327412
                  327896
                  328745
                  327895
                  326322
                  306971
                  328742
                  327414
                  326325
                  328500
                  327656
                  328743
                  326324
                  327413
                  328501
                  327655
                  326305
                  327878
                  327635
                  326307
                  326306
                  326309
                  306934
                  328729
                  117420
                  327881
                  328730
                  327880
                  327641
                  326310
                  328733
                  327643
                  327884
                  326311
                  327642
                  326314
                  327887
                  328732
                  326313
                  327644
                  327625
                  327867
                  305859
                  327624
                  327866
                  327627
                  327869
                  327626
                  327868
                  328714
                  328719
                  327629
                  327628
                  328718
                  327870
                  327872
                  306954
                  327871
                  327874
                  327873
                  327631
                  326300
                  327875
                  326302
                  327633
                  328704
                  327614
                  328705
                  328702
                  327616
                  327615
                  328703
                  327618
                  327617
                  306912
                  327619
                  328707
                  313448
                  328711
                  328712
                  306926
                  327845
                  327844
                  327847
                  327846
                  327849
                  327848
                  306924
                  314793
                  314797
                  314795
                  274264
                  306930
                  306932
                  327852
                  328700
                  327853
                  129609
                  328803
                  327713
                  327955
                  327712
                  94489
                  94247
                  328804
                  327715
                  327714
                  94487
                  94245
                  327717
                  328807
                  327716
                  328808
                  328805
                  94249
                  328806
                  94481
                  328809
                  94485
                  94243
                  94483
                  94241
                  328810
                  327962
                  327961
                  94479
                  94237
                  94477
                  327946
                  327948
                  327947
                  94239
                  327949
                  327707
                  255110
                  94471
                  94233
                  94475
                  94473
                  94231
                  327951
                  327950
                  327711
                  327710
                  325996
                  94269
                  325997
                  94267
                  94261
                  311591
                  94265
                  94263
                  121818
                  327922
                  327921
                  94499
                  325987
                  94257
                  327924
                  325988
                  327923
                  327926
                  327925
                  327928
                  327927
                  94251
                  94493
                  327929
                  94491
                  94497
                  94255
                  94253
                  94495
                  257743
                  325992
                  327931
                  325974
                  325975
                  325976
                  327913
                  94289
                  325977
                  327915
                  327914
                  327917
                  327916
                  327919
                  94283
                  155812
                  327918
                  307070
                  131844
                  94281
                  94287
                  155816
                  94285
                  307075
                  307073
                  323307
                  325981
                  327920
                  323301
                  325963
                  327900
                  323321
                  325964
                  94279
                  325965
                  325966
                  327904
                  325967
                  325968
                  94273
                  94271
                  94277
                  94275
                  323318
                  323316
                  325970
                  325971
                  323314
                  325972
                  323312
                  117371
                  325954
                  94069
                  325955
                  325958
                  255364
                  94063
                  325961
                  325962
                  94295
                  94293
                  94297
                  314821
                  325930
                  94643
                  94885
                  325931
                  94401
                  325933
                  94641
                  156301
                  94883
                  325934
                  94647
                  94405
                  325935
                  156306
                  325936
                  325937
                  94403
                  325938
                  325939
                  94881
                  307274
                  307031
                  307276
                  307033
                  94639
                  94633
                  94631
                  94637
                  94879
                  325925
                  94877
                  94635
                  155689
                  325927
                  325928
                  94871
                  313712
                  94629
                  314807
                  94627
                  94423
                  94665
                  325910
                  94421
                  94663
                  153057
                  325911
                  325912
                  94669
                  94427
                  94425
                  325915
                  133202
                  94667
                  325917
                  325918
                  94661
                  307010
                  307012
                  328194
                  328193
                  328198
                  328197
                  307017
                  328199
                  94419
                  307019
                  94413
                  94655
                  94653
                  94411
                  325900
                  325901
                  94659
                  94417
                  153047
                  325902
                  94415
                  94657
                  278273
                  278271
                  325907
                  325908
                  94651
                  325909
                  307021
                  307023
                  307029
                  94409
                  94649
                  94407
                  321554
                  307025
                  94203
                  94687
                  94445
                  94685
                  94201
                  94207
                  94449
                  94689
                  94205
                  94447
                  94683
                  94441
                  94681
                  328170
                  328172
                  307231
                  306385
                  328171
                  328174
                  328173
                  328176
                  258005
                  306381
                  328175
                  328177
                  307237
                  307239
                  306387
                  307235
                  94677
                  94435
                  94675
                  94433
                  94439
                  94437
                  94679
                  94673
                  94431
                  94671
                  306396
                  306392
                  328167
                  307006
                  328166
                  328169
                  307008
                  94429
                  328168
                  307004
                  94225
                  94467
                  94465
                  94223
                  307208
                  94229
                  94227
                  94469
                  94221
                  94461
                  307450
                  307210
                  306363
                  305270
                  328398
                  307212
                  306365
                  306367
                  94699
                  94215
                  94457
                  94697
                  94455
                  94213
                  94219
                  94217
                  94459
                  94691
                  94211
                  278079
                  94453
                  94695
                  94451
                  94693
                  306372
                  328381
                  328383
                  304196
                  328382
                  328385
                  328384
                  328387
                  306379
                  328386
                  94209
                  306377
                  94801
                  288706
                  328491
                  328490
                  328493
                  326073
                  326072
                  328495
                  326075
                  328253
                  326074
                  328255
                  328497
                  326077
                  326076
                  328496
                  328257
                  328015
                  326079
                  328498
                  328256
                  328014
                  326078
                  328259
                  328017
                  328258
                  328016
                  328019
                  328018
                  326061
                  328000
                  326063
                  328002
                  328486
                  326066
                  306479
                  328001
                  328004
                  328488
                  328487
                  328003
                  328006
                  328005
                  306475
                  328489
                  306438
                  94823
                  94821
                  120293
                  326290
                  328471
                  328473
                  326053
                  326294
                  328472
                  326297
                  328475
                  94817
                  326054
                  326296
                  328474
                  326057
                  94815
                  326298
                  326056
                  328479
                  326059
                  328478
                  94819
                  100679
                  328218
                  306449
                  121371
                  295023
                  326280
                  326282
                  326040
                  328462
                  326284
                  328220
                  328461
                  326283
                  326041
                  328464
                  326044
                  326286
                  306457
                  94805
                  326043
                  326046
                  326288
                  328223
                  94803
                  326287
                  328468
                  326048
                  306453
                  94809
                  326289
                  326047
                  94807
                  326049
                  306455
                  328469
                  328208
                  94841
                  328207
                  328209
                  94845
                  94601
                  94843
                  123383
                  326271
                  326273
                  328690
                  328691
                  326272
                  326033
                  326275
                  94839
                  328697
                  328210
                  326274
                  94837
                  326035
                  326277
                  328213
                  326276
                  326034
                  326279
                  326037
                  328215
                  328214
                  326278
                  326036
                  328456
                  328459
                  326039
                  328698
                  328217
                  328458
                  328216
                  328699
                  326019
                  94831
                  306427
                  94835
                  94833
                  327591
                  328681
                  328682
                  327590
                  326020
                  327593
                  328440
                  328680
                  327592
                  326261
                  328685
                  326264
                  328442
                  328200
                  327595
                  326263
                  328441
                  94827
                  327594
                  328686
                  326266
                  328444
                  327597
                  328683
                  326265
                  94825
                  328443
                  328684
                  328201
                  328204
                  326268
                  328689
                  327599
                  328446
                  326267
                  328445
                  326025
                  327598
                  328206
                  328687
                  306432
                  326269
                  328205
                  94829
                  328688
                  326027
                  94621
                  94863
                  326249
                  94861
                  94625
                  94867
                  94623
                  94865
                  326251
                  326250
                  306885
                  326253
                  94619
                  326252
                  326010
                  306887
                  94617
                  94859
                  327586
                  326255
                  328432
                  306404
                  326254
                  326012
                  327588
                  326257
                  326256
                  326014
                  326258
                  327589
                  328677
                  94611
                  94853
                  326239
                  326238
                  94851
                  328658
                  94615
                  94857
                  94613
                  94855
                  123108
                  306891
                  121168
                  326240
                  327571
                  327570
                  94607
                  327572
                  328664
                  326241
                  94849
                  326244
                  101334
                  94847
                  94605
                  326004
                  101578
                  326246
                  328424
                  327576
                  328423
                  326245
                  326248
                  327579
                  326247
                  94609
                  327578
                  326005
                  328425
                  326228
                  326227
                  328889
                  326229
                  328891
                  326231
                  100298
                  306864
                  326232
                  304688
                  306866
                  306860
                  326234
                  328412
                  326237
                  304684
                  326236
                  306862
                  328638
                  326217
                  326216
                  328636
                  326219
                  328878
                  326218
                  328879
                  328637
                  290630
                  125596
                  94195
                  94193
                  94199
                  94197
                  304690
                  94191
                  122078
                  328880
                  328641
                  328883
                  326220
                  328642
                  328884
                  326222
                  328400
                  328881
                  326221
                  328887
                  328645
                  306871
                  326223
                  326226
                  328404
                  328643
                  326225
                  306873
                  328644
                  326206
                  327779
                  327537
                  327778
                  327536
                  326208
                  326207
                  304656
                  306834
                  326209
                  328629
                  306836
                  327780
                  304663
                  327782
                  327540
                  328872
                  328873
                  327781
                  328631
                  326211
                  327542
                  327784
                  327541
                  306844
                  326210
                  327783
                  326213
                  328876
                  327544
                  327786
                  328635
                  304660
                  326212
                  328877
                  327785
                  327543
                  328874
                  328632
                  326215
                  306840
                  327787
                  328875
                  327545
                  326214
                  328633
                  327768
                  327526
                  327767
                  327527
                  304668
                  290651
                  327529
                  127745
                  326200
                  324263
                  302256
                  326201
                  326204
                  327535
                  306850
                  327534
                  327515
                  327999
                  328605
                  327998
                  327514
                  328606
                  327517
                  328845
                  328603
                  327759
                  327516
                  328846
                  328609
                  327518
                  328607
                  328608
                  327760
                  304643
                  327520
                  328610
                  306828
                  157146
                  327508
                  306826
                  304648
                  152704
                  328840
                  306832
                  304654
                  328843
                  327995
                  328844
                  327755
                  328841
                  327513
                  327997
                  327754
                  327512
                  328600
                  328842
                  327996
                  327977
                  327737
                  327736
                  326407
                  328827
                  328828
                  327982
                  328833
                  327966
                  327968
                  327726
                  327967
                  327728
                  327727
                  327969
                  328816
                  327729
                  304632
                  327971
                  327970
                  327973
                  327731
                  284188
                  327730
                  327972
                  326402
                  327732
                  327974
                  94369
                  94127
                  94367
                  325899
                  94125
                  94129
                  291555
                  94365
                  94123
                  94121
                  94363
                  327841
                  327843
                  327600
                  325886
                  94599
                  94357
                  94115
                  306906
                  325888
                  328911
                  94355
                  94597
                  325889
                  94113
                  305812
                  94119
                  94117
                  94359
                  314771
                  94591
                  306908
                  94111
                  94353
                  94595
                  94351
                  94593
                  314767
                  314765
                  325891
                  325892
                  306910
                  325894
                  325895
                  325896
                  94149
                  328902
                  328903
                  94147
                  94389
                  327814
                  328901
                  327813
                  325878
                  94383
                  94141
                  94381
                  94145
                  94387
                  94385
                  117440
                  314735
                  117442
                  314737
                  325881
                  304946
                  94137
                  94379
                  294856
                  304948
                  94135
                  94377
                  304700
                  304942
                  94139
                  94371
                  94375
                  94133
                  314750
                  94131
                  94373
                  314748
                  325872
                  325873
                  325853
                  325854
                  325855
                  94169
                  325858
                  94163
                  94161
                  94167
                  94165
                  325860
                  325861
                  325863
                  325842
                  94159
                  325843
                  325844
                  94399
                  94157
                  289686
                  325846
                  325847
                  325848
                  325849
                  94151
                  94393
                  94391
                  94155
                  94397
                  94395
                  94153
                  118106
                  325850
                  325851
                  325852
                  94185
                  94183
                  94189
                  94187
                  254148
                  94179
                  307180
                  254165
                  94171
                  94177
                  155708
                  117473
                  94523
                  94765
                  94521
                  131121
                  94769
                  94525
                  94767
                  285955
                  94761
                  328091
                  328090
                  328093
                  307394
                  328092
                  328095
                  307396
                  328094
                  307391
                  328097
                  328096
                  328098
                  94519
                  94517
                  94759
                  155340
                  94753
                  94751
                  94515
                  94757
                  94513
                  94755
                  328087
                  94509
                  328089
                  94749
                  94507
                  96929
                  94303
                  94787
                  94545
                  94301
                  94543
                  94785
                  94307
                  94549
                  94305
                  94789
                  94547
                  94783
                  94541
                  94781
                  308222
                  282899
                  306281
                  94539
                  307134
                  308226
                  94775
                  94533
                  94531
                  94773
                  94779
                  94537
                  94777
                  94535
                  328060
                  306296
                  308232
                  307385
                  306292
                  328066
                  94529
                  307387
                  307147
                  307389
                  94325
                  94567
                  94323
                  94565
                  94329
                  156623
                  94327
                  94569
                  94321
                  94563
                  94561
                  307351
                  122688
                  328290
                  306264
                  307110
                  328295
                  306260
                  307359
                  94319
                  307355
                  101988
                  307115
                  94313
                  94797
                  94555
                  94311
                  94795
                  94553
                  94317
                  94559
                  155522
                  94315
                  94557
                  94799
                  94793
                  94551
                  94791
                  307361
                  328040
                  306275
                  328288
                  328287
                  307127
                  94309
                  308219
                  328289
                  328049
                  100666
                  308212
                  100425
                  308215
                  94105
                  94347
                  94589
                  94345
                  94103
                  94587
                  94109
                  94107
                  94349
                  94581
                  94343
                  94101
                  94341
                  94583
                  306481
                  306483
                  326093
                  326095
                  328031
                  326094
                  326097
                  328033
                  328032
                  306489
                  101960
                  328035
                  328034
                  328037
                  328036
                  306485
                  306487
                  94335
                  94577
                  94333
                  94575
                  94339
                  94337
                  94331
                  94573
                  94571
                  326080
                  306493
                  326082
                  328020
                  328262
                  326084
                  328261
                  328022
                  328021
                  306491
                  328023
                  328026
                  307108
                  328025
                  328028
                  328027
                  307104
                  328029
                  Showing 10 of 1513 results

                  CARF
                  Jul 2026
                  Intent:
                  Palliative
                  Drugs Used:
                  carfilzomib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  325970
                  Quick Link(s):
                  Regimen Monograph

                  CABO+NIVL; CABO(MNT)
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab - In Combination with Cabozantinib for First Line Advanced or Metastatic Renal Cell Carcinoma Exceptional Access Program cabozantinib – For the first-line treatment of adult patients with advanced or metastatic renal cell carcinoma, in combination with nivolumab, based on criteria
                  Drugs Used:
                  nivolumab , cabozantinib (tablet)
                  nid:
                  328385
                  Quick Link(s):
                  Regimen Monograph

                  CLDN
                  Jul 2026
                  Intent:
                  Palliative
                  Funding Program:
                  ODB Limited Use clodronate - For the control and prophylaxis of hypercalcemia of malignancy (capsules)
                  Drugs Used:
                  clodronate
                  nid:
                  94217
                  Quick Link(s):
                  Regimen Monograph

                  ABEMFLVS
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit fulvestrant
                  Drugs Used:
                  abemaciclib , fulvestrant
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327672
                  Quick Link(s):
                  Regimen Monograph

                  BOSU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Myeloid (CML)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program bosutinib - For the treatment of patients with chronic, accelerated or blast phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML), according to specific criteria.
                  Drugs Used:
                  bosutinib
                  nid:
                  302256
                  Quick Link(s):
                  Regimen Monograph

                  BORTDEXA+BELA; BELA(MNT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit dexamethasone
                  Drugs Used:
                  , belantamab mafodotin bortezomib , dexamethasone
                  QBP Type:
                  Compassionate This drug is not publicly funded. Universal compassionate access program is available.
                  nid:
                  328745
                  Quick Link(s):
                  Regimen Monograph

                  ALL-R3(FLAD)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Lymphoblastic (ALL)
                  Intent:
                  Curative
                  Drugs Used:
                  fludarabine , cytarabine , liposomal DAUNOrubicin
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  326204
                  Quick Link(s):
                  Regimen Monograph

                  CAPECRBP+PEMB; CAPE+PEMB
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - First-line Treatment of Advanced HER2-negative Esophageal, Gastric, and Esophagogastric Junction Carcinoma ODB - General Benefit capecitabine
                  Drugs Used:
                  pembrolizumab , CARBOplatin , capecitabine
                  nid:
                  328498
                  Quick Link(s):
                  Regimen Monograph

                  CEMI
                  Jul 2026
                  Cancer Type:
                  Skin, Squamous Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Cemiplimab - Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma
                  Drugs Used:
                  cemiplimab
                  nid:
                  327692
                  Quick Link(s):
                  Regimen Monograph

                  ACAL
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Drugs Used:
                  acalabrutinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327754
                  Quick Link(s):
                  Regimen Monograph

                  CAPELAPA
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit capecitabine Exceptional Access Program lapatinib - Treatment of HER-2 positive metastatic breast cancer when used in combination with chemotherapy after use of trastuzumab in patients who have an adverse drug reaction or contraindication to trastuzumab therapy
                  Drugs Used:
                  capecitabine , lapatinib
                  nid:
                  94613
                  Quick Link(s):
                  Regimen Monograph

                  ANAS
                  Jul 2026
                  Cancer Type:
                  Breast, Gynecologic, Endometrial
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit anastrozole
                  Drugs Used:
                  anastrozole
                  nid:
                  94075
                  Quick Link(s):
                  Regimen Monograph

                  CISPETOP(3D)
                  Jul 2026
                  Cancer Type:
                  Lung, Small Cell, Head and Neck, Central Nervous System, Gynecologic, Cervix, Endometrial, Ovary, Gastrointestinal, Colorectal, Gastric Stomach, Esophagus, Hepatobiliary Liver Bile Duct, Pancreas, Genitourinary, Prostate, Bladder Urothelial, Breast
                  Intent:
                  Palliative
                  Drugs Used:
                  CISplatin , etoposide
                  nid:
                  94339
                  Quick Link(s):
                  Regimen Monograph

                  CISPFU+TRAS
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Trastuzumab (Biosimilar) - Advanced Gastric, Gastroesophageal, or Esophageal Cancer
                  Drugs Used:
                  trastuzumab , CISplatin , fluorouracil
                  nid:
                  94351
                  Quick Link(s):
                  Regimen Monograph

                  CEMI
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Cervix
                  Intent:
                  Palliative
                  Drugs Used:
                  cemiplimab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328176
                  Quick Link(s):
                  Regimen Monograph

                  CEDADECI
                  Jul 2026
                  Cancer Type:
                  Hematologic, Myelodysplastic Syndrome (MDS)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program decitabine / cedazuridine - For the treatment of adult patients with myelodysplastic syndromes (MDS), based on criteria
                  Drugs Used:
                  decitabine / cedazuridine
                  nid:
                  327904
                  Quick Link(s):
                  Regimen Monograph

                  ACAL+OBIN
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Drugs Used:
                  acalabrutinib , oBINutuzumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327874
                  Quick Link(s):
                  Regimen Monograph

                  ABEMEXEM
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Adjuvant
                  Funding Program:
                  Exceptional Access Program abemaciclib - For the adjuvant treatment, in combination with endocrine therapy, of adult patients with HR-positive, HER2-negative, node-positive early breast cancer at high risk of disease recurrence, according to specific criteria ODB - General Benefit exemestane
                  Drugs Used:
                  abemaciclib , exemestane
                  nid:
                  328121
                  Quick Link(s):
                  Regimen Monograph

                  ACAL
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program acalabrutinib - For the treatment of adult patients with chronic lymphocytic leukemia (CLL), based on criteria
                  Drugs Used:
                  acalabrutinib
                  nid:
                  327873
                  Quick Link(s):
                  Regimen Monograph

                  CAV
                  Jul 2026
                  Cancer Type:
                  Lung, Small Cell, Breast, Gastrointestinal, Colorectal, Gynecologic, Cervix, Endometrial, Ovary, Gastric Stomach, Esophagus, Hepatobiliary Liver Bile Duct, Pancreas, Genitourinary, Prostate, Bladder Urothelial
                  Intent:
                  Palliative
                  Drugs Used:
                  cyclophosphamide , DOXOrubicin , vinCRIStine
                  nid:
                  304632
                  Quick Link(s):
                  Regimen Monograph

                  BEVA(MNT)
                  Jul 2026
                  Cancer Type:
                  Lung, Mesothelioma (Pleural)
                  Intent:
                  Palliative
                  Drugs Used:
                  bevacizumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327625
                  Quick Link(s):
                  Regimen Monograph

                  BICA
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Prostate
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit bicalutamide
                  Drugs Used:
                  bicalutamide
                  nid:
                  94269
                  Quick Link(s):
                  Regimen Monograph

                  CEMI
                  Jul 2026
                  Cancer Type:
                  Skin, Basal Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Cemiplimab - Locally Advanced Basal Cell Carcinoma
                  Drugs Used:
                  cemiplimab
                  nid:
                  328120
                  Quick Link(s):
                  Regimen Monograph

                  ABIRNIRPPRED
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Prostate
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program niraparib / abiraterone - For the treatment of metastatic castration resistant prostate cancer in patients with a BRCA mutation ODB - General Benefit prednisone
                  Drugs Used:
                  niraparib / abiraterone , prednisone
                  nid:
                  328510
                  Quick Link(s):
                  Regimen Monograph

                  CISPPEME+PEMB
                  Jul 2026
                  Cancer Type:
                  Lung, Mesothelioma (Pleural), Gastrointestinal, Mesothelioma (Peritoneal)
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Previously Untreated Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
                  Drugs Used:
                  pembrolizumab , pemetrexed , CISplatin
                  nid:
                  328697
                  Quick Link(s):
                  Regimen Monograph

                  AZCT
                  Jul 2026
                  Cancer Type:
                  Hematologic, Myelodysplastic Syndrome (MDS), Leukemia - Acute Myeloid (AML), Myeloproliferative Neoplasms (MPNs)
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Azacitidine - Acute Myeloid Leukemia (AML) Greater Than 30% Blasts
                  Drugs Used:
                  azaCITIDine
                  nid:
                  94261
                  Quick Link(s):
                  Regimen Monograph

                  ABEM
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Drugs Used:
                  abemaciclib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327668
                  Quick Link(s):
                  Regimen Monograph

                  BEND+RITU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Drugs Used:
                  riTUXimab , bendamustine
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  314771
                  Quick Link(s):
                  Regimen Monograph

                  CARFDEXA; CARFDEXA(W)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Carfilzomib (Doublet Therapy) - In Combination with Dexamethasone for Relapsed Multiple Myeloma ODB - General Benefit dexamethasone
                  Drugs Used:
                  carfilzomib , dexamethasone
                  nid:
                  325971
                  Quick Link(s):
                  Regimen Monograph

                  BORTDEXALENA(LD)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  ODB Limited Use lenalidomide - For the treatment of patients with multiple myeloma, who are deemed to be lenalidomide sensitive, and/or have not experienced progression while on a lenalidomide-based regimen in the treatment or maintenance setting, according to specific criteria ODB - General Benefit dexamethasone
                  Drugs Used:
                  bortezomib , lenalidomide , dexamethasone
                  nid:
                  328193
                  Quick Link(s):
                  Regimen Monograph

                  BORTDEXASELI
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit dexamethasone Exceptional Access Program selinexor - In combination with bortezomib and dexamethasone for relapsed or refractory multiple myeloma
                  Drugs Used:
                  bortezomib , dexamethasone , selinexor
                  nid:
                  327657
                  Quick Link(s):
                  Regimen Monograph

                  CRBP
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Ovary, Vulva, Uterine Sarcoma, Sarcoma, Uterine, Endometrial
                  Intent:
                  Palliative
                  Drugs Used:
                  CARBOplatin
                  nid:
                  94517
                  Quick Link(s):
                  Regimen Monograph

                  CABO
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program cabozantinib - For the treatment of advanced renal cell carcinoma (RCC), based on criteria
                  Drugs Used:
                  cabozantinib (tablet)
                  nid:
                  327535
                  Quick Link(s):
                  Regimen Monograph

                  CISPFU+NIVL
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab - First-line Treatment of Advanced Gastric, Esophageal, and Esophagogastric Junction Adenocarcinoma
                  Drugs Used:
                  nivolumab , CISplatin , fluorouracil
                  nid:
                  328028
                  Quick Link(s):
                  Regimen Monograph

                  BREN
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - T-cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Brentuximab Vedotin - Systemic Anaplastic Large Cell Lymphoma
                  Drugs Used:
                  brentuximab vedotin
                  nid:
                  278271
                  Quick Link(s):
                  Regimen Monograph

                  CISPPEME+PEMB
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - In Combination with Platinum and Pemetrexed for First Line Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
                  Drugs Used:
                  pembrolizumab , pemetrexed , CISplatin
                  nid:
                  327517
                  Quick Link(s):
                  Regimen Monograph

                  ANGR
                  NEW Jul 2026
                  Cancer Type:
                  Hematologic, Myeloproliferative Neoplasms (MPNs)
                  Intent:
                  Palliative
                  Funding Program:
                  ODB Limited Use anagrelide
                  Drugs Used:
                  anagrelide
                  nid:
                  325965
                  Quick Link(s):
                  Regimen Monograph

                  CERI
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program ceritinib - Second-line monotherapy of ALK-positive locally advanced (not amenable to curative therapy) or metastatic NSCLC, in patients who have experienced disease progression or intolerance to crizotinib, according to specific criteria
                  Drugs Used:
                  ceritinib
                  nid:
                  323321
                  Quick Link(s):
                  Regimen Monograph

                  CISPETOP(3D)
                  Jul 2026
                  Cancer Type:
                  Lung, Small Cell, Head and Neck, Gynecologic, Cervix, Endometrial, Ovary, Gastrointestinal, Colorectal, Gastric Stomach, Esophagus, Hepatobiliary Liver Bile Duct, Pancreas, Genitourinary, Prostate, Bladder Urothelial, Breast
                  Intent:
                  Adjuvant
                  Drugs Used:
                  CISplatin , etoposide
                  nid:
                  326247
                  Quick Link(s):
                  Regimen Monograph

                  ABEMANAS
                  Jul 2026
                  Cancer Type:
                  Breast
                  Funding Program:
                  Exceptional Access Program abemaciclib - For the adjuvant treatment, in combination with endocrine therapy, of adult patients with HR-positive, HER2-negative, node-positive early breast cancer at high risk of disease recurrence, according to specific criteria ODB - General Benefit anastrozole
                  Drugs Used:
                  abemaciclib , anastrozole
                  nid:
                  327671
                  Quick Link(s):
                  Regimen Monograph

                  BSLF
                  Jul 2026
                  Cancer Type:
                  Hematologic, Myeloproliferative Neoplasms (MPNs)
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit busulfan - oral tablets
                  Drugs Used:
                  busulfan
                  nid:
                  326095
                  Quick Link(s):
                  Regimen Monograph

                  CEMI
                  Jul 2026
                  Cancer Type:
                  Skin, Squamous Cell
                  Drugs Used:
                  cemiplimab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328873
                  Quick Link(s):
                  Regimen Monograph

                  CAPE+TRAS
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit capecitabine New Drug Funding Program Trastuzumab (Biosimilar) - Second Line - Metastatic Breast Cancer
                  Drugs Used:
                  capecitabine , trastuzumab
                  nid:
                  326181
                  Quick Link(s):
                  Regimen Monograph

                  BORTDEXAPOMA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit dexamethasone Exceptional Access Program pomalidomide - In combination with bortezomib and dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma, based on criteria
                  Drugs Used:
                  bortezomib , dexamethasone , pomalidomide
                  nid:
                  325912
                  Quick Link(s):
                  Regimen Monograph

                  BREN(CONS)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Hodgkin
                  Intent:
                  Curative
                  Funding Program:
                  New Drug Funding Program Brentuximab Vedotin - Consolidation Post-Autologous Stem Cell Transplant (ASCT) for Hodgkin Lymphoma
                  Drugs Used:
                  brentuximab vedotin
                  nid:
                  326072
                  Quick Link(s):
                  Regimen Monograph

                  ANASRIBO
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Adjuvant
                  Funding Program:
                  ODB - General Benefit anastrozole
                  Drugs Used:
                  anastrozole , ribociclib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328803
                  Quick Link(s):
                  Regimen Monograph

                  AXIT+PEMB
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program aXitinib - In combination with pembrolizumab for first-line advanced or metastatic renal cell carcinoma New Drug Funding Program Pembrolizumab - In Combination with Axitinib for First Line Advanced or Metastatic Renal Cell Carcinoma
                  Drugs Used:
                  aXitinib , pembrolizumab
                  nid:
                  327732
                  Quick Link(s):
                  Regimen Monograph

                  CABO
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Hepatobiliary Liver Bile Duct
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program cabozantinib - For the treatment of unresectable, advanced hepatocellular carcinoma (HCC), based on criteria
                  Drugs Used:
                  cabozantinib (tablet)
                  nid:
                  327881
                  Quick Link(s):
                  Regimen Monograph

                  CABAPRED
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Prostate
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Cabazitaxel - Metastatic Castration Resistant Prostate Cancer ODB - General Benefit prednisone
                  Drugs Used:
                  cabazitaxel , prednisone
                  nid:
                  118106
                  Quick Link(s):
                  Regimen Monograph

                  ALEC
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program alectinib - Treatment of ALK-positive locally advanced or metastatic non-small cell lung cancer, according to specific criteria
                  Drugs Used:
                  alectinib
                  nid:
                  326161
                  Quick Link(s):
                  Regimen Monograph

                  BOSU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Myeloid (CML)
                  Intent:
                  Palliative
                  Drugs Used:
                  bosutinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327674
                  Quick Link(s):
                  Regimen Monograph

                  BORTDEXALENA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  ODB Limited Use lenalidomide - For the treatment of patients with multiple myeloma, who are deemed to be lenalidomide sensitive, and/or have not experienced progression while on a lenalidomide-based regimen in the treatment or maintenance setting, according to specific criteria ODB - General Benefit dexamethasone
                  Drugs Used:
                  bortezomib , lenalidomide , dexamethasone
                  nid:
                  323318
                  Quick Link(s):
                  Regimen Monograph

                  ATEZBEVA
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Hepatobiliary Liver Bile Duct
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Atezolizumab with Bevacizumab (Biosimilar) - Previously Untreated Unresectable or Metastatic Hepatocellular Carcinoma
                  Drugs Used:
                  atezolizumab , atezolizumab (subcut) , bevacizumab
                  nid:
                  327872
                  Quick Link(s):
                  Regimen Monograph

                  CAPETUCA+TRAS
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit capecitabine Exceptional Access Program tucatinib - in combination with trastuzumab and capecitabine for advanced breast cancer, according to specific criteria New Drug Funding Program Trastuzumab (Biosimilar) with Tucatinib and Capecitabine - Metastatic Breast Cancer
                  Drugs Used:
                  capecitabine , tucatinib , trastuzumab
                  nid:
                  327870
                  Quick Link(s):
                  Regimen Monograph

                  CHLO+OBIN
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma ODB - General Benefit chlorambucil
                  Drugs Used:
                  oBINutuzumab , chlorambucil
                  nid:
                  327600
                  Quick Link(s):
                  Regimen Monograph

                  ALEM
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - T-cell, Rare Diseases
                  Intent:
                  Palliative
                  Drugs Used:
                  alemtuzumab
                  QBP Type:
                  Compassionate This drug is not publicly funded. Universal compassionate access program is available.
                  nid:
                  327693
                  Quick Link(s):
                  Regimen Monograph

                  CAPENERT
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Drugs Used:
                  , neratinib capecitabine
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328287
                  Quick Link(s):
                  Regimen Monograph

                  CHLO+RITU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Indolent Lymphoma ODB - General Benefit chlorambucil
                  Drugs Used:
                  riTUXimab , chlorambucil , riTUXimab (subcut)
                  nid:
                  94841
                  Quick Link(s):
                  Regimen Monograph

                  ARSE
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Promyelocytic (APL)
                  Intent:
                  Palliative
                  Drugs Used:
                  arsenic trioxide
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  326189
                  Quick Link(s):
                  Regimen Monograph

                  CAPE
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Hepatobiliary Liver Bile Duct
                  Intent:
                  Adjuvant
                  Funding Program:
                  ODB - General Benefit capecitabine
                  Drugs Used:
                  capecitabine
                  nid:
                  327420
                  Quick Link(s):
                  Regimen Monograph

                  CHOP+IR-DHAP+R
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma ODB - General Benefit dexamethasone
                  Drugs Used:
                  riTUXimab , riTUXimab (subcut) , prednisone , vinCRIStine , DOXOrubicin , cyclophosphamide , iBRUtinib , CISplatin , cytarabine , dexamethasone
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328711
                  Quick Link(s):
                  Regimen Monograph

                  ARSEATRA(CONS LO/INT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Promyelocytic (APL)
                  Intent:
                  Curative
                  Funding Program:
                  Exceptional Access Program tretinoin (ATRA) New Drug Funding Program Arsenic Trioxide - Relapsed_Refractory Consolidation of Acute Promyelocytic Leukemia (APL)
                  Drugs Used:
                  tretinoin (ATRA) , arsenic trioxide
                  nid:
                  326225
                  Quick Link(s):
                  Regimen Monograph

                  APAL
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Prostate
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program apalutamide - For the treatment of metastatic castration sensitive prostate cancer (mCSPC), based on criteria
                  Drugs Used:
                  apalutamide
                  nid:
                  327572
                  Quick Link(s):
                  Regimen Monograph

                  BORTLENA(LD)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  ODB Limited Use lenalidomide - For the treatment of patients with multiple myeloma, who are deemed to be lenalidomide sensitive, and/or have not experienced progression while on a lenalidomide-based regimen in the treatment or maintenance setting, according to specific criteria
                  Drugs Used:
                  bortezomib , lenalidomide
                  nid:
                  328194
                  Quick Link(s):
                  Regimen Monograph

                  AZCTVENE
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Myeloid (AML)
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Azacitidine in combination with Venetoclax (Outpatient) - Previously Untreated Acute Myeloid Leukemia Exceptional Access Program venetoclax - Venetoclax in combination with azacitidine - Previously untreated acute myeloid leukemia, based on criteria
                  Drugs Used:
                  azaCITIDine , venetoclax
                  nid:
                  327848
                  Quick Link(s):
                  Regimen Monograph

                  ALEM; ALEM(IV)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Drugs Used:
                  alemtuzumab
                  QBP Type:
                  Compassionate This drug is not publicly funded. Universal compassionate access program is available.
                  nid:
                  94071
                  Quick Link(s):
                  Regimen Monograph

                  BORTDEXADARA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Daratumumab - In Combination with Bortezomib and Dexamethasone for Relapsed Multiple Myeloma ODB - General Benefit dexamethasone
                  Drugs Used:
                  bortezomib , daratumumab , dexamethasone
                  nid:
                  326114
                  Quick Link(s):
                  Regimen Monograph

                  CISPRALT
                  Jul 2026
                  Cancer Type:
                  Lung, Mesothelioma (Pleural)
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Raltitrexed - Advanced Malignant Pleural Mesothelioma (MPM)
                  Drugs Used:
                  raltitrexed , CISplatin
                  nid:
                  94503
                  Quick Link(s):
                  Regimen Monograph

                  BORTDEXALENA+DARA(SC); LENA+DARA(MNT-SC)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Daratumumab (subcut) – Daratumumab in combination with Bortezomib, Lenalidomide and Dexamethasone - Newly Diagnosed Transplant Eligible Multiple Myeloma ODB Limited Use lenalidomide - For the maintenance treatment of patients with newly diagnosed multiple myeloma, following ASCT, who have stable disease or better, with no evidence of disease progression, according to specific criteria ODB - General Benefit dexamethasone
                  Drugs Used:
                  daratumumab (subcut) , bortezomib , lenalidomide , dexamethasone
                  nid:
                  328682
                  Quick Link(s):
                  Regimen Monograph

                  ANASRIBO
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit anastrozole Exceptional Access Program ribociclib - For the treatment of patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER 2)-negative, unresectable locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant, according to specific criteria
                  Drugs Used:
                  anastrozole , ribociclib
                  nid:
                  327614
                  Quick Link(s):
                  Regimen Monograph

                  CETU(RT)
                  Jul 2026
                  Cancer Type:
                  Head and Neck
                  Intent:
                  Curative
                  Funding Program:
                  New Drug Funding Program Cetuximab and Radiation - Locally Advanced Squamous Cell Carcinoma of the Head and Neck
                  Drugs Used:
                  cetuximab
                  nid:
                  94717
                  Quick Link(s):
                  Regimen Monograph

                  ACALVENE
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Drugs Used:
                  acalabrutinib , venetoclax
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328901
                  Quick Link(s):
                  Regimen Monograph

                  CAPM
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Drugs Used:
                  capmatinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327998
                  Quick Link(s):
                  Regimen Monograph

                  ALEC
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Adjuvant
                  Funding Program:
                  Exceptional Access Program alectinib - Adjuvant treatment of ALK-positive non-small cell lung cancer, according to specific criteria
                  Drugs Used:
                  alectinib
                  nid:
                  328816
                  Quick Link(s):
                  Regimen Monograph

                  BREN
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Hodgkin
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Brentuximab Vedotin - Relapsed or Refractory Hodgkin Lymphoma
                  Drugs Used:
                  brentuximab vedotin
                  nid:
                  278273
                  Quick Link(s):
                  Regimen Monograph

                  CISPGEMC+TISL
                  Jul 2026
                  Cancer Type:
                  Head and Neck, Nasopharynx
                  Intent:
                  Palliative
                  Drugs Used:
                  , tislelizumab gemcitabine , CISplatin
                  QBP Type:
                  Compassionate This drug is not publicly funded. Universal compassionate access program is available.
                  nid:
                  328490
                  Quick Link(s):
                  Regimen Monograph

                  CAPE
                  NEW Jul 2026
                  Cancer Type:
                  Head and Neck
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit capecitabine
                  Drugs Used:
                  capecitabine
                  nid:
                  326258
                  Quick Link(s):
                  Regimen Monograph

                  CEMI(MNT)
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Cemiplimab - In Combination with Chemotherapy for First-Line Treatment of Advanced Non-Small Cell Lung Cancer
                  Drugs Used:
                  cemiplimab
                  nid:
                  328553
                  Quick Link(s):
                  Regimen Monograph

                  CEP+BREN
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - T-cell, Lymphoma - Non-Hodgkin's Intermediate Grade
                  Funding Program:
                  ODB - General Benefit etoposide - oral capsules New Drug Funding Program Brentuximab Vedotin - In Combination with Chemotherapy for Previously Untreated Peripheral T-cell Lymphoma (PTCL)
                  Drugs Used:
                  prednisone , cyclophosphamide , etoposide , brentuximab vedotin
                  nid:
                  327884
                  Quick Link(s):
                  Regimen Monograph

                  BLIN
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Lymphoblastic (ALL)
                  Intent:
                  Curative
                  Funding Program:
                  New Drug Funding Program Blinatumomab - Minimal Residual Disease (MRD)-Positive B-cell Precursor Acute Lymphoblastic Leukemia
                  Drugs Used:
                  blinatumomab
                  nid:
                  327982
                  Quick Link(s):
                  Regimen Monograph

                  AVEL(MNT)
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Bladder Urothelial
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Avelumab - Maintenance Treatment for Unresectable Locally Advanced or Metastatic Urothelial Carcinoma
                  Drugs Used:
                  avelumab
                  nid:
                  327914
                  Quick Link(s):
                  Regimen Monograph

                  CISPGEMC+PEMB
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - In Combination with Carboplatin and Paclitaxel for First-Line Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
                  Drugs Used:
                  pembrolizumab , CISplatin , gemcitabine
                  QBP Type:
                  PDRP prior authorization Prior authorization is required for PDRP funding of this drug within this regimen
                  nid:
                  327844
                  Quick Link(s):
                  Regimen Monograph

                  ALEM+RITU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Drugs Used:
                  alemtuzumab , riTUXimab
                  QBP Type:
                  Compassionate This drug is not publicly funded. Universal compassionate access program is available. Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  307210
                  Quick Link(s):
                  Regimen Monograph

                  CAPE
                  NEW Jul 2026
                  Cancer Type:
                  Gastrointestinal, Pancreas
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit capecitabine
                  Drugs Used:
                  capecitabine
                  nid:
                  307006
                  Quick Link(s):
                  Regimen Monograph

                  ATEZ
                  Jul 2026
                  Intent:
                  Palliative
                  Drugs Used:
                  atezolizumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  326407
                  Quick Link(s):
                  Regimen Monograph

                  CAPE(RT)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Hepatobiliary Liver Bile Duct
                  Intent:
                  Adjuvant
                  Funding Program:
                  ODB - General Benefit capecitabine
                  Drugs Used:
                  capecitabine
                  nid:
                  326320
                  Quick Link(s):
                  Regimen Monograph

                  ARSEATRA(IND LO/INT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Promyelocytic (APL)
                  Intent:
                  Curative
                  Funding Program:
                  Exceptional Access Program tretinoin (ATRA) New Drug Funding Program Arsenic Trioxide - Relapsed_Refractory Induction of Acute Promyelocytic Leukemia (APL)
                  Drugs Used:
                  tretinoin (ATRA) , arsenic trioxide
                  nid:
                  326226
                  Quick Link(s):
                  Regimen Monograph

                  ACAL(MNT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Drugs Used:
                  acalabrutinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327875
                  Quick Link(s):
                  Regimen Monograph

                  AZCT(MNT-PO)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Myeloid (AML)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program azaCITIDine (tablets) - For maintenance therapy in adult patients with AML who achieved complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following induction therapy with or without consolidation treatment, and who are not eligible for hematopoietic stem cell transplantation
                  Drugs Used:
                  azaCITIDine (tablets)
                  nid:
                  327948
                  Quick Link(s):
                  Regimen Monograph

                  AVAP
                  Jul 2026
                  Cancer Type:
                  Hematologic, Rare Diseases
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program avapritinib - For the treatment of Advanced Systemic Mastocytosis, according to specific criteria
                  Drugs Used:
                  avapritinib
                  nid:
                  328664
                  Quick Link(s):
                  Regimen Monograph

                  BINIENCO
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program encorafenib - For the treatment of patients with locally advanced unresectable or metastatic melanoma with a BRAF V600 mutation, based on criteria
                  Drugs Used:
                  binimetinib , encorafenib
                  nid:
                  328177
                  Quick Link(s):
                  Regimen Monograph

                  BLIN
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Lymphoblastic (ALL)
                  Funding Program:
                  New Drug Funding Program Blinatumomab - Front-line Consolidation for B-cell Precursor Acute Lymphoblastic Leukemia
                  Drugs Used:
                  blinatumomab
                  nid:
                  328685
                  Quick Link(s):
                  Regimen Monograph

                  CISPIRIN
                  Jul 2026
                  Cancer Type:
                  Lung, Small Cell, Breast, Gastrointestinal, Colorectal, Esophagus, Gastric Stomach, Hepatobiliary Liver Bile Duct, Pancreas, Genitourinary, Bladder Urothelial, Prostate, Gynecologic, Cervix, Endometrial, Ovary, Head and Neck, Central Nervous System
                  Drugs Used:
                  CISplatin , irinotecan
                  nid:
                  327438
                  Quick Link(s):
                  Regimen Monograph

                  ANASPALB
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit anastrozole Exceptional Access Program palbociclib - For the treatment of patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER 2)-negative, unresectable locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant, according to specific criteria
                  Drugs Used:
                  anastrozole , palbociclib
                  nid:
                  327617
                  Quick Link(s):
                  Regimen Monograph

                  BEND+POLA+RITU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Polatuzumab Vedotin with Bendamustine and Rituximab (Biosimilar) - Relapsed or Refractory Diffuse Large B-cell Lymphoma
                  Drugs Used:
                  riTUXimab , polatuzumab vedotin , bendamustine
                  nid:
                  327755
                  Quick Link(s):
                  Regimen Monograph

                  BRIG
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program brigatinib - For the treatment of anaplastic lymphoma kinase-positive locally advanced or metastatic non-small cell lung cancer, based on criteria
                  Drugs Used:
                  brigatinib
                  nid:
                  327590
                  Quick Link(s):
                  Regimen Monograph

                  CAPE
                  NEW Jul 2026
                  Cancer Type:
                  Unknown Primary
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit capecitabine
                  Drugs Used:
                  capecitabine
                  nid:
                  326257
                  Quick Link(s):
                  Regimen Monograph

                  CETU
                  Jul 2026
                  Cancer Type:
                  Skin, Squamous Cell
                  Intent:
                  Palliative
                  Drugs Used:
                  cetuximab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  325850
                  Quick Link(s):
                  Regimen Monograph

                  CAPECRBP+NIVL
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Esophagus, Gastric Stomach
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab - First-line Treatment of Advanced Gastric, Esophageal, and Esophagogastric Junction Adenocarcinoma
                  Drugs Used:
                  nivolumab , CARBOplatin , capecitabine
                  nid:
                  328032
                  Quick Link(s):
                  Regimen Monograph

                  AVEL
                  Jul 2026
                  Cancer Type:
                  Skin, Merkel Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Avelumab - Metastatic Merkel Cell Carcinoma
                  Drugs Used:
                  avelumab
                  nid:
                  326342
                  Quick Link(s):
                  Regimen Monograph

                  CAPE(RT)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Adjuvant
                  Funding Program:
                  ODB - General Benefit capecitabine
                  Drugs Used:
                  capecitabine
                  nid:
                  325891
                  Quick Link(s):
                  Regimen Monograph

                  BLIN
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Lymphoblastic (ALL)
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Blinatumomab - Relapsed or Refractory Acute Lymphoblastic Leukemia (Ph- BCP-ALL)
                  Drugs Used:
                  blinatumomab
                  nid:
                  325963
                  Quick Link(s):
                  Regimen Monograph

                  CISPPACL+CEMI
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Cemiplimab - In Combination with Chemotherapy for First-Line Treatment of Advanced Non-Small Cell Lung Cancer
                  Drugs Used:
                  PACLitaxel , CISplatin , cemiplimab
                  nid:
                  328552
                  Quick Link(s):
                  Regimen Monograph

                  BELA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Drugs Used:
                  belantamab mafodotin
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327782
                  Quick Link(s):
                  Regimen Monograph

                  AFAT
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program AFAtinib - For first-line monotherapy in patients with advanced or metastatic non-small cell lung cancer (NSCLC), according to specific criteria
                  Drugs Used:
                  AFAtinib
                  nid:
                  291555
                  Quick Link(s):
                  Regimen Monograph

                  BEVA+PEMB(MNT)
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Cervix
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Bevacizumab (Biosimilar) - Metastatic (Stage IVB), Persistent, or Recurrent Carcinoma of the Cervix
                  Drugs Used:
                  pembrolizumab , bevacizumab
                  nid:
                  328358
                  Quick Link(s):
                  Regimen Monograph

                  ABEMLETR
                  Jul 2026
                  Cancer Type:
                  Breast
                  Funding Program:
                  Exceptional Access Program abemaciclib - For the adjuvant treatment, in combination with endocrine therapy, of adult patients with HR-positive, HER2-negative, node-positive early breast cancer at high risk of disease recurrence, according to specific criteria ODB - General Benefit letrozole
                  Drugs Used:
                  abemaciclib , letrozole
                  nid:
                  327669
                  Quick Link(s):
                  Regimen Monograph

                  ALPEFLVS
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit fulvestrant
                  Drugs Used:
                  fulvestrant , alpelisib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327895
                  Quick Link(s):
                  Regimen Monograph

                  ARSEATRA(CONS HI)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Promyelocytic (APL)
                  Intent:
                  Curative
                  Funding Program:
                  Exceptional Access Program tretinoin (ATRA) New Drug Funding Program Arsenic Trioxide - Relapsed_Refractory Consolidation of Acute Promyelocytic Leukemia (APL)
                  Drugs Used:
                  tretinoin (ATRA) , arsenic trioxide
                  nid:
                  326227
                  Quick Link(s):
                  Regimen Monograph

                  CEMI
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Cemiplimab - Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
                  Drugs Used:
                  cemiplimab
                  nid:
                  328635
                  Quick Link(s):
                  Regimen Monograph

                  BEVA
                  Jul 2026
                  Cancer Type:
                  Central Nervous System
                  Intent:
                  Palliative
                  Drugs Used:
                  bevacizumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  94267
                  Quick Link(s):
                  Regimen Monograph

                  CAPECISP+NIVL
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Esophagus, Gastric Stomach
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab - First-line Treatment of Advanced Gastric, Esophageal, and Esophagogastric Junction Adenocarcinoma
                  Drugs Used:
                  nivolumab , CISplatin , capecitabine
                  nid:
                  328031
                  Quick Link(s):
                  Regimen Monograph

                  CHLO
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Leukemia - Chronic Lymphocytic (CLL), Lymphoma - Non-Hodgkin's High Grade
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit prednisone
                  Drugs Used:
                  chlorambucil
                  nid:
                  94755
                  Quick Link(s):
                  Regimen Monograph

                  CAPE
                  NEW Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix
                  Funding Program:
                  ODB - General Benefit capecitabine
                  Drugs Used:
                  capecitabine
                  nid:
                  94289
                  Quick Link(s):
                  Regimen Monograph

                  CAPECISP+TRAS
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Trastuzumab (Biosimilar) - Advanced Gastric, Gastroesophageal, or Esophageal Cancer ODB - General Benefit capecitabine
                  Drugs Used:
                  trastuzumab , CISplatin , capecitabine
                  nid:
                  94293
                  Quick Link(s):
                  Regimen Monograph

                  AXIT
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program aXitinib - For second or third line treatment of advanced renal cell carcinoma, based on criteria
                  Drugs Used:
                  aXitinib
                  nid:
                  155812
                  Quick Link(s):
                  Regimen Monograph

                  CARFDEXALENA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Carfilzomib (Triplet Therapy) - In Combination with Lenalidomide and Dexamethasone for Relapsed Multiple Myeloma ODB - General Benefit dexamethasone ODB Limited Use lenalidomide - For the treatment of patients with multiple myeloma, who are deemed to be lenalidomide sensitive, and/or have not experienced progression while on a lenalidomide-based regimen in the treatment or maintenance setting, according to specific criteria
                  Drugs Used:
                  carfilzomib , dexamethasone , lenalidomide
                  nid:
                  325972
                  Quick Link(s):
                  Regimen Monograph

                  CISPPEME+OSIM
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program osimertinib - In combination with pemetrexed and platinum-based chemotherapy for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC), based on criteria
                  Drugs Used:
                  pemetrexed , CISplatin , osimertinib
                  nid:
                  328555
                  Quick Link(s):
                  Regimen Monograph

                  AZCTIVOS
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Myeloid (AML)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program Ivosidenib in combination with Azacitidine (Outpatient) - Previously Untreated Acute Myeloid Leukemia New Drug Funding Program Azacitidine in combination with Ivosidenib (Outpatient) - Previously Untreated Acute Myeloid Leukemia
                  Drugs Used:
                  ivosidenib , azaCITIDine
                  nid:
                  328730
                  Quick Link(s):
                  Regimen Monograph

                  ABEMTMXF
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Adjuvant
                  Funding Program:
                  Exceptional Access Program abemaciclib - For the adjuvant treatment, in combination with endocrine therapy, of adult patients with HR-positive, HER2-negative, node-positive early breast cancer at high risk of disease recurrence, according to specific criteria ODB - General Benefit tamoxifen
                  Drugs Used:
                  abemaciclib , tamoxifen
                  nid:
                  328122
                  Quick Link(s):
                  Regimen Monograph

                  ABIROLAPPRED
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Prostate
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit prednisone Exceptional Access Program olaparib - In combination with abiraterone, and prednisone or prednisolone for the treatment of metastatic castration resistant prostate cancer (mCRPC), based on criteria
                  Drugs Used:
                  abiraterone , olaparib , prednisone
                  nid:
                  328590
                  Quick Link(s):
                  Regimen Monograph

                  BEVA
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Ovary
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Bevacizumab (Biosimilar) with Paclitaxel and Carboplatin - Front-line Treatment (Previously Untreated) Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
                  Drugs Used:
                  bevacizumab
                  nid:
                  325981
                  Quick Link(s):
                  Regimen Monograph

                  COBIVEMU
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program vemURAFenib - In combination with cobimetinib for the treatment of patients with previously untreated BRAF V600 mutation-positive unresectable stage Ill or stage IV melanoma, with specific criteria
                  Drugs Used:
                  cobimetinib , vemURAFenib
                  nid:
                  326033
                  Quick Link(s):
                  Regimen Monograph

                  AMIV
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Drugs Used:
                  amivantamab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328198
                  Quick Link(s):
                  Regimen Monograph

                  CLAD+RITU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Hairy Cell, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Rituximab (Biosimilar IV) and Rituximab SC - Maintenance Treatment - Lymphoma
                  Drugs Used:
                  cladribine , riTUXimab
                  nid:
                  325933
                  Quick Link(s):
                  Regimen Monograph

                  CAPIFLVS
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program capivasertib - For the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer, based on criteria ODB - General Benefit fulvestrant
                  Drugs Used:
                  capivasertib , fulvestrant
                  nid:
                  328548
                  Quick Link(s):
                  Regimen Monograph

                  CAPE+BEVA
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit capecitabine New Drug Funding Program Bevacizumab (Biosimilar) - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer
                  Drugs Used:
                  capecitabine , bevacizumab
                  nid:
                  306312
                  Quick Link(s):
                  Regimen Monograph

                  CLDN
                  Jul 2026
                  Intent:
                  Palliative
                  Funding Program:
                  ODB Limited Use clodronate - For the control and prophylaxis of hypercalcemia of malignancy (capsules)
                  Drugs Used:
                  clodronate
                  nid:
                  94703
                  Quick Link(s):
                  Regimen Monograph

                  ASCI
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Myeloid (CML)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program asciminib - For the treatment of Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase, based on criteria
                  Drugs Used:
                  asciminib
                  nid:
                  328118
                  Quick Link(s):
                  Regimen Monograph

                  CISPPEME+CEMI
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Cemiplimab - In Combination with Chemotherapy for First-Line Treatment of Advanced Non-Small Cell Lung Cancer
                  Drugs Used:
                  pemetrexed , CISplatin , cemiplimab
                  nid:
                  328550
                  Quick Link(s):
                  Regimen Monograph

                  ABFM(INTERIM MNT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Lymphoblastic (ALL)
                  Intent:
                  Curative
                  Funding Program:
                  New Drug Funding Program Calaspargase Pegol (Outpatient) - Newly Diagnosed Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed_Biphenotypic Leukemia
                  Drugs Used:
                  vinCRIStine , methotrexate , pegaspargase
                  nid:
                  328462
                  Quick Link(s):
                  Regimen Monograph

                  BELZ
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney, Endocrine, Pancreatic Neuroendocrine
                  Funding Program:
                  Exceptional Access Program Belzutifan – For the treatment of adult patients with von Hippel-Lindau (VHL) disease, based on criteria
                  Drugs Used:
                  belzutifan
                  nid:
                  328331
                  Quick Link(s):
                  Regimen Monograph

                  CAPECISP+PEMB; CAPE+PEMB
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - First-line Treatment of Advanced HER2-negative Esophageal, Gastric, and Esophagogastric Junction Carcinoma ODB - General Benefit capecitabine
                  Drugs Used:
                  pembrolizumab , CISplatin , capecitabine
                  nid:
                  328497
                  Quick Link(s):
                  Regimen Monograph

                  CALGB8811(IND)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Lymphoblastic (ALL)
                  Funding Program:
                  New Drug Funding Program Calaspargase Pegol (Outpatient) - Newly Diagnosed Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed_Biphenotypic Leukemia
                  Drugs Used:
                  pegaspargase , vinCRIStine
                  nid:
                  326194
                  Quick Link(s):
                  Regimen Monograph

                  BEND+OBIN
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma
                  Drugs Used:
                  oBINutuzumab , bendamustine
                  nid:
                  326236
                  Quick Link(s):
                  Regimen Monograph

                  CETU
                  Jul 2026
                  Cancer Type:
                  Head and Neck
                  Intent:
                  Palliative
                  Drugs Used:
                  cetuximab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  326241
                  Quick Link(s):
                  Regimen Monograph

                  CAPECRBP+TRAS
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit capecitabine
                  Drugs Used:
                  trastuzumab , CARBOplatin , capecitabine
                  QBP Type:
                  PDRP prior authorization Prior authorization is required for PDRP funding of this drug within this regimen
                  nid:
                  326076
                  Quick Link(s):
                  Regimen Monograph

                  CAPE(RT)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Small bowel and appendix
                  Intent:
                  Neoadjuvant
                  Funding Program:
                  ODB - General Benefit capecitabine
                  Drugs Used:
                  capecitabine
                  nid:
                  326356
                  Quick Link(s):
                  Regimen Monograph

                  CABO
                  Jul 2026
                  Cancer Type:
                  Endocrine, Thyroid
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program cabozantinib - For the treatment of adult patients with locally advanced or metastatic differentiated thyroid carcinoma that has progressed following prior VEGFR-targeted therapy and who are radioactive iodine-refractory or ineligible
                  Drugs Used:
                  cabozantinib (tablet)
                  nid:
                  328464
                  Quick Link(s):
                  Regimen Monograph

                  CLAD
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Hairy Cell, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Drugs Used:
                  cladribine
                  nid:
                  94509
                  Quick Link(s):
                  Regimen Monograph

                  BREN
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - T-cell, Rare Diseases, Lymphoma - Non-Hodgkin's Intermediate Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Brentuximab Vedotin - Previously Treated Primary Cutaneous Anaplastic Large Cell Lymphoma or Mycosis Fungoides
                  Drugs Used:
                  brentuximab vedotin
                  nid:
                  328037
                  Quick Link(s):
                  Regimen Monograph

                  FCM(PO)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit cyclophosphamide - oral tablets
                  Drugs Used:
                  fludarabine , cyclophosphamide , mitoXANTRONE
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  325967
                  Quick Link(s):
                  Regimen Monograph

                  ERDA
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Bladder Urothelial
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program erdafitinib - For the treatment of locally advanced unresectable or metastatic urothelial carcinoma, according to specific criteria
                  Drugs Used:
                  erdafitinib
                  nid:
                  328015
                  Quick Link(s):
                  Regimen Monograph

                  DURV
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Curative
                  Funding Program:
                  New Drug Funding Program Durvalumab - Locally Advanced Unresectable Stage III Non-Small Cell Lung Cancer Following Concurrent Chemoradiation
                  Drugs Used:
                  durvalumab
                  nid:
                  327542
                  Quick Link(s):
                  Regimen Monograph

                  CRBPPEME+PEMB
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - In Combination with Platinum and Pemetrexed for First Line Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
                  Drugs Used:
                  pembrolizumab , pemetrexed , CARBOplatin
                  nid:
                  327518
                  Quick Link(s):
                  Regimen Monograph

                  DURV(MNT)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Adjuvant
                  Funding Program:
                  New Drug Funding Program Durvalumab - In Combination with FLOT for (Neo)adjuvant Gastric or Gastroesophageal Junction Adenocarcinoma
                  Drugs Used:
                  durvalumab
                  nid:
                  328879
                  Quick Link(s):
                  Regimen Monograph

                  CRBPGEMC+TISL
                  Jul 2026
                  Cancer Type:
                  Head and Neck, Nasopharynx
                  Intent:
                  Palliative
                  Drugs Used:
                  , tislelizumab gemcitabine , CARBOplatin
                  QBP Type:
                  Compassionate This drug is not publicly funded. Universal compassionate access program is available.
                  nid:
                  328493
                  Quick Link(s):
                  Regimen Monograph

                  DASA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Myeloid (CML)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program daSAtinib - Accelerated phase or blast phase Ph+ CML with documented resistance or intolerance to imatinib, with specific criteria
                  Drugs Used:
                  daSATinib
                  nid:
                  94121
                  Quick Link(s):
                  Regimen Monograph

                  ESHAP
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Hodgkin
                  Intent:
                  Curative
                  Drugs Used:
                  etoposide , CISplatin , cytarabine , methylprednisolone
                  nid:
                  326163
                  Quick Link(s):
                  Regimen Monograph

                  DURV
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Bladder Urothelial
                  Intent:
                  Palliative
                  Drugs Used:
                  durvalumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327439
                  Quick Link(s):
                  Regimen Monograph

                  DEXAPOMA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program pomalidomide - As dual therapy in combination with dexamethasone, for patients with relapsed and/or refractory multiple myeloma, according to specific criteria ODB - General Benefit dexamethasone
                  Drugs Used:
                  pomalidomide , dexamethasone
                  nid:
                  294856
                  Quick Link(s):
                  Regimen Monograph

                  ENTR
                  Jul 2026
                  Cancer Type:
                  Breast, Endocrine, Adrenal, Neuroendocrine, Thymoma, Thyroid, Pancreatic Neuroendocrine, Parathyroid, Gastrointestinal, Anus, Colorectal, Esophagus, Gastric Stomach, Hepatobiliary Liver Bile Duct, Pancreas, Rectal, Small bowel and appendix, Neuroendocrine (GI), Gastrointestinal Stromal Tumours, Mesothelioma (Peritoneal), Genitourinary, Bladder Urothelial, Penile, Prostate, Renal cell Kidney, Testis, Gynecologic, Cervix, Endometrial, Gestational Trophoblastic Disease, Ovary, Uterine Sarcoma, Vulva, Germ Cell, Vagina, Head and Neck, Larynx, Pharynx, Nasopharynx, Paranasal Sinus, Oral, Salivary Gland, Squamous Cell, Lung, Mesothelioma (Pleural), Non-Small Cell, Small Cell, Neuroendocrine (Lung), Skin, Basal Cell, Merkel Cell, Squamous Cell, Melanoma, Sarcoma, Ewing's, GIST, Osteogenic Bone, Soft Tissue, Ewing's and Soft Tissue, Uterine, Desmoid Tumour, Wilm's Tumour, Giant Cell Tumour, Kaposi's Sarcoma, Unknown Primary
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program entrectinib - Treatment of patients with unresectable locally advanced, or metastatic solid extracranial tumours documented to have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion without a known acquired resistance mutation, according to specific criteria
                  Drugs Used:
                  entrectinib
                  nid:
                  328366
                  Quick Link(s):
                  Regimen Monograph

                  GEFI
                  Jul 2026
                  Intent:
                  Palliative
                  Drugs Used:
                  gefitinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  307025
                  Quick Link(s):
                  Regimen Monograph

                  EVER
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Neuroendocrine (GI)
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit everolimus
                  Drugs Used:
                  everolimus
                  nid:
                  127745
                  Quick Link(s):
                  Regimen Monograph

                  DARA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Drugs Used:
                  daratumumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  326100
                  Quick Link(s):
                  Regimen Monograph

                  FLVSINAVPALB
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program palbociclib - For the treatment of patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER 2)-negative, unresectable locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant, according to specific criteria ODB - General Benefit fulvestrant
                  Drugs Used:
                  , inavolisib palbociclib , fulvestrant
                  nid:
                  328773
                  Quick Link(s):
                  Regimen Monograph

                  CRBPGEMC+PEMB
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - In Combination with Carboplatin and Paclitaxel for First-Line Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
                  Drugs Used:
                  pembrolizumab , CARBOplatin , gemcitabine
                  QBP Type:
                  PDRP prior authorization Prior authorization is required for PDRP funding of this drug within this regimen
                  nid:
                  327843
                  Quick Link(s):
                  Regimen Monograph

                  DENO
                  Jul 2026
                  Cancer Type:
                  Breast, Lung, Non-Small Cell, Unknown Primary, Mesothelioma (Pleural), Thymoma, Genitourinary, Renal cell Kidney, Small Cell
                  Intent:
                  Palliative
                  Drugs Used:
                  denosumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  326160
                  Quick Link(s):
                  Regimen Monograph

                  DASA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Lymphoblastic (ALL)
                  Funding Program:
                  Exceptional Access Program daSAtinib - PH+ ALL, with specific criteria
                  Drugs Used:
                  daSATinib
                  nid:
                  326111
                  Quick Link(s):
                  Regimen Monograph

                  FLTM
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Prostate
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit flutamide
                  Drugs Used:
                  flutamide
                  nid:
                  303247
                  Quick Link(s):
                  Regimen Monograph

                  CRBPIRIN
                  Jul 2026
                  Cancer Type:
                  Lung, Small Cell, Breast, Gastrointestinal, Colorectal, Esophagus, Gastric Stomach, Hepatobiliary Liver Bile Duct, Pancreas, Genitourinary, Bladder Urothelial, Prostate, Gynecologic, Cervix, Endometrial, Ovary, Head and Neck, Central Nervous System
                  Drugs Used:
                  CARBOplatin , irinotecan
                  nid:
                  327626
                  Quick Link(s):
                  Regimen Monograph

                  DURV(MNT)
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Endometrial
                  Drugs Used:
                  durvalumab
                  QBP Type:
                  Compassionate This drug is not publicly funded. Universal compassionate access program is available.
                  nid:
                  328732
                  Quick Link(s):
                  Regimen Monograph

                  CYTA(LD)VENE
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Myeloid (AML)
                  Intent:
                  Palliative
                  Drugs Used:
                  cytarabine , venetoclax
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328330
                  Quick Link(s):
                  Regimen Monograph

                  ENFO+PEMB
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Bladder Urothelial
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Enfortumab Vedotin with Pembrolizumab - Previously Untreated Locally Advanced Unresectable or Metastatic Urothelial Cancer
                  Drugs Used:
                  enfortumab vedotin , pembrolizumab
                  nid:
                  328559
                  Quick Link(s):
                  Regimen Monograph

                  ERLO
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Vulva
                  Intent:
                  Palliative
                  Drugs Used:
                  erlotinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  325910
                  Quick Link(s):
                  Regimen Monograph

                  DABR
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program daBRAfenib - As monotherapy for the treatment of patients with BRAF V600 mutation-positive unresectable melanoma or metastatic disease, according to specific criteria
                  Drugs Used:
                  daBRAFenib
                  nid:
                  284188
                  Quick Link(s):
                  Regimen Monograph

                  ENZL
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Prostate
                  Funding Program:
                  Exceptional Access Program enzalutamide - For the treatment of patients with non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk of metastasis (high-risk BCR), based on criteria
                  Drugs Used:
                  enzalutamide
                  nid:
                  281150
                  Quick Link(s):
                  Regimen Monograph

                  FOLFIRI+ENCO+PNTM
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Panitumumab - In Combination with Encorafenib and Chemotherapy for Previously Untreated Metastatic Colorectal Cancer Exceptional Access Program Encorafenib - In combination with panitumumab and chemotherapy for previously untreated metastatic colorectal cancer, according to specific criteria
                  Drugs Used:
                  PANitumumab , irinotecan , leucovorin , fluorouracil , encorafenib
                  nid:
                  328883
                  Quick Link(s):
                  Regimen Monograph

                  ENHE
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Trastuzumab Deruxtecan - HER2-low Unresectable Locally Advanced or Metastatic Breast Cancer
                  Drugs Used:
                  Enhertu trastuzumab deruxtecan
                  nid:
                  328016
                  Quick Link(s):
                  Regimen Monograph

                  DEXAPOMA+BELA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit dexamethasone
                  Drugs Used:
                  , belantamab mafodotin pomalidomide , dexamethasone
                  QBP Type:
                  Compassionate This drug is not publicly funded. Universal compassionate access program is available. Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328746
                  Quick Link(s):
                  Regimen Monograph

                  FCM+R
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Rituximab (Biosimilar IV) and Rituximab SC - Second Line - Chronic Lymphocytic Leukemia
                  Drugs Used:
                  riTUXimab , mitoXANTRONE , fludarabine , cyclophosphamide , riTUXimab (subcut)
                  QBP Type:
                  PDRP prior authorization Prior authorization is required for PDRP funding of this drug within this regimen
                  nid:
                  325927
                  Quick Link(s):
                  Regimen Monograph

                  FC(PO)+R
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit cyclophosphamide - oral tablets New Drug Funding Program Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Indolent Lymphoma
                  Drugs Used:
                  riTUXimab , fludarabine , cyclophosphamide , riTUXimab (subcut)
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  307276
                  Quick Link(s):
                  Regimen Monograph

                  DURV(MNT)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Hepatobiliary Liver Bile Duct
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Durvalumab in combination with Tremelimumab - Previously Untreated Unresectable or Metastatic Hepatocellular Carcinoma (HCC)
                  Drugs Used:
                  durvalumab
                  nid:
                  328256
                  Quick Link(s):
                  Regimen Monograph

                  DARO(MNT)
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Prostate
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program darolutamide - For the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC) in combination with docetaxel, based on criteria
                  Drugs Used:
                  darolutamide
                  nid:
                  328333
                  Quick Link(s):
                  Regimen Monograph

                  CRBPETOP
                  Jul 2026
                  Cancer Type:
                  Lung, Small Cell, Head and Neck, Gastrointestinal, Colorectal, Gastric Stomach, Esophagus, Hepatobiliary Liver Bile Duct, Pancreas, Genitourinary, Prostate, Bladder Urothelial
                  Intent:
                  Adjuvant
                  Drugs Used:
                  CARBOplatin , etoposide
                  nid:
                  306530
                  Quick Link(s):
                  Regimen Monograph

                  DURV+TREM
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Hepatobiliary Liver Bile Duct
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Durvalumab in combination with Tremelimumab - Previously Untreated Unresectable or Metastatic Hepatocellular Carcinoma (HCC)
                  Drugs Used:
                  tremelimumab , durvalumab
                  nid:
                  328295
                  Quick Link(s):
                  Regimen Monograph

                  ENAS
                  Jul 2026
                  Intent:
                  Palliative
                  Drugs Used:
                  enasidenib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327650
                  Quick Link(s):
                  Regimen Monograph

                  DANAFARBER(INT-CALA)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Lymphoblastic (ALL)
                  Intent:
                  Curative
                  Funding Program:
                  ODB - General Benefit mercaptopurine New Drug Funding Program Calaspargase Pegol (Outpatient) - Newly Diagnosed Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed_Biphenotypic Leukemia
                  Drugs Used:
                  DOXOrubicin , vinCRIStine , dexamethasone , mercaptopurine , calaspargase pegol , methotrexate , cytarabine , hydrocortisone
                  nid:
                  328576
                  Quick Link(s):
                  Regimen Monograph

                  EVERLENV
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit everolimus
                  Drugs Used:
                  lenvatinib , everolimus
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327737
                  Quick Link(s):
                  Regimen Monograph

                  FLVSPALB
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program palbociclib - For the treatment of patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER 2)-negative, unresectable locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant, according to specific criteria ODB - General Benefit fulvestrant
                  Drugs Used:
                  palbociclib , fulvestrant
                  nid:
                  326344
                  Quick Link(s):
                  Regimen Monograph

                  CRBPPACL+BEVA
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Ovary
                  Funding Program:
                  New Drug Funding Program Bevacizumab (Biosimilar) with Paclitaxel and Carboplatin - Front-line Treatment (Previously Untreated) Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
                  Drugs Used:
                  PACLitaxel , CARBOplatin , bevacizumab
                  nid:
                  308222
                  Quick Link(s):
                  Regimen Monograph

                  DARA(MNT-SC)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma, Amyloidosis
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Daratumumab and Bortezomib in combo with Cyclophosphamide and Dexamethasone - Previously Untreated Light Chain (AL) Amyloidosis
                  Drugs Used:
                  daratumumab (subcut)
                  nid:
                  328210
                  Quick Link(s):
                  Regimen Monograph

                  CYTA(SC)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Myeloid (AML)
                  Intent:
                  Palliative
                  Drugs Used:
                  cytarabine
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327784
                  Quick Link(s):
                  Regimen Monograph

                  DARODOCE
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Prostate
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program darolutamide - For the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC) in combination with docetaxel, based on criteria
                  Drugs Used:
                  DOCEtaxel , darolutamide
                  nid:
                  328332
                  Quick Link(s):
                  Regimen Monograph

                  ENHE
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Trastuzumab Deruxtecan - Previously Treated Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
                  Drugs Used:
                  Enhertu trastuzumab deruxtecan
                  nid:
                  328558
                  Quick Link(s):
                  Regimen Monograph

                  CRBPFU+NIVL
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab - First-line Treatment of Advanced Gastric, Esophageal, and Esophagogastric Junction Adenocarcinoma
                  Drugs Used:
                  nivolumab , CARBOplatin , fluorouracil
                  nid:
                  328029
                  Quick Link(s):
                  Regimen Monograph

                  CRBPNPAC
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Cervix, Endometrial, Ovary
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nab-Paclitaxel - Hypersensitivity Reactions to Taxanes
                  Drugs Used:
                  nab-PACLitaxel , CARBOplatin
                  nid:
                  327915
                  Quick Link(s):
                  Regimen Monograph

                  FRUQ
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program fruquintinib - For the treatment of metastatic colorectal cancer according to specific criteria
                  Drugs Used:
                  fruquintinib
                  nid:
                  328547
                  Quick Link(s):
                  Regimen Monograph

                  GEFI
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program gefitinib - First-line monotherapy in locally advanced (not amenable to curative therapy) or metastatic NSCLC patients who have activating mutations of EGFR-TK, with specific criteria
                  Drugs Used:
                  gefitinib
                  nid:
                  94673
                  Quick Link(s):
                  Regimen Monograph

                  DURV
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Bladder Urothelial
                  Drugs Used:
                  durvalumab
                  QBP Type:
                  Compassionate This drug is not publicly funded. Universal compassionate access program is available.
                  nid:
                  328771
                  Quick Link(s):
                  Regimen Monograph

                  ELRA; ELRA(RAMP)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Drugs Used:
                  elranatamab
                  QBP Type:
                  Compassionate This drug is not publicly funded. Universal compassionate access program is available.
                  nid:
                  328444
                  Quick Link(s):
                  Regimen Monograph

                  DOCE+TRAS
                  Jul 2026
                  Cancer Type:
                  Head and Neck, Salivary Gland
                  Intent:
                  Palliative
                  Drugs Used:
                  trastuzumab , DOCEtaxel
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328218
                  Quick Link(s):
                  Regimen Monograph

                  DARADEXALENA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Daratumumab in Combination with Lenalidomide and Dexamethasone for Newly Diagnosed Transplant Ineligible Multiple Myeloma ODB - General Benefit dexamethasone ODB Limited Use lenalidomide - For the treatment of patients with multiple myeloma, who are deemed to be lenalidomide sensitive, and/or have not experienced progression while on a lenalidomide-based regimen in the treatment or maintenance setting, according to specific criteria
                  Drugs Used:
                  daratumumab , dexamethasone , lenalidomide
                  nid:
                  326152
                  Quick Link(s):
                  Regimen Monograph

                  DARA(MNT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Daratumumab in Combination with a Bortezomib-Based Regimen for Newly Diagnosed Transplant Ineligible Multiple Myeloma
                  Drugs Used:
                  daratumumab
                  nid:
                  327635
                  Quick Link(s):
                  Regimen Monograph

                  DACO
                  Jul 2026
                  Intent:
                  Palliative
                  Drugs Used:
                  dacomitinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327686
                  Quick Link(s):
                  Regimen Monograph

                  FLUD(PO)+OBIN
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma
                  Drugs Used:
                  oBINutuzumab , fludarabine
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327599
                  Quick Link(s):
                  Regimen Monograph

                  DENO
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Drugs Used:
                  denosumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327619
                  Quick Link(s):
                  Regimen Monograph

                  EVER
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit everolimus
                  Drugs Used:
                  everolimus
                  nid:
                  94661
                  Quick Link(s):
                  Regimen Monograph

                  FC(PO)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit cyclophosphamide - oral tablets
                  Drugs Used:
                  fludarabine , cyclophosphamide
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  325936
                  Quick Link(s):
                  Regimen Monograph

                  EXEMPALB
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit exemestane Exceptional Access Program palbociclib - For the treatment of patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER 2)-negative, unresectable locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant, according to specific criteria
                  Drugs Used:
                  exemestane , palbociclib
                  nid:
                  327618
                  Quick Link(s):
                  Regimen Monograph

                  DABRTRAM
                  Jul 2026
                  Cancer Type:
                  Central Nervous System
                  Intent:
                  Palliative
                  Drugs Used:
                  daBRAFenib , trametinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328214
                  Quick Link(s):
                  Regimen Monograph

                  FLUD(PO)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Drugs Used:
                  fludarabine
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  94767
                  Quick Link(s):
                  Regimen Monograph

                  FLVSRIBO
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program ribociclib - For the treatment of patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER 2)-negative, unresectable locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant, according to specific criteria ODB - General Benefit fulvestrant
                  Drugs Used:
                  ribociclib , fulvestrant
                  nid:
                  327667
                  Quick Link(s):
                  Regimen Monograph

                  FLUD(PO)+R
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Rituximab (Biosimilar IV) and Rituximab SC - Second Line - Chronic Lymphocytic Leukemia
                  Drugs Used:
                  riTUXimab , fludarabine , riTUXimab (subcut)
                  QBP Type:
                  PDRP prior authorization Prior authorization is required for PDRP funding of this drug within this regimen
                  nid:
                  325931
                  Quick Link(s):
                  Regimen Monograph

                  ENFO
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Bladder Urothelial
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Enfortumab Vedotin - Previously Treated Advanced or Metastatic Urothelial Cancer
                  Drugs Used:
                  enfortumab vedotin
                  nid:
                  328014
                  Quick Link(s):
                  Regimen Monograph

                  CYCL(PO)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Leukemia - Chronic Lymphocytic (CLL), Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit cyclophosphamide - oral tablets
                  Drugs Used:
                  cyclophosphamide
                  nid:
                  94867
                  Quick Link(s):
                  Regimen Monograph

                  DEXAPOMA+ISAT
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Isatuximab - In Combination with Pomalidomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma Exceptional Access Program pomalidomide - In combination with isatuximab and dexamethasone for relapsed and/or refractory multiple myeloma, according to specific criteria ODB - General Benefit dexamethasone
                  Drugs Used:
                  dexamethasone , isatuximab , pomalidomide
                  nid:
                  327849
                  Quick Link(s):
                  Regimen Monograph

                  DEXAIMATVNCR
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Lymphoblastic (ALL)
                  Intent:
                  Curative
                  Funding Program:
                  ODB - General Benefit iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
                  Drugs Used:
                  dexamethasone , iMAtinib , vinCRIStine
                  nid:
                  327651
                  Quick Link(s):
                  Regimen Monograph

                  FLUD+OBIN
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma
                  Drugs Used:
                  oBINutuzumab , fludarabine
                  nid:
                  327597
                  Quick Link(s):
                  Regimen Monograph

                  ENCO+CETU
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program encorafenib - In combination with cetuximab or panitumumab in previously treated BRAF V600E-mutated metastatic colorectal cancer, based on criteria New Drug Funding Program Cetuximab - In Combination with Encorafenib for Previously Treated Metastatic Colorectal Cancer
                  Drugs Used:
                  encorafenib , cetuximab
                  nid:
                  327871
                  Quick Link(s):
                  Regimen Monograph

                  CYTA(HD)+QUIZ
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Myeloid (AML)
                  Intent:
                  Curative
                  Drugs Used:
                  cytarabine , quizartinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328845
                  Quick Link(s):
                  Regimen Monograph

                  DHAP
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Hodgkin
                  Intent:
                  Curative
                  Funding Program:
                  ODB - General Benefit dexamethasone
                  Drugs Used:
                  CISplatin , cytarabine , dexamethasone
                  nid:
                  307405
                  Quick Link(s):
                  Regimen Monograph

                  ERLO
                  Jul 2026
                  Cancer Type:
                  Head and Neck
                  Intent:
                  Palliative
                  Drugs Used:
                  erlotinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  307023
                  Quick Link(s):
                  Regimen Monograph

                  FCM(PO)+OBIN
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma ODB - General Benefit cyclophosphamide - oral tablets
                  Drugs Used:
                  oBINutuzumab , mitoXANTRONE , fludarabine , cyclophosphamide
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327593
                  Quick Link(s):
                  Regimen Monograph

                  FLUD+R
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Rituximab (Biosimilar IV) and Rituximab SC - Second Line - Chronic Lymphocytic Leukemia
                  Drugs Used:
                  riTUXimab , fludarabine , riTUXimab (subcut)
                  QBP Type:
                  PDRP prior authorization Prior authorization is required for PDRP funding of this drug within this regimen
                  nid:
                  325930
                  Quick Link(s):
                  Regimen Monograph

                  CYTA(HD)+MIDO
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Myeloid (AML)
                  Intent:
                  Curative
                  Funding Program:
                  Exceptional Access Program midostaurin - First-line treatment of adult patients diagnosed with FLT3-mutated acute myeloid leukemia, in combination with specific standard induction followed by consolidation chemotherapy, according to specific criteria
                  Drugs Used:
                  cytarabine , midostaurin
                  nid:
                  326402
                  Quick Link(s):
                  Regimen Monograph

                  EVER
                  Jul 2026
                  Cancer Type:
                  Lung, Neuroendocrine (Lung)
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit everolimus
                  Drugs Used:
                  everolimus
                  nid:
                  327426
                  Quick Link(s):
                  Regimen Monograph

                  FLUD(PO)+R
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Indolent Lymphoma
                  Drugs Used:
                  riTUXimab , fludarabine , riTUXimab (subcut)
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  120293
                  Quick Link(s):
                  Regimen Monograph

                  FC(PO)+OBIN
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma ODB - General Benefit cyclophosphamide - oral tablets
                  Drugs Used:
                  oBINutuzumab , fludarabine , cyclophosphamide
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327592
                  Quick Link(s):
                  Regimen Monograph

                  EXEMRIBO
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit exemestane Exceptional Access Program ribociclib - For the treatment of patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER 2)-negative, unresectable locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant, according to specific criteria
                  Drugs Used:
                  exemestane , ribociclib
                  nid:
                  327615
                  Quick Link(s):
                  Regimen Monograph

                  DECI
                  Jul 2026
                  Cancer Type:
                  Hematologic, Myelodysplastic Syndrome (MDS)
                  Intent:
                  Palliative
                  Drugs Used:
                  decitabine
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  307351
                  Quick Link(s):
                  Regimen Monograph

                  DEXALENA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  ODB Limited Use lenalidomide - For the treatment of patients with multiple myeloma, who are deemed to be lenalidomide sensitive, and/or have not experienced progression while on a lenalidomide-based regimen in the treatment or maintenance setting, according to specific criteria ODB - General Benefit dexamethasone
                  Drugs Used:
                  lenalidomide , dexamethasone
                  nid:
                  157146
                  Quick Link(s):
                  Regimen Monograph

                  ETOP(PO)
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Bladder Urothelial
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit etoposide - oral capsules
                  Drugs Used:
                  etoposide
                  nid:
                  326043
                  Quick Link(s):
                  Regimen Monograph

                  ETOP(PO)
                  Jul 2026
                  Cancer Type:
                  Central Nervous System
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit etoposide - oral capsules
                  Drugs Used:
                  etoposide
                  nid:
                  94157
                  Quick Link(s):
                  Regimen Monograph

                  CRBPPEME+OSIM
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program osimertinib - In combination with pemetrexed and platinum-based chemotherapy for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC), based on criteria
                  Drugs Used:
                  pemetrexed , CARBOplatin , osimertinib
                  nid:
                  328556
                  Quick Link(s):
                  Regimen Monograph

                  ETOP(PO)
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell, Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit etoposide - oral capsules
                  Drugs Used:
                  etoposide
                  nid:
                  325892
                  Quick Link(s):
                  Regimen Monograph

                  DABRTRAM
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program trametinib - In combination with dabrafenib for the treatment of BRAF V600 mutation-positive, unresectable or metastatic melanoma, according to specific criteria
                  Drugs Used:
                  daBRAFenib , trametinib
                  nid:
                  325861
                  Quick Link(s):
                  Regimen Monograph

                  CRBPRALT
                  Jul 2026
                  Cancer Type:
                  Lung, Mesothelioma (Pleural)
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Raltitrexed - Advanced Malignant Pleural Mesothelioma (MPM)
                  Drugs Used:
                  raltitrexed , CARBOplatin
                  nid:
                  311591
                  Quick Link(s):
                  Regimen Monograph

                  DASA
                  Jul 2026
                  Intent:
                  Curative
                  Funding Program:
                  Exceptional Access Program daSAtinib - Ph+ CML in the chronic phase, with specific criteria
                  Drugs Used:
                  daSATinib
                  nid:
                  101334
                  Quick Link(s):
                  Regimen Monograph

                  DEXASELI
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit dexamethasone
                  Drugs Used:
                  selinexor , dexamethasone
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327852
                  Quick Link(s):
                  Regimen Monograph

                  FEDR
                  Jul 2026
                  Cancer Type:
                  Hematologic, Myeloproliferative Neoplasms (MPNs)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program fedratinib - For the treatment of splenomegaly and/or disease related symptoms of myelofibrosis, based on criteria
                  Drugs Used:
                  fedratinib
                  nid:
                  327947
                  Quick Link(s):
                  Regimen Monograph

                  ENTR
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program entrectinib - For the treatment of locally advanced (not amenable to curative therapy) or metastatic NSCLC, based on criteria
                  Drugs Used:
                  entrectinib
                  nid:
                  328087
                  Quick Link(s):
                  Regimen Monograph

                  DENO
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Prostate
                  Intent:
                  Palliative
                  Funding Program:
                  ODB Limited Use denosumab (Wyost™ brand) - For the treatment of bony metastases for patients with hormone refractory prostate cancer as determined by an elevated PSA level, or evidence of progressive bony disease, despite castrate serum testosterone levels or having undergone orchidectomy, based on criteria New Drug Funding Program Denosumab (Biosimilar) - Hormone Refractory Prostate Cancer
                  Drugs Used:
                  denosumab
                  nid:
                  125596
                  Quick Link(s):
                  Regimen Monograph

                  EXEMRIBO
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Adjuvant
                  Funding Program:
                  ODB - General Benefit exemestane
                  Drugs Used:
                  exemestane , ribociclib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328810
                  Quick Link(s):
                  Regimen Monograph

                  EXEM
                  Jul 2026
                  Cancer Type:
                  Breast, Gynecologic, Endometrial
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit exemestane
                  Drugs Used:
                  exemestane
                  nid:
                  94165
                  Quick Link(s):
                  Regimen Monograph

                  CYTA(IT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Leukemia - Acute Lymphoblastic (ALL), Leukemia - Acute Myeloid (AML)
                  Intent:
                  Palliative
                  Drugs Used:
                  cytarabine
                  nid:
                  307444
                  Quick Link(s):
                  Regimen Monograph

                  CRBPPEME+PEMB
                  Jul 2026
                  Cancer Type:
                  Lung, Mesothelioma (Pleural), Gastrointestinal, Mesothelioma (Peritoneal)
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Previously Untreated Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
                  Drugs Used:
                  pembrolizumab , pemetrexed , CARBOplatin
                  nid:
                  328698
                  Quick Link(s):
                  Regimen Monograph

                  CRBPPACL+PEMB
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - In Combination with Carboplatin and Paclitaxel for First-Line Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
                  Drugs Used:
                  pembrolizumab , PACLitaxel , CARBOplatin
                  nid:
                  327683
                  Quick Link(s):
                  Regimen Monograph

                  CRIZ
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program crizotinib - First-line treatment for ROS1-positive locally advanced (not amenable to curative therapy) or metastatic NSCLC, according to specific criteria
                  Drugs Used:
                  crizotinib
                  nid:
                  133202
                  Quick Link(s):
                  Regimen Monograph

                  DENO
                  Jul 2026
                  Cancer Type:
                  Sarcoma, Giant Cell Tumour
                  Intent:
                  Curative
                  Drugs Used:
                  denosumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  325918
                  Quick Link(s):
                  Regimen Monograph

                  DARO
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Prostate
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program darolutamide - For the treatment of metastatic castration-sensitive prostate cancer (mCSPC), based on criteria
                  Drugs Used:
                  darolutamide
                  nid:
                  327780
                  Quick Link(s):
                  Regimen Monograph

                  EPCO; EPCO(RAMP)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Epcoritamab (Outpatient) - Relapsed or Refractory Diffuse Large B-Cell Lymphoma High Cost Therapy Funding Program Epcoritamab (Inpatient) - Relapsed or Refractory Diffuse Large B-Cell Lymphoma
                  Drugs Used:
                  epcoritamab
                  nid:
                  328445
                  Quick Link(s):
                  Regimen Monograph

                  DARADEXALENA(SC)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Daratumumab - In Combination with Lenalidomide and Dexamethasone for Relapsed Multiple Myeloma ODB - General Benefit dexamethasone ODB Limited Use lenalidomide - For the treatment of patients with multiple myeloma, who are deemed to be lenalidomide sensitive, and/or have not experienced progression while on a lenalidomide-based regimen in the treatment or maintenance setting, according to specific criteria
                  Drugs Used:
                  daratumumab (subcut) , dexamethasone , lenalidomide
                  nid:
                  328209
                  Quick Link(s):
                  Regimen Monograph

                  FCM(PO)+R
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma ODB - General Benefit cyclophosphamide - oral tablets
                  Drugs Used:
                  riTUXimab , mitoXANTRONE , fludarabine , cyclophosphamide , riTUXimab (subcut)
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  325968
                  Quick Link(s):
                  Regimen Monograph

                  DURV
                  Jul 2026
                  Cancer Type:
                  Lung, Small Cell
                  Intent:
                  Adjuvant
                  Funding Program:
                  New Drug Funding Program Durvalumab - Limited Stage Small Cell Lung Cancer
                  Drugs Used:
                  durvalumab
                  nid:
                  328608
                  Quick Link(s):
                  Regimen Monograph

                  FLUD+R
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma
                  Drugs Used:
                  riTUXimab , fludarabine , riTUXimab (subcut)
                  nid:
                  94393
                  Quick Link(s):
                  Regimen Monograph

                  DURV(MNT)
                  Jul 2026
                  Cancer Type:
                  Lung, Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Durvalumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer
                  Drugs Used:
                  durvalumab
                  nid:
                  327921
                  Quick Link(s):
                  Regimen Monograph

                  ENCO+PNTM
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program encorafenib - In combination with cetuximab or panitumumab in previously treated BRAF V600E-mutated metastatic colorectal cancer, based on criteria New Drug Funding Program Panitumumab - In Combination with Encorafenib for Previously Treated Metastatic Colorectal Cancer
                  Drugs Used:
                  encorafenib , PANitumumab
                  nid:
                  328253
                  Quick Link(s):
                  Regimen Monograph

                  GEMC
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade
                  Intent:
                  Palliative
                  Drugs Used:
                  gemcitabine
                  nid:
                  325855
                  Quick Link(s):
                  Regimen Monograph

                  GDP+OBIN
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma ODB - General Benefit dexamethasone
                  Drugs Used:
                  oBINutuzumab , gemcitabine , CISplatin , dexamethasone
                  nid:
                  327783
                  Quick Link(s):
                  Regimen Monograph

                  CRBPETOP
                  Jul 2026
                  Cancer Type:
                  Lung, Small Cell, Head and Neck, Central Nervous System, Gastrointestinal, Colorectal, Gastric Stomach, Esophagus, Hepatobiliary Liver Bile Duct, Pancreas, Genitourinary, Prostate, Bladder Urothelial, Unknown Primary
                  Intent:
                  Palliative
                  Drugs Used:
                  CARBOplatin , etoposide
                  nid:
                  94359
                  Quick Link(s):
                  Regimen Monograph

                  DABRTRAM
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Funding Program:
                  Exceptional Access Program trametinib - For the adjuvant treatment of resected Stage III cutaneous melanoma, according to specific criteria
                  Drugs Used:
                  daBRAFenib , trametinib
                  nid:
                  327631
                  Quick Link(s):
                  Regimen Monograph

                  ERLO
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program erlotinib - Incurable progressive NSCLC, with specific criteria
                  Drugs Used:
                  erlotinib
                  nid:
                  94773
                  Quick Link(s):
                  Regimen Monograph

                  DOCE+PEMB
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Neoadjuvant
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Previously Untreated High-Risk Early-Stage Triple Negative Breast Cancer
                  Drugs Used:
                  pembrolizumab , DOCEtaxel
                  nid:
                  328309
                  Quick Link(s):
                  Regimen Monograph

                  ERIB
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Eribulin - Metastatic or Incurable Locally Advanced - Breast Cancer
                  Drugs Used:
                  eriBULin
                  nid:
                  123108
                  Quick Link(s):
                  Regimen Monograph

                  ETOP(PO)
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Ovary
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit etoposide - oral capsules
                  Drugs Used:
                  etoposide
                  nid:
                  94159
                  Quick Link(s):
                  Regimen Monograph

                  CYTAMTRX(IT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's High Grade, Leukemia - Acute Lymphoblastic (ALL), Leukemia - Acute Myeloid (AML)
                  Drugs Used:
                  methotrexate , cytarabine , hydrocortisone
                  nid:
                  307446
                  Quick Link(s):
                  Regimen Monograph

                  LENA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  ODB Limited Use lenalidomide - For the maintenance treatment of patients with newly diagnosed multiple myeloma, following ASCT, who have stable disease or better, with no evidence of disease progression, according to specific criteria
                  Drugs Used:
                  lenalidomide
                  nid:
                  307208
                  Quick Link(s):
                  Regimen Monograph

                  RETI(MNT)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Anus
                  Intent:
                  Palliative
                  Drugs Used:
                  retifanlimab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328842
                  Quick Link(s):
                  Regimen Monograph

                  PEMB(MNT)
                  Jul 2026
                  Cancer Type:
                  Head and Neck, Squamous Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
                  Drugs Used:
                  pembrolizumab
                  nid:
                  327869
                  Quick Link(s):
                  Regimen Monograph

                  LOMU+BEVA
                  Jul 2026
                  Cancer Type:
                  Central Nervous System
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit lomustine New Drug Funding Program Bevacizumab (Biosimilar) - In Combination with Lomustine for Recurrent Glioblastoma
                  Drugs Used:
                  lomustine , bevacizumab
                  nid:
                  327781
                  Quick Link(s):
                  Regimen Monograph

                  MOGA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - T-cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Mogamulizumab - Relapsed or Refractory Mycosis Fungoides or Sezary Syndrome
                  Drugs Used:
                  mogamulizumab
                  nid:
                  328400
                  Quick Link(s):
                  Regimen Monograph

                  RAMU(MNT)
                  Jul 2026
                  Cancer Type:
                  Lung
                  Intent:
                  Palliative
                  Drugs Used:
                  ramucirumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328875
                  Quick Link(s):
                  Regimen Monograph

                  LENA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's High Grade
                  Intent:
                  Palliative
                  Drugs Used:
                  lenalidomide
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  326341
                  Quick Link(s):
                  Regimen Monograph

                  IMAT
                  Jul 2026
                  Cancer Type:
                  Sarcoma, GIST, Gastrointestinal, Gastrointestinal Stromal Tumours
                  Intent:
                  Adjuvant
                  Funding Program:
                  ODB - General Benefit iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
                  Drugs Used:
                  iMAtinib
                  nid:
                  94219
                  Quick Link(s):
                  Regimen Monograph

                  PENT+ALEM
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - T-cell, Rare Diseases
                  Intent:
                  Palliative
                  Drugs Used:
                  , pentostatin alemtuzumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent Compassionate This drug is not publicly funded. Universal compassionate access program is available.
                  nid:
                  327785
                  Quick Link(s):
                  Regimen Monograph

                  MEGE
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit megestrol - oral tablets
                  Drugs Used:
                  megestrol
                  nid:
                  94227
                  Quick Link(s):
                  Regimen Monograph

                  PEMB; PEMB(RT)
                  Jul 2026
                  Cancer Type:
                  Head and Neck, Squamous Cell
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - (Neo)adjuvant Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
                  Drugs Used:
                  pembrolizumab
                  nid:
                  328776
                  Quick Link(s):
                  Regimen Monograph

                  TECL; TECL(RAMP)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Teclistamab (Outpatient) - Relapsed or Refractory Multiple Myeloma High Cost Therapy Funding Program Teclistamab (Inpatient) - Relapsed or Refractory Multiple Myeloma
                  Drugs Used:
                  teclistamab
                  nid:
                  328386
                  Quick Link(s):
                  Regimen Monograph

                  MFOLFOX6+ENCO+PNTM
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Panitumumab - In Combination with Encorafenib and Chemotherapy for Previously Untreated Metastatic Colorectal Cancer Exceptional Access Program Encorafenib - In combination with panitumumab and chemotherapy for previously untreated metastatic colorectal cancer, according to specific criteria
                  Drugs Used:
                  PANitumumab , oxaliplatin , leucovorin , fluorouracil , encorafenib
                  nid:
                  328884
                  Quick Link(s):
                  Regimen Monograph

                  TMZL
                  Jul 2026
                  Cancer Type:
                  Sarcoma, Soft Tissue
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit temozolomide
                  Drugs Used:
                  temozolomide
                  nid:
                  326321
                  Quick Link(s):
                  Regimen Monograph

                  QUIZ(MNT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Myeloid (AML)
                  Intent:
                  Curative
                  Drugs Used:
                  quizartinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328846
                  Quick Link(s):
                  Regimen Monograph

                  NIVL
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab - Advanced or Metastatic Non-Small Cell Lung Cancer
                  Drugs Used:
                  nivolumab
                  nid:
                  325974
                  Quick Link(s):
                  Regimen Monograph

                  NILO
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Myeloid (CML)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program niLOtinib - Accelerated phase Ph+ CML with documented resistance or intolerance to imatinib therapy, with specific criteria
                  Drugs Used:
                  niLOtinib
                  nid:
                  100425
                  Quick Link(s):
                  Regimen Monograph

                  NIRP
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Ovary
                  Funding Program:
                  Exceptional Access Program niraparib - For the maintenance treatment of newly diagnosed or recurrent high grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, according to specific criteria
                  Drugs Used:
                  niraparib
                  nid:
                  327853
                  Quick Link(s):
                  Regimen Monograph

                  PEMB
                  Jul 2026
                  Cancer Type:
                  Head and Neck, Squamous Cell
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - (Neo)adjuvant Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
                  Drugs Used:
                  pembrolizumab
                  nid:
                  328774
                  Quick Link(s):
                  Regimen Monograph

                  LETR
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Ovary
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit letrozole
                  Drugs Used:
                  letrozole
                  nid:
                  325844
                  Quick Link(s):
                  Regimen Monograph

                  VEMU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Hairy Cell
                  Intent:
                  Palliative
                  Drugs Used:
                  vemURAFenib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328382
                  Quick Link(s):
                  Regimen Monograph

                  MTRX(PO)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade, Lymphoma - Non-Hodgkin's Intermediate Grade
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit methotrexate - oral tablets
                  Drugs Used:
                  methotrexate
                  nid:
                  307274
                  Quick Link(s):
                  Regimen Monograph

                  IVOS
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Hepatobiliary Liver Bile Duct
                  Intent:
                  Palliative
                  Drugs Used:
                  ivosidenib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328638
                  Quick Link(s):
                  Regimen Monograph

                  IBRU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program iBRUtinib - For relapsed and refractory mantle cell lymphoma, based on criteria
                  Drugs Used:
                  iBRUtinib
                  nid:
                  295023
                  Quick Link(s):
                  Regimen Monograph

                  VENE+RITU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program venetoclax - In Combination with Rituximab - Relapsed Chronic Lymphocytic Leukemia, based on criteria New Drug Funding Program Rituximab (Biosimilar IV) and Rituximab SC - In Combination with Venetoclax - Relapsed Chronic Lymphocytic Leukemia
                  Drugs Used:
                  venetoclax , riTUXimab , riTUXimab (subcut)
                  nid:
                  327654
                  Quick Link(s):
                  Regimen Monograph

                  NIVL+IPIL
                  Jul 2026
                  Cancer Type:
                  Lung, Mesothelioma (Pleural)
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab plus Ipilimumab - Advanced Malignant Pleural Mesothelioma
                  Drugs Used:
                  nivolumab , ipilimumab
                  nid:
                  327972
                  Quick Link(s):
                  Regimen Monograph

                  TOPO+BEVA
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Ovary
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Bevacizumab (Biosimilar) for Platinum-Resistant Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
                  Drugs Used:
                  topotecan , bevacizumab
                  nid:
                  326349
                  Quick Link(s):
                  Regimen Monograph

                  VENE
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program venetoclax - Treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), based on criteria
                  Drugs Used:
                  venetoclax
                  nid:
                  326156
                  Quick Link(s):
                  Regimen Monograph

                  MTTN
                  Jul 2026
                  Intent:
                  Palliative
                  Drugs Used:
                  mitotane
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327456
                  Quick Link(s):
                  Regimen Monograph

                  VAND
                  Jul 2026
                  Intent:
                  Palliative
                  Drugs Used:
                  vanDETanib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327457
                  Quick Link(s):
                  Regimen Monograph

                  NIVL
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Adjuvant
                  Funding Program:
                  New Drug Funding Program Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma
                  Drugs Used:
                  nivolumab
                  nid:
                  328719
                  Quick Link(s):
                  Regimen Monograph

                  NIVL
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab - Advanced Melanoma (Unresectable or Metastatic Melanoma)
                  Drugs Used:
                  nivolumab
                  nid:
                  325958
                  Quick Link(s):
                  Regimen Monograph

                  IMAT
                  Jul 2026
                  Cancer Type:
                  Sarcoma, GIST, Gastrointestinal, Gastrointestinal Stromal Tumours
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
                  Drugs Used:
                  iMAtinib
                  nid:
                  94221
                  Quick Link(s):
                  Regimen Monograph

                  TARL; TARL(RAMP)
                  Jul 2026
                  Cancer Type:
                  Lung, Small Cell
                  Intent:
                  Palliative
                  Drugs Used:
                  tarlatamab
                  QBP Type:
                  Compassionate This drug is not publicly funded. Universal compassionate access program is available.
                  nid:
                  328527
                  Quick Link(s):
                  Regimen Monograph

                  PERT+TRAS
                  Jul 2026
                  Cancer Type:
                  Breast
                  Funding Program:
                  New Drug Funding Program Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer
                  Drugs Used:
                  PERTuzumab , trastuzumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327728
                  Quick Link(s):
                  Regimen Monograph

                  HYDR
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Lymphoblastic (ALL), Leukemia - Acute Myeloid (AML)
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit hydroxyurea
                  Drugs Used:
                  hydroxyurea
                  nid:
                  326173
                  Quick Link(s):
                  Regimen Monograph

                  LURB
                  Jul 2026
                  Cancer Type:
                  Lung, Small Cell
                  Intent:
                  Palliative
                  Drugs Used:
                  lurbinectedin
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327970
                  Quick Link(s):
                  Regimen Monograph

                  SOTO
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Drugs Used:
                  sotorasib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328097
                  Quick Link(s):
                  Regimen Monograph

                  MPT
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit prednisone Exceptional Access Program thalidomide - Multiple myeloma in patients ≥65 years of age in combination with melphalan and prednisone, with specific criteria
                  Drugs Used:
                  melphalan , prednisone , thalidomide
                  nid:
                  307205
                  Quick Link(s):
                  Regimen Monograph

                  PEMB
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney
                  Intent:
                  Adjuvant
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Adjuvant Treatment for Renal Cell Carcinoma
                  Drugs Used:
                  pembrolizumab
                  nid:
                  328021
                  Quick Link(s):
                  Regimen Monograph

                  MIRV
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Ovary
                  Intent:
                  Palliative
                  Drugs Used:
                  mirvetuximab soravtansine
                  QBP Type:
                  Compassionate This drug is not publicly funded. Universal compassionate access program is available.
                  nid:
                  328808
                  Quick Link(s):
                  Regimen Monograph

                  LORL
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program lorlatinib - For the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer.
                  Drugs Used:
                  lorlatinib
                  nid:
                  327685
                  Quick Link(s):
                  Regimen Monograph

                  NIVL+IPIL
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal
                  Intent:
                  Palliative
                  Drugs Used:
                  nivolumab , ipilimumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327643
                  Quick Link(s):
                  Regimen Monograph

                  XELOX+ENCO+PNTM
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Panitumumab - In Combination with Encorafenib and Chemotherapy for Previously Untreated Metastatic Colorectal Cancer ODB - General Benefit capecitabine Exceptional Access Program Encorafenib - In combination with panitumumab and chemotherapy for previously untreated metastatic colorectal cancer, according to specific criteria
                  Drugs Used:
                  PANitumumab , oxaliplatin , capecitabine , encorafenib
                  nid:
                  328887
                  Quick Link(s):
                  Regimen Monograph

                  PACL(W)+PERTRAS(SC)
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Drugs Used:
                  , PERTuzumab / trastuzumab (subcut) PACLitaxel
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328167
                  Quick Link(s):
                  Regimen Monograph

                  TEBE; TEBE(RAMP)
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Tebentafusp (Outpatient) - Unresectable or Metastatic Uveal Melanoma High Cost Therapy Funding Program Tebentafusp (Inpatient) - Unresectable or Metastatic Uveal Melanoma
                  Drugs Used:
                  tebentafusp
                  nid:
                  328289
                  Quick Link(s):
                  Regimen Monograph

                  NIVL(MNT)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab - First-line Treatment of Advanced Gastric, Esophageal, and Esophagogastric Junction Adenocarcinoma
                  Drugs Used:
                  nivolumab
                  nid:
                  328262
                  Quick Link(s):
                  Regimen Monograph

                  NIVL+IPIL
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab plus Ipilimumab - MSI-H/dMMR Locally Advanced Unresectable or Metastatic Colorectal Cancer
                  Drugs Used:
                  nivolumab , ipilimumab
                  nid:
                  328767
                  Quick Link(s):
                  Regimen Monograph

                  TISL(MNT)
                  Jul 2026
                  Cancer Type:
                  Head and Neck, Nasopharynx
                  Intent:
                  Palliative
                  Drugs Used:
                  tislelizumab
                  QBP Type:
                  Compassionate This drug is not publicly funded. Universal compassionate access program is available.
                  nid:
                  328491
                  Quick Link(s):
                  Regimen Monograph

                  NIVL+IPIL
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab plus Ipilimumab - Metastatic Renal Cell Carcinoma
                  Drugs Used:
                  nivolumab , ipilimumab
                  nid:
                  327527
                  Quick Link(s):
                  Regimen Monograph

                  REGO
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal
                  Intent:
                  Palliative
                  Drugs Used:
                  regorafenib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  278079
                  Quick Link(s):
                  Regimen Monograph

                  PEMB
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Adjuvant
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - (Neo)adjuvant Therapy for Resectable Non-Small Cell Lung Cancer
                  Drugs Used:
                  pembrolizumab
                  nid:
                  328537
                  Quick Link(s):
                  Regimen Monograph

                  TRAS
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Adjuvant
                  Funding Program:
                  New Drug Funding Program Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer
                  Drugs Used:
                  trastuzumab
                  nid:
                  94849
                  Quick Link(s):
                  Regimen Monograph

                  NIVL+IPIL(MNT)
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab plus Ipilimumab - In Combination with Platinum Doublet Chemotherapy for First Line Metastatic or Recurrent Non-Small Cell Lung Cancer
                  Drugs Used:
                  nivolumab , ipilimumab
                  nid:
                  327928
                  Quick Link(s):
                  Regimen Monograph

                  TAFA(MNT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Intermediate Grade
                  Intent:
                  Palliative
                  Drugs Used:
                  tafasitamab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328217
                  Quick Link(s):
                  Regimen Monograph

                  RITU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Rituximab (Biosimilar IV) - Single Agent - Indolent Lymphoma
                  Drugs Used:
                  riTUXimab
                  nid:
                  94757
                  Quick Link(s):
                  Regimen Monograph

                  PEMB
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Endometrial
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Previously Treated MSI-H/dMMR Advanced Endometrial Cancer
                  Drugs Used:
                  pembrolizumab
                  nid:
                  328095
                  Quick Link(s):
                  Regimen Monograph

                  PGIFNA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Myeloproliferative Neoplasms (MPNs)
                  Intent:
                  Palliative
                  Drugs Used:
                  pegylated interferon alpha 2a
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  325854
                  Quick Link(s):
                  Regimen Monograph

                  IRIN+CETU; IRIN(Q2W)+CETU
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Cetuximab with Irinotecan - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer
                  Drugs Used:
                  cetuximab , irinotecan
                  nid:
                  94651
                  Quick Link(s):
                  Regimen Monograph

                  PIRT
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Drugs Used:
                  pirtobrutinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328606
                  Quick Link(s):
                  Regimen Monograph

                  IBRUVENE
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program venetoclax - For the treatment of patients with chronic lymphocytic leukemia (CLL), in combination with ibrutinib, based on criteria
                  Drugs Used:
                  iBRUtinib , venetoclax
                  nid:
                  328440
                  Quick Link(s):
                  Regimen Monograph

                  VEMU
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program vemURAFenib - Monotherapy in patients with BRAF V600 mutation-positive unresectable stage Ill or stage IV melanoma, with specific criteria
                  Drugs Used:
                  vemURAFenib
                  nid:
                  129609
                  Quick Link(s):
                  Regimen Monograph

                  GLOF(MNT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade
                  Intent:
                  Palliative
                  Drugs Used:
                  glofitamab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328707
                  Quick Link(s):
                  Regimen Monograph

                  NIVL+IPIL
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Neoadjuvant
                  Funding Program:
                  New Drug Funding Program Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma
                  Drugs Used:
                  nivolumab , ipilimumab
                  nid:
                  328718
                  Quick Link(s):
                  Regimen Monograph

                  LUSP
                  Jul 2026
                  Cancer Type:
                  Hematologic, Myelodysplastic Syndrome (MDS)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program luspatercept - For the treatment of red-blood cell (RBC) transfusion-dependent anemia associated with Myelodysplastic Syndromes (MDS), according to specific criteria
                  Drugs Used:
                  luspatercept
                  nid:
                  327949
                  Quick Link(s):
                  Regimen Monograph

                  PEMB(MNT)
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - In Combination with Carboplatin and Paclitaxel for First-Line Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
                  Drugs Used:
                  pembrolizumab
                  nid:
                  327684
                  Quick Link(s):
                  Regimen Monograph

                  TRBC
                  Jul 2026
                  Cancer Type:
                  Sarcoma, Soft Tissue
                  Intent:
                  Palliative
                  Drugs Used:
                  trabectedin
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  101238
                  Quick Link(s):
                  Regimen Monograph

                  VENE(MNT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program venetoclax - In Combination with Rituximab - Relapsed Chronic Lymphocytic Leukemia, based on criteria
                  Drugs Used:
                  venetoclax
                  nid:
                  327813
                  Quick Link(s):
                  Regimen Monograph

                  NIVL(MNT)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal
                  Intent:
                  Palliative
                  Drugs Used:
                  nivolumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327644
                  Quick Link(s):
                  Regimen Monograph

                  TRAS
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Trastuzumab (Biosimilar) - Second Line - Metastatic Breast Cancer
                  Drugs Used:
                  trastuzumab
                  nid:
                  94831
                  Quick Link(s):
                  Regimen Monograph

                  MTTN
                  Jul 2026
                  Cancer Type:
                  Endocrine, Adrenal
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit mitotane
                  Drugs Used:
                  mitotane
                  nid:
                  94555
                  Quick Link(s):
                  Regimen Monograph

                  SORA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Myeloid (AML)
                  Intent:
                  Curative
                  Drugs Used:
                  SORAfenib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  326035
                  Quick Link(s):
                  Regimen Monograph

                  NPAC
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Bladder Urothelial
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nab-Paclitaxel - Hypersensitivity Reactions to Taxanes
                  Drugs Used:
                  nab-PACLitaxel
                  nid:
                  306866
                  Quick Link(s):
                  Regimen Monograph

                  PEMB(MNT)
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Locally Recurrent Unresectable or Metastatic Triple Negative Breast Cancer
                  Drugs Used:
                  pembrolizumab
                  nid:
                  328543
                  Quick Link(s):
                  Regimen Monograph

                  MATRIX
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Intermediate Grade
                  Intent:
                  Curative
                  Funding Program:
                  New Drug Funding Program Rituximab (Biosimilar IV) - As Part of the MATRix Regimen in Newly Diagnosed Previously Untreated PCNSL
                  Drugs Used:
                  riTUXimab , methotrexate , cytarabine , thiotepa
                  nid:
                  326297
                  Quick Link(s):
                  Regimen Monograph

                  RALT
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix, Esophagus, Gastric Stomach
                  Funding Program:
                  New Drug Funding Program Raltitrexed - Adjuvant Esophageal, Gastroesophageal Junction, or Gastric Cancer
                  Drugs Used:
                  raltitrexed
                  nid:
                  326289
                  Quick Link(s):
                  Regimen Monograph

                  MOME
                  Jul 2026
                  Cancer Type:
                  Hematologic, Myelofibrosis
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program momelotinib - For the treatment of splenomegaly and/or disease-related symptoms of myelofibrosis, according to specific criteria
                  Drugs Used:
                  momelotinib
                  nid:
                  328658
                  Quick Link(s):
                  Regimen Monograph

                  IMAT
                  Jul 2026
                  Cancer Type:
                  Sarcoma, Soft Tissue
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
                  Drugs Used:
                  iMAtinib
                  nid:
                  94233
                  Quick Link(s):
                  Regimen Monograph

                  PEMB
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Advanced Melanoma (Unresectable or Metastatic Melanoma) and Prior Ipilimumab
                  Drugs Used:
                  pembrolizumab
                  nid:
                  325911
                  Quick Link(s):
                  Regimen Monograph

                  RITU(MNT-SC)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Rituximab (Biosimilar IV) and Rituximab SC - Maintenance Treatment - Lymphoma
                  Drugs Used:
                  riTUXimab (subcut)
                  nid:
                  327491
                  Quick Link(s):
                  Regimen Monograph

                  TRAS
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Trastuzumab (Biosimilar) - Advanced Gastric, Gastroesophageal, or Esophageal Cancer
                  Drugs Used:
                  trastuzumab
                  nid:
                  325954
                  Quick Link(s):
                  Regimen Monograph

                  OLAR(MNT)
                  Jul 2026
                  Intent:
                  Palliative
                  Drugs Used:
                  olaratumab
                  QBP Type:
                  Compassionate This drug is not publicly funded. Universal compassionate access program is available.
                  nid:
                  327466
                  Quick Link(s):
                  Regimen Monograph

                  NPAC(W)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nab-Paclitaxel - Hypersensitivity Reactions to Taxanes
                  Drugs Used:
                  nab-PACLitaxel
                  nid:
                  328598
                  Quick Link(s):
                  Regimen Monograph

                  SORA
                  Jul 2026
                  Cancer Type:
                  Endocrine, Thyroid
                  Intent:
                  Palliative
                  Drugs Used:
                  SORAfenib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  313448
                  Quick Link(s):
                  Regimen Monograph

                  PEMB
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
                  Drugs Used:
                  pembrolizumab
                  nid:
                  326066
                  Quick Link(s):
                  Regimen Monograph

                  NPAC
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nab-Paclitaxel - Hypersensitivity Reactions to Taxanes
                  Drugs Used:
                  nab-PACLitaxel
                  nid:
                  328597
                  Quick Link(s):
                  Regimen Monograph

                  PGLDX
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Ovary
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Liposomal Doxorubicin - Platinum-Resistant Ovarian Fallopian Tube or Primary Peritoneal Cancer
                  Drugs Used:
                  pegylated liposomal DOXOrubicin
                  nid:
                  94461
                  Quick Link(s):
                  Regimen Monograph

                  REGO
                  Jul 2026
                  Cancer Type:
                  Sarcoma, GIST, Gastrointestinal, Gastrointestinal Stromal Tumours
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program regorafenib - For the treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) in patients who have had disease progression on, or intolerance to, imatinib and sunitinib, according to specific criteria
                  Drugs Used:
                  regorafenib
                  nid:
                  289686
                  Quick Link(s):
                  Regimen Monograph

                  OBIN(MNT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Obinutuzumab - Maintenance Treatment for Refractory Follicular Lymphoma
                  Drugs Used:
                  oBINutuzumab
                  nid:
                  327579
                  Quick Link(s):
                  Regimen Monograph

                  LENV+PEMB
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program lenvatinib - In Combination with Pembrolizumab for First-Line Advanced or Metastatic Renal Cell Carcinoma New Drug Funding Program Pembrolizumab - In Combination with Lenvatinib for First-Line Advanced or Metastatic Renal Cell Carcinoma
                  Drugs Used:
                  lenvatinib , pembrolizumab
                  nid:
                  328404
                  Quick Link(s):
                  Regimen Monograph

                  MEGE
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Endometrial
                  Funding Program:
                  ODB - General Benefit megestrol - oral tablets
                  Drugs Used:
                  megestrol
                  nid:
                  326277
                  Quick Link(s):
                  Regimen Monograph

                  LENV
                  Jul 2026
                  Cancer Type:
                  Endocrine, Thyroid
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program lenvatinib - For the treatment of patients with locally recurrent or metastatic, progressive, radioactive-iodine-refractory differentiated thyroid cancer (DTC) according to specific criteria
                  Drugs Used:
                  lenvatinib
                  nid:
                  326027
                  Quick Link(s):
                  Regimen Monograph

                  RIPR
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastrointestinal Stromal Tumours
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program ripretinib - For adult patients with advanced gastrointestinal stromal tumours (GIST) who have progression on or intolerance to imatinib, sunitinib and regorafenib
                  Drugs Used:
                  ripretinib
                  nid:
                  327918
                  Quick Link(s):
                  Regimen Monograph

                  LENA+TAFA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Intermediate Grade
                  Intent:
                  Palliative
                  Drugs Used:
                  , tafasitamab lenalidomide
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328216
                  Quick Link(s):
                  Regimen Monograph

                  NPAC(W)
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nab-Paclitaxel - Metastatic Breast Cancer
                  Drugs Used:
                  nab-PACLitaxel
                  nid:
                  306404
                  Quick Link(s):
                  Regimen Monograph

                  PEMB
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Adjuvant
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - (Neo)adjuvant Treatment for Completely Resectable Stage III or IV Melanoma
                  Drugs Used:
                  pembrolizumab
                  nid:
                  327676
                  Quick Link(s):
                  Regimen Monograph

                  IBRUVENE
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Drugs Used:
                  iBRUtinib , venetoclax
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328714
                  Quick Link(s):
                  Regimen Monograph

                  PEMB
                  Jul 2026
                  Cancer Type:
                  Head and Neck, Squamous Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
                  Drugs Used:
                  pembrolizumab
                  nid:
                  327866
                  Quick Link(s):
                  Regimen Monograph

                  LETRRIBO
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Adjuvant
                  Funding Program:
                  ODB - General Benefit letrozole
                  Drugs Used:
                  letrozole , ribociclib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328804
                  Quick Link(s):
                  Regimen Monograph

                  TORI(MNT)
                  Jul 2026
                  Cancer Type:
                  Head and Neck, Nasopharynx
                  Intent:
                  Palliative
                  Drugs Used:
                  toripalimab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328844
                  Quick Link(s):
                  Regimen Monograph

                  IMAT
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Lymphoblastic (ALL)
                  Funding Program:
                  ODB - General Benefit iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
                  Drugs Used:
                  iMAtinib
                  nid:
                  326034
                  Quick Link(s):
                  Regimen Monograph

                  SUNI
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program SUNItinib - Metastatic renal cell carcinoma, with specific criteria
                  Drugs Used:
                  SUNItinib
                  nid:
                  94473
                  Quick Link(s):
                  Regimen Monograph

                  POMP
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Lymphoblastic (ALL)
                  Intent:
                  Curative
                  Funding Program:
                  ODB - General Benefit mercaptopurine New Drug Funding Program Calaspargase Pegol (Outpatient) - Newly Diagnosed Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed_Biphenotypic Leukemia
                  Drugs Used:
                  methotrexate , vinCRIStine , prednisone , mercaptopurine , pegaspargase
                  nid:
                  326213
                  Quick Link(s):
                  Regimen Monograph

                  TRAM
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Ovary
                  Intent:
                  Palliative
                  Drugs Used:
                  trametinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328175
                  Quick Link(s):
                  Regimen Monograph

                  VEMU+RITU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Hairy Cell
                  Intent:
                  Palliative
                  Drugs Used:
                  vemURAFenib , riTUXimab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328119
                  Quick Link(s):
                  Regimen Monograph

                  TOPO(W)+BEVA
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Ovary
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Bevacizumab (Biosimilar) for Platinum-Resistant Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
                  Drugs Used:
                  topotecan , bevacizumab
                  nid:
                  326348
                  Quick Link(s):
                  Regimen Monograph

                  NIVL(MNT)
                  Jul 2026
                  Intent:
                  Palliative
                  Drugs Used:
                  nivolumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328632
                  Quick Link(s):
                  Regimen Monograph

                  LENA+RITU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Drugs Used:
                  riTUXimab , lenalidomide
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328381
                  Quick Link(s):
                  Regimen Monograph

                  SELP
                  Jul 2026
                  Cancer Type:
                  Endocrine, Thyroid
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program selpercatinib - For the treatments of advanced or metastatic RET fusion-positive differentiated thyroid carcinoma (DTC); and unresectable advanced or metastatic RET-mutant medullary thyroid cancer (MTC)
                  Drugs Used:
                  selpercatinib
                  nid:
                  328412
                  Quick Link(s):
                  Regimen Monograph

                  REGO
                  Jul 2026
                  Cancer Type:
                  Sarcoma, Osteogenic Bone
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program regorafenib - For the treatment of patients with osteosarcoma, according to specific criteria
                  Drugs Used:
                  regorafenib
                  nid:
                  328911
                  Quick Link(s):
                  Regimen Monograph

                  IMAT
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Myeloid (CML)
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
                  Drugs Used:
                  iMAtinib
                  nid:
                  94231
                  Quick Link(s):
                  Regimen Monograph

                  RUXO
                  Jul 2026
                  Cancer Type:
                  Hematologic, Myeloproliferative Neoplasms (MPNs)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program ruxolitinib - For the treatment of patients with polycythemia vera, according to specific criteria
                  Drugs Used:
                  ruxolitinib
                  nid:
                  155816
                  Quick Link(s):
                  Regimen Monograph

                  TMXF
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Endometrial, Ovary
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit tamoxifen
                  Drugs Used:
                  tamoxifen
                  nid:
                  306392
                  Quick Link(s):
                  Regimen Monograph

                  PEMB(FIXED)
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Bladder Urothelial
                  Intent:
                  Palliative
                  Drugs Used:
                  pembrolizumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327437
                  Quick Link(s):
                  Regimen Monograph

                  PEMB
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - First Line Treatment of MSI-H/dMMR Metastatic Colorectal Cancer
                  Drugs Used:
                  pembrolizumab
                  nid:
                  327917
                  Quick Link(s):
                  Regimen Monograph

                  SILT
                  Jul 2026
                  Cancer Type:
                  Hematologic, Rare Diseases
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Siltuximab - Multicentric Castleman’s Disease (MCD)
                  Drugs Used:
                  siltuximab
                  nid:
                  326014
                  Quick Link(s):
                  Regimen Monograph

                  NIVL
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Bladder Urothelial
                  Intent:
                  Adjuvant
                  Funding Program:
                  New Drug Funding Program Nivolumab - Adjuvant Treatment of Urothelial Carcinoma
                  Drugs Used:
                  nivolumab
                  nid:
                  328213
                  Quick Link(s):
                  Regimen Monograph

                  PEMB(MNT)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - First-line Treatment of Advanced HER2-negative Esophageal, Gastric, and Esophagogastric Junction Carcinoma
                  Drugs Used:
                  pembrolizumab
                  nid:
                  328502
                  Quick Link(s):
                  Regimen Monograph

                  NIVL+IPIL
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab plus Ipilimumab - Advanced Melanoma (Unresectable or Metastatic Melanoma)
                  Drugs Used:
                  nivolumab , ipilimumab
                  nid:
                  325961
                  Quick Link(s):
                  Regimen Monograph

                  OLAP
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Prostate
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program olaparib - For the treatment of metastatic castration resistant prostate cancer (mCRPC), based on criteria
                  Drugs Used:
                  olaparib
                  nid:
                  327913
                  Quick Link(s):
                  Regimen Monograph

                  OLAP
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Drugs Used:
                  olaparib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327424
                  Quick Link(s):
                  Regimen Monograph

                  PMDR(HYPER CA)
                  Jul 2026
                  Cancer Type:
                  Breast, Genitourinary, Gynecologic, Head and Neck, Hematologic, Lung, Skin, Sarcoma, Unknown Primary, Central Nervous System, Endocrine, Gastrointestinal
                  Drugs Used:
                  pamidronate
                  nid:
                  325938
                  Quick Link(s):
                  Regimen Monograph

                  OSIM
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Funding Program:
                  Exceptional Access Program osimertinib - For the treatment of locally advanced, unresectable (stage III) non-squamous non-small cell lung cancer (NSCLC), based on criteria
                  Drugs Used:
                  osimertinib
                  nid:
                  326112
                  Quick Link(s):
                  Regimen Monograph

                  SELP
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program selpercatinib - For the treatment of metastatic RET fusion-positive non-small cell lung cancer (NSCLC)
                  Drugs Used:
                  selpercatinib
                  nid:
                  327971
                  Quick Link(s):
                  Regimen Monograph

                  NPAC(W)
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nab-Paclitaxel - Hypersensitivity Reactions to Taxanes
                  Drugs Used:
                  nab-PACLitaxel
                  nid:
                  306834
                  Quick Link(s):
                  Regimen Monograph

                  PACL(W)+BEVA+PEMB
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Ovary
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Bevacizumab (Biosimilar) for Platinum-Resistant Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
                  Drugs Used:
                  pembrolizumab , bevacizumab , PACLitaxel
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328903
                  Quick Link(s):
                  Regimen Monograph

                  PEMI
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Hepatobiliary Liver Bile Duct
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program pemigatinib - For the treatment of unresectable locally advanced or metastatic cholangiocarcinoma, according to specific criteria
                  Drugs Used:
                  pemigatinib
                  nid:
                  328201
                  Quick Link(s):
                  Regimen Monograph

                  IBRU+RITU
                  Jul 2026
                  Cancer Type:
                  Hematologic
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program iBRUtinib - For the treatment of patients with relapsed or refractory Waldenstrӧm Macroglobulinemia, in combination with rituximab, based on criteria. New Drug Funding Program Rituximab (Biosimilar IV) and Rituximab SC - In Combination with Ibrutinib for Previously Treated Waldenstrӧms Macroglobulinemia
                  Drugs Used:
                  iBRUtinib , riTUXimab , riTUXimab (subcut)
                  nid:
                  328677
                  Quick Link(s):
                  Regimen Monograph

                  NPAC
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nab-Paclitaxel - Metastatic Breast Cancer
                  Drugs Used:
                  nab-PACLitaxel
                  nid:
                  94225
                  Quick Link(s):
                  Regimen Monograph

                  SUNI
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Neuroendocrine (GI)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program SUNItinib - For patients who have progressive, unresectable, well or moderately differentiated, locally advanced or metastatic pancreatic neuroendocrine tumours (pNET), according to specific criteria
                  Drugs Used:
                  SUNItinib
                  nid:
                  100394
                  Quick Link(s):
                  Regimen Monograph

                  HYDR
                  Jul 2026
                  Cancer Type:
                  Hematologic, Myeloproliferative Neoplasms (MPNs)
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit hydroxyurea
                  Drugs Used:
                  hydroxyurea
                  nid:
                  326274
                  Quick Link(s):
                  Regimen Monograph

                  PRAL
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - T-cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pralatrexate - Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
                  Drugs Used:
                  PRALAtrexate , leucovorin
                  nid:
                  327543
                  Quick Link(s):
                  Regimen Monograph

                  OFAT
                  Jul 2026
                  Intent:
                  Palliative
                  Drugs Used:
                  oFAtumumab
                  QBP Type:
                  Compassionate This drug is not publicly funded. Universal compassionate access program is available.
                  nid:
                  131844
                  Quick Link(s):
                  Regimen Monograph

                  TMZL
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Neuroendocrine (GI), Lung, Neuroendocrine (Lung)
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit temozolomide
                  Drugs Used:
                  temozolomide
                  nid:
                  304668
                  Quick Link(s):
                  Regimen Monograph

                  OXALRALT
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix, Esophagus, Gastric Stomach
                  Funding Program:
                  New Drug Funding Program Raltitrexed - Adjuvant Esophageal, Gastroesophageal Junction, or Gastric Cancer
                  Drugs Used:
                  raltitrexed , oxaliplatin
                  nid:
                  306275
                  Quick Link(s):
                  Regimen Monograph

                  NIVL+IPIL
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Hepatobiliary Liver Bile Duct
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab plus Ipilimumab – Previously Untreated Unresectable or Advanced Hepatocellular Carcinoma
                  Drugs Used:
                  nivolumab , ipilimumab
                  nid:
                  328760
                  Quick Link(s):
                  Regimen Monograph

                  PEMB(MNT)
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Endometrial
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Primary Advanced or Recurrent Endometrial Carcinoma
                  Drugs Used:
                  pembrolizumab
                  nid:
                  328683
                  Quick Link(s):
                  Regimen Monograph

                  IBRU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program iBRUtinib - For patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), based on criteria
                  Drugs Used:
                  iBRUtinib
                  nid:
                  307212
                  Quick Link(s):
                  Regimen Monograph

                  PNAT
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Lymphoblastic (ALL)
                  Funding Program:
                  Exceptional Access Program ponatinib - For the treatment of Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), according to specific criteria
                  Drugs Used:
                  ponatinib
                  nid:
                  326115
                  Quick Link(s):
                  Regimen Monograph

                  MTTN
                  Jul 2026
                  Cancer Type:
                  Endocrine, Adrenal
                  Intent:
                  Adjuvant
                  Funding Program:
                  ODB - General Benefit mitotane
                  Drugs Used:
                  mitotane
                  nid:
                  94453
                  Quick Link(s):
                  Regimen Monograph

                  THAL
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Drugs Used:
                  thalidomide
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  94475
                  Quick Link(s):
                  Regimen Monograph

                  LETRPALB
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program palbociclib - For the treatment of patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER 2)-negative, unresectable locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant, according to specific criteria ODB - General Benefit letrozole
                  Drugs Used:
                  palbociclib , letrozole
                  nid:
                  326093
                  Quick Link(s):
                  Regimen Monograph

                  REGO
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Hepatobiliary Liver Bile Duct
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program regorafenib - For the treatment of unresectable, advanced hepatocellular carcinoma (HCC), according to specific criteria
                  Drugs Used:
                  regorafenib
                  nid:
                  327412
                  Quick Link(s):
                  Regimen Monograph

                  PEMB+TRAS(MNT)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab and Trastuzumab (Biosimilar) - First-line Treatment of Advanced HER2-Positive Gastric or Esophagogastric Junction Adenocarcinoma
                  Drugs Used:
                  pembrolizumab , trastuzumab
                  nid:
                  328469
                  Quick Link(s):
                  Regimen Monograph

                  IRINRALT
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix, Esophagus, Gastric Stomach
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Raltitrexed - Metastatic Esophageal, Gastroesophageal Junction, or Gastric Cancer
                  Drugs Used:
                  irinotecan , raltitrexed
                  nid:
                  306321
                  Quick Link(s):
                  Regimen Monograph

                  HYDR
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Myeloid (CML)
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit hydroxyurea
                  Drugs Used:
                  hydroxyurea
                  nid:
                  94215
                  Quick Link(s):
                  Regimen Monograph

                  OLAP
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Adjuvant
                  Funding Program:
                  Exceptional Access Program olaparib - For the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated, human epidermal growth factor receptor 2-negative high risk early breast cancer, based on criteria
                  Drugs Used:
                  olaparib
                  nid:
                  328018
                  Quick Link(s):
                  Regimen Monograph

                  LOMU
                  Jul 2026
                  Cancer Type:
                  Central Nervous System
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit lomustine
                  Drugs Used:
                  lomustine
                  nid:
                  94239
                  Quick Link(s):
                  Regimen Monograph

                  PEME+PEMB(MNT)
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - In Combination with Platinum and Pemetrexed for First Line Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
                  Drugs Used:
                  pembrolizumab , pemetrexed
                  nid:
                  327520
                  Quick Link(s):
                  Regimen Monograph

                  TEPO
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Drugs Used:
                  tepotinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328747
                  Quick Link(s):
                  Regimen Monograph

                  RITU(DESENS)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL), Leukemia - Hairy Cell, Lymphoma - Hodgkin, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Lymphoma - Non-Hodgkin's Low Grade, Leukemia - Acute Lymphoblastic (ALL)
                  Drugs Used:
                  trastuzumab
                  nid:
                  328750
                  Quick Link(s):
                  Regimen Monograph

                  TMZL
                  Jul 2026
                  Cancer Type:
                  Central Nervous System
                  Intent:
                  Adjuvant
                  Funding Program:
                  ODB - General Benefit temozolomide
                  Drugs Used:
                  temozolomide
                  nid:
                  326397
                  Quick Link(s):
                  Regimen Monograph

                  SONI
                  Jul 2026
                  Cancer Type:
                  Skin, Basal Cell
                  Intent:
                  Palliative
                  Drugs Used:
                  sonidegib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327946
                  Quick Link(s):
                  Regimen Monograph

                  GEMC+PEMB(MNT)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Hepatobiliary Liver Bile Duct
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Locally Advanced Unresectable or Metastatic Biliary Tract Cancer
                  Drugs Used:
                  pembrolizumab , gemcitabine
                  nid:
                  328489
                  Quick Link(s):
                  Regimen Monograph

                  IBRU+RITU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Drugs Used:
                  iBRUtinib , riTUXimab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327768
                  Quick Link(s):
                  Regimen Monograph

                  GILT
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Myeloid (AML)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program gilteritinib - Relapsed or refractory FLT3-mutated Acute Myeloid Leukemia
                  Drugs Used:
                  gilteritinib
                  nid:
                  328066
                  Quick Link(s):
                  Regimen Monograph

                  PACL+PEMB
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Neoadjuvant
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Previously Untreated High-Risk Early-Stage Triple Negative Breast Cancer
                  Drugs Used:
                  pembrolizumab , PACLitaxel
                  nid:
                  328311
                  Quick Link(s):
                  Regimen Monograph

                  PAZO
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program pazopanib - For first-line treatment of advanced or metastatic renal cell carcinoma of clear cell histology in patients with good performance status (ECOG 0-1), with specific criteria
                  Drugs Used:
                  pazopanib
                  nid:
                  94567
                  Quick Link(s):
                  Regimen Monograph

                  PEMB(MNT)
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Bladder Urothelial
                  Intent:
                  Adjuvant
                  Drugs Used:
                  pembrolizumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328880
                  Quick Link(s):
                  Regimen Monograph

                  NPAC(W)+ATEZ
                  Jul 2026
                  Intent:
                  Palliative
                  Drugs Used:
                  atezolizumab , nab-PACLitaxel
                  QBP Type:
                  Compassionate This drug is not publicly funded. Universal compassionate access program is available. Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327673
                  Quick Link(s):
                  Regimen Monograph

                  IDEL+RITU; IDEL(MNT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program idelalisib - For the treatment of relapsed chronic lymphocytic leukemia, in combination with rituximab, based on criteria New Drug Funding Program Rituximab (Biosimilar IV) - In Combination with Idelalisib - Relapsed Chronic Lymphocytic Leukemia
                  Drugs Used:
                  idelalisib , riTUXimab
                  nid:
                  325872
                  Quick Link(s):
                  Regimen Monograph

                  RITU(IT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Leukemia - Acute Lymphoblastic (ALL)
                  Intent:
                  Curative
                  Drugs Used:
                  riTUXimab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  326025
                  Quick Link(s):
                  Regimen Monograph

                  TOPO
                  Jul 2026
                  Cancer Type:
                  Lung, Small Cell, Breast, Central Nervous System, Gastrointestinal, Colorectal, Esophagus, Gastric Stomach, Hepatobiliary Liver Bile Duct, Pancreas, Neuroendocrine (GI), Gynecologic, Cervix, Endometrial, Ovary, Unknown Primary, Head and Neck, Genitourinary, Bladder Urothelial, Prostate
                  Intent:
                  Palliative
                  Drugs Used:
                  topotecan
                  nid:
                  94577
                  Quick Link(s):
                  Regimen Monograph

                  VAND
                  Jul 2026
                  Cancer Type:
                  Endocrine, Thyroid
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program vanDETanib - Monotherapy for symptomatic and/or progressive medullary thyroid cancer (MTC), with specific criteria
                  Drugs Used:
                  vanDETanib
                  nid:
                  122688
                  Quick Link(s):
                  Regimen Monograph

                  NIVL
                  Jul 2026
                  Cancer Type:
                  Head and Neck
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab - Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck which is Platinum Resistant or Refractory
                  Drugs Used:
                  nivolumab
                  nid:
                  326284
                  Quick Link(s):
                  Regimen Monograph

                  XELOX+PEMB
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - First-line Treatment of Advanced HER2-negative Esophageal, Gastric, and Esophagogastric Junction Carcinoma ODB - General Benefit capecitabine
                  Drugs Used:
                  pembrolizumab , oxaliplatin , capecitabine
                  nid:
                  328501
                  Quick Link(s):
                  Regimen Monograph

                  TMXF
                  Jul 2026
                  Cancer Type:
                  Sarcoma, Desmoid Tumour
                  Intent:
                  Curative
                  Funding Program:
                  ODB - General Benefit tamoxifen
                  Drugs Used:
                  tamoxifen
                  nid:
                  307127
                  Quick Link(s):
                  Regimen Monograph

                  LARO
                  Jul 2026
                  Cancer Type:
                  Breast, Central Nervous System, Endocrine, Adrenal, Neuroendocrine, Thymoma, Thyroid, Pancreatic Neuroendocrine, Parathyroid, Gastrointestinal, Anus, Colorectal, Esophagus, Gastric Stomach, Hepatobiliary Liver Bile Duct, Pancreas, Rectal, Small bowel and appendix, Neuroendocrine (GI), Gastrointestinal Stromal Tumours, Mesothelioma (Peritoneal), Genitourinary, Bladder Urothelial, Penile, Prostate, Renal cell Kidney, Testis, Gynecologic, Cervix, Endometrial, Gestational Trophoblastic Disease, Ovary, Uterine Sarcoma, Vulva, Germ Cell, Vagina, Head and Neck, Larynx, Pharynx, Nasopharynx, Paranasal Sinus, Oral, Salivary Gland, Squamous Cell, Kaposi's Sarcoma, Lung, Mesothelioma (Pleural), Non-Small Cell, Small Cell, Neuroendocrine (Lung), Skin, Basal Cell, Merkel Cell, Squamous Cell, Melanoma, Sarcoma, Ewing's, GIST, Osteogenic Bone, Soft Tissue, Ewing's and Soft Tissue, Uterine, Desmoid Tumour, Wilm's Tumour, Giant Cell Tumour, Kaposi's Sarcoma, Unknown Primary
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program larotrectinib - For the treatment of unresectable locally advanced, or metastatic solid tumours with neurotrophic tyrosine receptor kinase (NTRK) gene fusion, based on criteria
                  Drugs Used:
                  larotrectinib
                  nid:
                  327995
                  Quick Link(s):
                  Regimen Monograph

                  IBRU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's High Grade
                  Intent:
                  Palliative
                  Drugs Used:
                  iBRUtinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327649
                  Quick Link(s):
                  Regimen Monograph

                  LENV
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney
                  Intent:
                  Palliative
                  Drugs Used:
                  lenvatinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327736
                  Quick Link(s):
                  Regimen Monograph

                  PERT+TRAS
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pertuzumab with Trastuzumab (Biosimilar) - Unresectable Locally Recurrent or Metastatic Breast Cancer
                  Drugs Used:
                  PERTuzumab , trastuzumab
                  nid:
                  326012
                  Quick Link(s):
                  Regimen Monograph

                  PACL(W)+PERT+TRAS
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Curative
                  Funding Program:
                  New Drug Funding Program Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer
                  Drugs Used:
                  PERTuzumab , trastuzumab , PACLitaxel
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328876
                  Quick Link(s):
                  Regimen Monograph

                  OCTR
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Neuroendocrine (GI), Lung, Neuroendocrine (Lung)
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit octreotide
                  Drugs Used:
                  octreotide
                  nid:
                  94433
                  Quick Link(s):
                  Regimen Monograph

                  PERTRAS(SC)
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Drugs Used:
                  PERTuzumab / trastuzumab (subcut)
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328170
                  Quick Link(s):
                  Regimen Monograph

                  LAZE+AMIV
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Drugs Used:
                  amivantamab , lazertinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328751
                  Quick Link(s):
                  Regimen Monograph

                  NIVL(MNT)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Hepatobiliary Liver Bile Duct
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab plus Ipilimumab – Previously Untreated Unresectable or Advanced Hepatocellular Carcinoma
                  Drugs Used:
                  nivolumab
                  nid:
                  328768
                  Quick Link(s):
                  Regimen Monograph

                  IXAZ
                  Jul 2026
                  Cancer Type:
                  Hematologic, Multiple Myeloma
                  Intent:
                  Palliative
                  Drugs Used:
                  ixazomib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327656
                  Quick Link(s):
                  Regimen Monograph

                  TALI
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Palliative
                  Drugs Used:
                  talimogene laherparepvec
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327474
                  Quick Link(s):
                  Regimen Monograph

                  PEME+OSIM(MNT)
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program osimertinib - In combination with pemetrexed and platinum-based chemotherapy for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC), based on criteria
                  Drugs Used:
                  pemetrexed , osimertinib
                  nid:
                  328557
                  Quick Link(s):
                  Regimen Monograph

                  PRLS
                  Jul 2026
                  Intent:
                  Palliative
                  Drugs Used:
                  pralsetinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327999
                  Quick Link(s):
                  Regimen Monograph

                  TRAS(MNT)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Esophagus, Gastric Stomach
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab and Trastuzumab (Biosimilar) - First-line Treatment of Advanced HER2-Positive Gastric or Esophagogastric Junction Adenocarcinoma
                  Drugs Used:
                  trastuzumab
                  nid:
                  328586
                  Quick Link(s):
                  Regimen Monograph

                  MTRX(IT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Leukemia - Acute Lymphoblastic (ALL), Leukemia - Acute Myeloid (AML)
                  Drugs Used:
                  methotrexate
                  nid:
                  326238
                  Quick Link(s):
                  Regimen Monograph

                  TRAS(MNT)
                  Jul 2026
                  Cancer Type:
                  Head and Neck, Salivary Gland
                  Intent:
                  Palliative
                  Drugs Used:
                  trastuzumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328220
                  Quick Link(s):
                  Regimen Monograph

                  PEMB
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Hodgkin
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab (Adult Who Failed Prior Brentuximab Vedotin) - Relapsed Classical Hodgkin Lymphoma Post-Autologous Stem Cell Transplant or ASCT Ineligible
                  Drugs Used:
                  pembrolizumab
                  nid:
                  327841
                  Quick Link(s):
                  Regimen Monograph

                  PNTM
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Panitumumab - Metastatic Colorectal Small Bowel or Appendiceal Cancer
                  Drugs Used:
                  PANitumumab
                  nid:
                  94679
                  Quick Link(s):
                  Regimen Monograph

                  PEMB(MNT)
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Cervix
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Metastatic, Persistent, or Recurrent Carcinoma of the Cervix
                  Drugs Used:
                  pembrolizumab
                  nid:
                  328092
                  Quick Link(s):
                  Regimen Monograph

                  HCKETO
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Prostate
                  Intent:
                  Palliative
                  Drugs Used:
                  , ketoconazole hydrocortisone
                  nid:
                  306891
                  Quick Link(s):
                  Regimen Monograph

                  TRAS
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Endometrial
                  Funding Program:
                  New Drug Funding Program Trastuzumab (Biosimilar) - Advanced or Recurrent Endometrial Cancer
                  Drugs Used:
                  trastuzumab
                  nid:
                  327925
                  Quick Link(s):
                  Regimen Monograph

                  RITU(MNT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Rituximab (Biosimilar IV) and Rituximab SC - Maintenance Treatment - Lymphoma
                  Drugs Used:
                  riTUXimab
                  nid:
                  94769
                  Quick Link(s):
                  Regimen Monograph

                  NELA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Lymphoblastic (ALL)
                  Intent:
                  Curative
                  Drugs Used:
                  nelarabine
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  326214
                  Quick Link(s):
                  Regimen Monograph

                  NILO
                  Jul 2026
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program niLOtinib - Accelerated phase Ph+ CML with documented resistance or intolerance to imatinib therapy, with specific criteria
                  Drugs Used:
                  niLOtinib
                  nid:
                  94431
                  Quick Link(s):
                  Regimen Monograph

                  NIVL(MNT)
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab plus Ipilimumab - Metastatic Renal Cell Carcinoma
                  Drugs Used:
                  nivolumab
                  nid:
                  327534
                  Quick Link(s):
                  Regimen Monograph

                  PEMB(MNT)
                  Jul 2026
                  Cancer Type:
                  Lung, Mesothelioma (Pleural), Gastrointestinal, Mesothelioma (Peritoneal)
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Previously Untreated Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
                  Drugs Used:
                  pembrolizumab
                  nid:
                  328699
                  Quick Link(s):
                  Regimen Monograph

                  OSIM
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Adjuvant
                  Funding Program:
                  Exceptional Access Program osimertinib - For adjuvant therapy after tumour resection in patients with stage IB-IIIA (AJCC 7th edition, or equivalent) NSCLC whose tumours have EGFR exon 19 deletions or exon 21 (L858 R) substitution mutations, based on criteria
                  Drugs Used:
                  osimertinib
                  nid:
                  327919
                  Quick Link(s):
                  Regimen Monograph

                  VRNS
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - T-cell
                  Intent:
                  Palliative
                  Drugs Used:
                  vorinostat
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  94657
                  Quick Link(s):
                  Regimen Monograph

                  NIVL(MNT)
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Adjuvant
                  Drugs Used:
                  nivolumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327967
                  Quick Link(s):
                  Regimen Monograph

                  LETRRIBO
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit letrozole Exceptional Access Program ribociclib - For the treatment of patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER 2)-negative, unresectable locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant, according to specific criteria
                  Drugs Used:
                  letrozole , ribociclib
                  nid:
                  327526
                  Quick Link(s):
                  Regimen Monograph

                  VORA
                  Jul 2026
                  Cancer Type:
                  Central Nervous System
                  Funding Program:
                  Exceptional Access Program vorasidenib - For the treatment of Grade 2 astrocytoma or oligodendroglioma in patients with a susceptible IDH1 mutation or IDH2 mutation following surgery, based on criteria
                  Drugs Used:
                  vorasidenib
                  nid:
                  328605
                  Quick Link(s):
                  Regimen Monograph

                  NIVL(MNT)
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab plus Ipilimumab - Advanced Melanoma (Unresectable or Metastatic Melanoma)
                  Drugs Used:
                  nivolumab
                  nid:
                  327598
                  Quick Link(s):
                  Regimen Monograph

                  XELOX+NIVL
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab - First-line Treatment of Advanced Gastric, Esophageal, and Esophagogastric Junction Adenocarcinoma ODB - General Benefit capecitabine
                  Drugs Used:
                  nivolumab , oxaliplatin , capecitabine
                  nid:
                  328001
                  Quick Link(s):
                  Regimen Monograph

                  LANR
                  Jul 2026
                  Cancer Type:
                  Lung, Neuroendocrine (Lung), Gastrointestinal, Neuroendocrine (GI)
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit lanreotide
                  Drugs Used:
                  lanreotide
                  nid:
                  326080
                  Quick Link(s):
                  Regimen Monograph

                  PACL(W)+RAMU
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Ramucirumab - Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
                  Drugs Used:
                  ramucirumab , PACLitaxel
                  nid:
                  323307
                  Quick Link(s):
                  Regimen Monograph

                  RAMU
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Drugs Used:
                  ramucirumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  325863
                  Quick Link(s):
                  Regimen Monograph

                  TRAM
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program trametinib - As monotherapy in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma, according to specific criteria
                  Drugs Used:
                  trametinib
                  nid:
                  284472
                  Quick Link(s):
                  Regimen Monograph

                  SORA
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program SORAfenib - Metastatic renal cell carcinoma of clear cell histology as second-line treatment, with specific criteria
                  Drugs Used:
                  SORAfenib
                  nid:
                  94595
                  Quick Link(s):
                  Regimen Monograph

                  MIDO
                  Jul 2026
                  Cancer Type:
                  Hematologic, Rare Diseases
                  Intent:
                  Palliative
                  Drugs Used:
                  midostaurin
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327655
                  Quick Link(s):
                  Regimen Monograph

                  LENA(MNT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's High Grade
                  Intent:
                  Curative
                  Drugs Used:
                  lenalidomide
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327471
                  Quick Link(s):
                  Regimen Monograph

                  TMXFRIBO
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit tamoxifen
                  Drugs Used:
                  tamoxifen , ribociclib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327616
                  Quick Link(s):
                  Regimen Monograph

                  PACL+PERTRAS(SC)
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Drugs Used:
                  , PERTuzumab / trastuzumab (subcut) PACLitaxel
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328166
                  Quick Link(s):
                  Regimen Monograph

                  TRBC
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Uterine Sarcoma, Sarcoma, Uterine
                  Intent:
                  Palliative
                  Drugs Used:
                  trabectedin
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  325909
                  Quick Link(s):
                  Regimen Monograph

                  TRIFTIPI+BEVA
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program trifluridine / tipiracil - In combination with bevacizumab for treatment of metastatic colorectal cancer, according to specific criteria New Drug Funding Program Bevacizumab (Biosimilar) - In Combination with Trifluridine and Tipiracil for Previously Treated Metastatic Colorectal Cancer
                  Drugs Used:
                  trifluridine / tipiracil , bevacizumab
                  nid:
                  328425
                  Quick Link(s):
                  Regimen Monograph

                  VENE+OBIN
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Obinutuzumab - in Combination with Venetoclax for Previously Untreated Chronic Lymphocytic Leukemia Exceptional Access Program venetoclax - In Combination with Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia, based on criteria
                  Drugs Used:
                  oBINutuzumab , venetoclax
                  nid:
                  327760
                  Quick Link(s):
                  Regimen Monograph

                  PEMB
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Bladder Urothelial
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma
                  Drugs Used:
                  pembrolizumab
                  nid:
                  327814
                  Quick Link(s):
                  Regimen Monograph

                  NIVL
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Esophagus
                  Intent:
                  Adjuvant
                  Funding Program:
                  New Drug Funding Program Nivolumab - Adjuvant Treatment of Completely Resected Esophageal or Esophagogastric Junction Cancer
                  Drugs Used:
                  nivolumab
                  nid:
                  328022
                  Quick Link(s):
                  Regimen Monograph

                  MOSU; MOSU(RAMP)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Drugs Used:
                  mosunetuzumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328881
                  Quick Link(s):
                  Regimen Monograph

                  IBRU(MNT)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Drugs Used:
                  iBRUtinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328712
                  Quick Link(s):
                  Regimen Monograph

                  IDEL
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Drugs Used:
                  idelalisib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  325873
                  Quick Link(s):
                  Regimen Monograph

                  MEGE
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Endometrial
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit megestrol - oral tablets
                  Drugs Used:
                  megestrol
                  nid:
                  306387
                  Quick Link(s):
                  Regimen Monograph

                  LENA
                  Jul 2026
                  Cancer Type:
                  Hematologic, Myelodysplastic Syndrome (MDS)
                  Intent:
                  Palliative
                  Funding Program:
                  ODB Limited Use lenalidomide - For the treatment of patients with anemia due to myelodysplastic syndrome (MDS), according to specific criteria
                  Drugs Used:
                  lenalidomide
                  nid:
                  94237
                  Quick Link(s):
                  Regimen Monograph

                  IBRU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program iBRUtinib - For the treatment of patients with relapsed or refractory Waldenstrӧm Macroglobulinemia, as monotherapy, based on criteria
                  Drugs Used:
                  iBRUtinib
                  nid:
                  326061
                  Quick Link(s):
                  Regimen Monograph

                  MTPR(HD)
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Drugs Used:
                  methylprednisolone
                  nid:
                  325935
                  Quick Link(s):
                  Regimen Monograph

                  PAZO
                  Jul 2026
                  Cancer Type:
                  Sarcoma, Soft Tissue
                  Intent:
                  Palliative
                  Drugs Used:
                  pazopanib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  152704
                  Quick Link(s):
                  Regimen Monograph

                  OXALRALT+ENCO+PNTM
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Raltitrexed - Metastatic Colorectal Small Bowel or Appendiceal Cancer Exceptional Access Program Encorafenib - In combination with panitumumab and chemotherapy for previously untreated metastatic colorectal cancer, according to specific criteria
                  Drugs Used:
                  PANitumumab , raltitrexed , oxaliplatin , encorafenib
                  nid:
                  328889
                  Quick Link(s):
                  Regimen Monograph

                  PEMB(MNT)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Hepatobiliary Liver Bile Duct
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Locally Advanced Unresectable or Metastatic Biliary Tract Cancer
                  Drugs Used:
                  pembrolizumab
                  nid:
                  328488
                  Quick Link(s):
                  Regimen Monograph

                  VISM
                  Jul 2026
                  Cancer Type:
                  Skin, Basal Cell
                  Funding Program:
                  Exceptional Access Program vismodegib - Treatment for metastatic basal cell carcinoma (BCC) or with locally advanced BCC (including patients with basal cell nevus syndrome, i.e. Gorlin syndrome), according to specific criteria
                  Drugs Used:
                  vismodegib
                  nid:
                  285955
                  Quick Link(s):
                  Regimen Monograph

                  NPAC+PERTRAS(SC)
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nab-Paclitaxel - Metastatic Breast Cancer
                  Drugs Used:
                  , PERTuzumab / trastuzumab (subcut) nab-PACLitaxel
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent Unfunded with exceptions Publicly funded under specific conditions, see PDRP (NDFP) eligibility forms
                  nid:
                  328169
                  Quick Link(s):
                  Regimen Monograph

                  PEMB
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Adjuvant
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Previously Untreated High-Risk Early-Stage Triple Negative Breast Cancer
                  Drugs Used:
                  pembrolizumab
                  nid:
                  328116
                  Quick Link(s):
                  Regimen Monograph

                  PACL(W)+BEVA
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Ovary
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Bevacizumab (Biosimilar) for Platinum-Resistant Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
                  Drugs Used:
                  PACLitaxel , bevacizumab
                  nid:
                  326059
                  Quick Link(s):
                  Regimen Monograph

                  IPIL
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Ipilimumab - Previously Treated Advanced Unresectable Melanoma
                  Drugs Used:
                  ipilimumab
                  nid:
                  123383
                  Quick Link(s):
                  Regimen Monograph

                  TEMS
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Temsirolimus - Metastatic Renal Cell Carcinoma
                  Drugs Used:
                  temsirolimus
                  nid:
                  94113
                  Quick Link(s):
                  Regimen Monograph

                  NIVL
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Drugs Used:
                  nivolumab
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  327464
                  Quick Link(s):
                  Regimen Monograph

                  SORA
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Hepatobiliary Liver Bile Duct
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program SORAfenib - Advanced hepatocellular carcinoma, with specific criteria
                  Drugs Used:
                  SORAfenib
                  nid:
                  94447
                  Quick Link(s):
                  Regimen Monograph

                  PEME+CEMI(MNT)
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Cemiplimab - In Combination with Chemotherapy for First-Line Treatment of Advanced Non-Small Cell Lung Cancer
                  Drugs Used:
                  pemetrexed , cemiplimab
                  nid:
                  328554
                  Quick Link(s):
                  Regimen Monograph

                  INOT
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Acute Lymphoblastic (ALL)
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Inotuzumab Ozogamicin (Outpatient) - Relapsed or Refractory Acute Lymphoblastic Leukemia
                  Drugs Used:
                  inotuzumab ozogamicin
                  nid:
                  327586
                  Quick Link(s):
                  Regimen Monograph

                  GLOF; GLOF(RAMP)
                  NEW Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Glofitamab (Outpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma High Cost Therapy Funding Program Glofitamab (Inpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma
                  Drugs Used:
                  oBINutuzumab , glofitamab
                  nid:
                  328446
                  Quick Link(s):
                  Regimen Monograph

                  PEMB
                  Jul 2026
                  Cancer Type:
                  Breast, Central Nervous System, Endocrine, Adrenal, Neuroendocrine, Thymoma, Thyroid, Pancreatic Neuroendocrine, Parathyroid, Gastrointestinal, Anus, Colorectal, Esophagus, Gastric Stomach, Hepatobiliary Liver Bile Duct, Pancreas, Rectal, Small bowel and appendix, Neuroendocrine (GI), Gastrointestinal Stromal Tumours, Mesothelioma (Peritoneal), Genitourinary, Bladder Urothelial, Penile, Prostate, Renal cell Kidney, Testis, Gynecologic, Cervix, Endometrial, Gestational Trophoblastic Disease, Ovary, Uterine Sarcoma, Vulva, Germ Cell, Vagina, Head and Neck, Larynx, Pharynx, Nasopharynx, Paranasal Sinus, Oral, Salivary Gland, Squamous Cell, Kaposi's Sarcoma, Lung, Mesothelioma (Pleural), Non-Small Cell, Small Cell, Neuroendocrine (Lung), Skin, Basal Cell, Merkel Cell, Squamous Cell, Melanoma, Sarcoma, Ewing's, GIST, Osteogenic Bone, Soft Tissue, Ewing's and Soft Tissue, Uterine, Desmoid Tumour, Wilm's Tumour, Giant Cell Tumour, Kaposi's Sarcoma, Mesothelioma, Unknown Primary, Ocular Eye
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab (Adult and Pediatric) - Unresectable or Metastatic MSI-H or dMMR Advanced Solid Tumours
                  Drugs Used:
                  pembrolizumab
                  nid:
                  328729
                  Quick Link(s):
                  Regimen Monograph

                  NIVL
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Renal cell Kidney
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab - Advanced or Metastatic Renal Cell Carcinoma and Prior mTOR Inhibitor
                  Drugs Used:
                  nivolumab
                  nid:
                  326047
                  Quick Link(s):
                  Regimen Monograph

                  TMZL
                  Jul 2026
                  Cancer Type:
                  Central Nervous System
                  Intent:
                  Palliative
                  Funding Program:
                  ODB - General Benefit temozolomide
                  Drugs Used:
                  temozolomide
                  nid:
                  94563
                  Quick Link(s):
                  Regimen Monograph

                  NPAC(W)+PERTRAS(SC)
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nab-Paclitaxel - Metastatic Breast Cancer
                  Drugs Used:
                  , PERTuzumab / trastuzumab (subcut) nab-PACLitaxel
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent Unfunded with exceptions Publicly funded under specific conditions, see PDRP (NDFP) eligibility forms
                  nid:
                  328168
                  Quick Link(s):
                  Regimen Monograph

                  TRBC(MNT)
                  Jul 2026
                  Cancer Type:
                  Sarcoma, Soft Tissue
                  Intent:
                  Palliative
                  Drugs Used:
                  trabectedin
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328703
                  Quick Link(s):
                  Regimen Monograph

                  NIVL+RELA
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab and Relatlimab - Advanced Melanoma (Unresectable or Metastatic Melanoma)
                  Drugs Used:
                  nivolumab / relatlimab
                  nid:
                  328513
                  Quick Link(s):
                  Regimen Monograph

                  IRINRALT+ENCO+PNTM
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Raltitrexed - Metastatic Colorectal Small Bowel or Appendiceal Cancer Exceptional Access Program Encorafenib - In combination with panitumumab and chemotherapy for previously untreated metastatic colorectal cancer, according to specific criteria
                  Drugs Used:
                  PANitumumab , irinotecan , raltitrexed , encorafenib
                  nid:
                  328891
                  Quick Link(s):
                  Regimen Monograph

                  SACI
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Sacituzumab Govitecan - HR-positive HER2-negative Unresectable Locally Advanced or Metastatic Breast Cancer
                  Drugs Used:
                  sacituzumab govitecan
                  nid:
                  328017
                  Quick Link(s):
                  Regimen Monograph

                  NPAC(W)
                  Jul 2026
                  Cancer Type:
                  Genitourinary, Bladder Urothelial
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nab-Paclitaxel - Hypersensitivity Reactions to Taxanes
                  Drugs Used:
                  nab-PACLitaxel
                  nid:
                  326255
                  Quick Link(s):
                  Regimen Monograph

                  PEMB
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Adjuvant
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - Adjuvant Treatment for Non-Small Cell Lung Cancer
                  Drugs Used:
                  pembrolizumab
                  nid:
                  328424
                  Quick Link(s):
                  Regimen Monograph

                  XELOX+BEVA
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal, Small bowel and appendix
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Bevacizumab (Biosimilar) - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer ODB - General Benefit capecitabine
                  Drugs Used:
                  bevacizumab , oxaliplatin , capecitabine
                  nid:
                  326363
                  Quick Link(s):
                  Regimen Monograph

                  NIVL
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Intent:
                  Adjuvant
                  Funding Program:
                  New Drug Funding Program Nivolumab - Adjuvant Treatment for Completely Resected Stage III or IV Melanoma
                  Drugs Used:
                  nivolumab
                  nid:
                  327473
                  Quick Link(s):
                  Regimen Monograph

                  SUNI
                  Jul 2026
                  Cancer Type:
                  Sarcoma, GIST, Gastrointestinal, Gastrointestinal Stromal Tumours
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program SUNItinib - Unresectable or metastatic/recurrent Gastrointestinal Stromal Tumour, with specific criteria
                  Drugs Used:
                  SUNItinib
                  nid:
                  94223
                  Quick Link(s):
                  Regimen Monograph

                  SEVA
                  Jul 2026
                  Cancer Type:
                  Lung, Non-Small Cell
                  Intent:
                  Palliative
                  Drugs Used:
                  sevabertinib
                  QBP Type:
                  Unfunded This drug is not currently publicly funded for this regimen and intent
                  nid:
                  328872
                  Quick Link(s):
                  Regimen Monograph

                  PEMB
                  Jul 2026
                  Cancer Type:
                  Skin, Melanoma
                  Funding Program:
                  New Drug Funding Program Pembrolizumab - (Neo)adjuvant Treatment for Completely Resectable Stage III or IV Melanoma
                  Drugs Used:
                  pembrolizumab
                  nid:
                  328545
                  Quick Link(s):
                  Regimen Monograph

                  OLAP
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Ovary
                  Funding Program:
                  Exceptional Access Program olaparib - For the maintenance treatment of BRCA-mutated, high grade epithelial ovarian, fallopian tube, or primary peritoneal cancer in adult patients, based on criteria
                  Drugs Used:
                  olaparib
                  nid:
                  327529
                  Quick Link(s):
                  Regimen Monograph

                  TRIFTIPI
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program trifluridine / tipiracil - For the treatment of metastatic gastric cancer (mGC) or adenocarcinoma of the gastroesophageal junction (GEJ) in adult patients, according to specific criteria
                  Drugs Used:
                  trifluridine / tipiracil
                  nid:
                  327955
                  Quick Link(s):
                  Regimen Monograph

                  NPAC+PERT+TRAS
                  Jul 2026
                  Cancer Type:
                  Breast
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nab-Paclitaxel - Metastatic Breast Cancer
                  Drugs Used:
                  PERTuzumab , trastuzumab , nab-PACLitaxel
                  QBP Type:
                  Unfunded with exceptions Publicly funded under specific conditions, see PDRP (NDFP) eligibility forms
                  nid:
                  308212
                  Quick Link(s):
                  Regimen Monograph

                  NIVL(MNT)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Colorectal
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab plus Ipilimumab - MSI-H/dMMR Locally Advanced Unresectable or Metastatic Colorectal Cancer
                  Drugs Used:
                  nivolumab
                  nid:
                  328769
                  Quick Link(s):
                  Regimen Monograph

                  PNAT
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Myeloid (CML)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program ponatinib - For the treatment of Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia, according to specific criteria
                  Drugs Used:
                  ponatinib
                  nid:
                  325878
                  Quick Link(s):
                  Regimen Monograph

                  LENV
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Hepatobiliary Liver Bile Duct
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program lenvatinib - For the treatment of unresectable advanced hepatocellular carcinoma, according to specific criteria
                  Drugs Used:
                  lenvatinib
                  nid:
                  327767
                  Quick Link(s):
                  Regimen Monograph

                  LENV+PEMB
                  Jul 2026
                  Cancer Type:
                  Gynecologic, Endometrial
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program lenvatinib - In Combination with Pembrolizumab for Advanced Endometrial Cancer New Drug Funding Program Pembrolizumab - In Combination with Lenvatinib for Advanced Endometrial Cancer
                  Drugs Used:
                  lenvatinib , pembrolizumab
                  nid:
                  328098
                  Quick Link(s):
                  Regimen Monograph

                  NIVL
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Hodgkin
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Nivolumab - Relapsed Classical Hodgkin Lymphoma (cHL) Post-Autologous Stem Cell Transplant (ASCT) or ASCT Ineligible
                  Drugs Used:
                  nivolumab
                  nid:
                  326036
                  Quick Link(s):
                  Regimen Monograph

                  ZANU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Leukemia - Chronic Lymphocytic (CLL)
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program zanubrutinib - For the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) who have received at least one prior therapy; and for the treatment of adult patients with previously untreated CLL.
                  Drugs Used:
                  zanubrutinib
                  nid:
                  328456
                  Quick Link(s):
                  Regimen Monograph

                  ZOLE
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Anus, Colorectal, Esophagus, Hepatobiliary Liver Bile Duct, Pancreas, Small bowel and appendix, Gastric Stomach, Neuroendocrine (GI), Gastrointestinal Stromal Tumours, Sarcoma, GIST
                  Intent:
                  Palliative
                  Drugs Used:
                  zoledronic acid
                  nid:
                  327419
                  Quick Link(s):
                  Regimen Monograph

                  ZOLB(MNT)
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Zolbetuximab - First-line Treatment of Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
                  Drugs Used:
                  zolbetuximab
                  nid:
                  328645
                  Quick Link(s):
                  Regimen Monograph

                  XELOX+TRAS
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach, Esophagus
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Trastuzumab (Biosimilar) - Advanced Gastric, Gastroesophageal, or Esophageal Cancer ODB - General Benefit capecitabine
                  Drugs Used:
                  trastuzumab , oxaliplatin , capecitabine
                  nid:
                  327880
                  Quick Link(s):
                  Regimen Monograph

                  ZANU
                  Jul 2026
                  Cancer Type:
                  Hematologic, Lymphoma - Non-Hodgkin's Low Grade
                  Intent:
                  Palliative
                  Funding Program:
                  Exceptional Access Program zanubrutinib - For the treatment of relapsed or refractory Waldenström Macroglobulinemia, according to specific criteria
                  Drugs Used:
                  zanubrutinib
                  nid:
                  327996
                  Quick Link(s):
                  Regimen Monograph

                  XELOX+PEMB+TRAS
                  Jul 2026
                  Cancer Type:
                  Gastrointestinal, Gastric Stomach
                  Intent:
                  Palliative
                  Funding Program:
                  New Drug Funding Program Pembrolizumab and Trastuzumab (Biosimilar) - First-line Treatment of Advanced HER2-Positive Gastric or Esophagogastric Junction Adenocarcinoma ODB - General Benefit capecitabine
                  Drugs Used:
                  pembrolizumab , trastuzumab , oxaliplatin , capecitabine
                  nid:
                  328474
                  Quick Link(s):
                  Regimen Monograph

                  ZOLE(HYPER CA)
                  Jul 2026
                  Cancer Type:
                  Breast, Central Nervous System, Endocrine, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Hematologic, Lung, Skin, Sarcoma, Unknown Primary
                  Drugs Used:
                  zoledronic acid
                  nid:
                  325939
                  Quick Link(s):
                  Regimen Monograph

                  No results found

                  We were unable to find a match. Please reset the filters or search again.
                  / 152

                  What's New - Drugs

                  All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

                  Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.

                  Suggested Pages
                    Suggested Searches

                      Filters

                      Filters

                      Cancer Type

                      Breast
                      Genitourinary
                      Prostate
                      Bladder Urothelial
                      Endocrine
                      Adrenal
                      Thymoma
                      Thyroid
                      Hematologic
                      Myeloproliferative Neoplasms (MPNs)
                      Leukemia - Chronic Lymphocytic (CLL)
                      Lymphoma - Non-Hodgkin's Low Grade
                      Lymphoma - Non-Hodgkin's High Grade
                      Lymphoma - Non-Hodgkin's Intermediate Grade
                      Multiple Myeloma
                      Lymphoma - Hodgkin
                      Lymphoma - T-cell
                      Leukemia - Acute Lymphoblastic (ALL)
                      Rare Diseases
                      Amyloidosis
                      Sarcoma
                      Ewing's
                      Soft Tissue
                      Wilm's Tumour
                      Gynecologic
                      Gestational Trophoblastic Disease
                      Cervix
                      Endometrial
                      Ovary
                      Lung
                      Small Cell
                      Gastrointestinal
                      Colorectal
                      Gastric Stomach
                      Esophagus
                      Hepatobiliary Liver Bile Duct
                      Pancreas
                      Neuroendocrine (GI)
                      Head and Neck

                      nid

                      3
                      36
                      172
                      215
                      152
                      Showing 4 of 4 results
                      drug

                      cyclophosphamide
                      NEW Jul 2026
                      Trade Name:
                      Procytox®
                      Cancer Type:
                      Breast, Sarcoma, Ewing's, Soft Tissue, Gynecologic, Gestational Trophoblastic Disease, Hematologic, Leukemia - Chronic Lymphocytic (CLL), Lung, Thymoma, Lymphoma - Non-Hodgkin's Low Grade, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Multiple Myeloma, Lymphoma - Hodgkin, Small Cell, Gastrointestinal, Colorectal, Cervix, Endometrial, Ovary, Gastric Stomach, Esophagus, Hepatobiliary Liver Bile Duct, Pancreas, Genitourinary, Prostate, Bladder Urothelial, Endocrine, Adrenal, Lymphoma - T-cell, Head and Neck, Leukemia - Acute Lymphoblastic (ALL), Wilm's Tumour, Neuroendocrine (GI), Rare Diseases, Amyloidosis
                      nid:
                      36
                      Quick Link(s):
                      Drug Monograph ,  Patient Info Sheet

                      No results found

                      We were unable to find a match. Please reset the filters or search again.
                      / 1

                      What's New - Regimens

                      All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

                      Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.

                      Suggested Pages
                        Suggested Searches

                          Filters

                          Filters

                          Sort By

                          Cancer Type

                          Breast
                          Hematologic
                          Myeloproliferative Neoplasms (MPNs)
                          Lymphoma - Hodgkin
                          Lymphoma - Non-Hodgkin's Low Grade
                          Lymphoma - Non-Hodgkin's High Grade
                          Lymphoma - Non-Hodgkin's Intermediate Grade
                          Head and Neck
                          Gastrointestinal
                          Pancreas
                          Colorectal
                          Small bowel and appendix
                          Unknown Primary
                          Genitourinary
                          Testis

                          nid

                          94633
                          274264
                          325965
                          327417
                          94289
                          94081
                          94607
                          307006
                          326257
                          328446
                          326258
                          Showing 10 of 11 results

                          ANGR
                          NEW Jul 2026
                          Cancer Type:
                          Hematologic, Myeloproliferative Neoplasms (MPNs)
                          Intent:
                          Palliative
                          Funding Program:
                          ODB Limited Use anagrelide
                          Drugs Used:
                          anagrelide
                          nid:
                          325965
                          Quick Link(s):
                          Regimen Monograph

                          CAPE
                          NEW Jul 2026
                          Cancer Type:
                          Head and Neck
                          Intent:
                          Palliative
                          Funding Program:
                          ODB - General Benefit capecitabine
                          Drugs Used:
                          capecitabine
                          nid:
                          326258
                          Quick Link(s):
                          Regimen Monograph

                          CAPE
                          NEW Jul 2026
                          Cancer Type:
                          Gastrointestinal, Pancreas
                          Intent:
                          Palliative
                          Funding Program:
                          ODB - General Benefit capecitabine
                          Drugs Used:
                          capecitabine
                          nid:
                          307006
                          Quick Link(s):
                          Regimen Monograph

                          CAPE
                          NEW Jul 2026
                          Cancer Type:
                          Unknown Primary
                          Intent:
                          Palliative
                          Funding Program:
                          ODB - General Benefit capecitabine
                          Drugs Used:
                          capecitabine
                          nid:
                          326257
                          Quick Link(s):
                          Regimen Monograph

                          CAPE
                          NEW Jul 2026
                          Cancer Type:
                          Gastrointestinal, Colorectal, Small bowel and appendix
                          Funding Program:
                          ODB - General Benefit capecitabine
                          Drugs Used:
                          capecitabine
                          nid:
                          94289
                          Quick Link(s):
                          Regimen Monograph

                          GLOF; GLOF(RAMP)
                          NEW Jul 2026
                          Cancer Type:
                          Hematologic, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade
                          Intent:
                          Palliative
                          Funding Program:
                          New Drug Funding Program Glofitamab (Outpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma High Cost Therapy Funding Program Glofitamab (Inpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma
                          Drugs Used:
                          oBINutuzumab , glofitamab
                          nid:
                          328446
                          Quick Link(s):
                          Regimen Monograph

                          No results found

                          We were unable to find a match. Please reset the filters or search again.
                          / 2

                          Last Updated: July 21, 2026

                          The information on this website is intended for informational purposes only and is not a substitute for medical advice. Always consult your health care provider if you have questions or concerns. The use of the information on this website does not create a physician-patient relationship between Ontario Health and you.
                          Ontario Health is committed to ensuring accessible services and communications to individuals with disabilities. To receive any information on this website in an alternate format, please contact Ontario Health’s Communications Department at: 1-877-280-8538,TTY 1-800-855-0511, or by email at info@ontariohealth.ca.

                          The province of Ontario Logo
                          © Ontario Health 2025